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Dissertation Abstract 
Over the last decade, microRNAs (miRNAs) have earned a lot of attention 
due to their critical roles in several biological processes and human 
diseases. However, progress in this field has been limited by the difficulty of 
discovering miRNA target genes, as each miRNA can potentially bind to 
hundreds of different mRNAs. Therefore, the main focus of this thesis was 
to develop an integrated framework that could be used to discover novel 
genes and pathways regulated by a given miRNA. We applied this 
framework to study the miR-200 family, which was previously shown to be 
involved in embryonic development and tumor metastasis but only a few 
target genes were known. 
In Chapter 1, miRNA biogenesis and action mechanism are described. 
miRNA target prediction tools, both computational and experimental, are 
also reviewed. Also, a basic overview of the epithelial to mesenchymal 
transition (EMT) and TGF-β signaling is given as both are regulated by 
miR-200. We also provide an overview of the miR-200 family and a detailed 
list of published miR-200 target genes.  
In Chapter 2, we describe the framework we developed to discover novel 
miR-200c-regulated genes and cellular pathways. We found 520 putative 
miR-200c-regulated mRNAs in mouse, most of which were novel targets 
not described before, as in the beginning of this project only a dozen of 
miR-200 targets were known. Accordingly, these putative target mRNAs 
were highly enriched for miR-200c seed pairing and most were down-
regulated by miR-200c over-expression. We also show that this framework 
has a low false-positive discovery rate. Additionally, results show that miR-
200c mainly regulates 13 cellular pathways. The pathways most 
significantly regulated are the epidermal growth factor receptor (EGFR) and 
the mitogen-activated protein kinase (MAPK) signaling pathways. 
x 
Moreover, we show that miR-200c regulates the transforming growth factor-
beta (TGF-β) signaling pathway, among other pathways. Accordingly, we 
experimentally showed that miR-200c counteracts the suppressive effects 
of TGF-β and bone morphogenetic protein-2 (BMP-2) on epithelial gene 
expression. Additionally, we showed that miR-200c regulates the 3’-
untranslated regions (3’UTRs) of 12 (Crtap, Fhod1, Smad2, Map3k1, Tob1, 
Ywhag/14-3-3γ, Ywhab/14-3-3β, Smad5, Zfp36, Xbp1, Mapk12, Snail1) of 
14 putative miR-200c-binding mRNAs tested. These 12 genes were 
experimentally validated as miR-200c targets by identifying their 3’UTR 
miR-200c recognition elements. We also experimentally showed that for 
these 12 genes the extent of mRNA binding to miR-200c strongly 
correlated with gene suppression.  
Smad2 and Smad5 form a complex with Zeb2 and Ywhab/14-3-3β and 
Ywhag/14-3-3γ form a complex with Snail1. These complexes that repress 
transcription assemble on epithelial gene promoters. We showed that miR-
200c over-expression increases RNA polymerase II binding to epithelial 
gene promoters, while reducing binding of Zeb2 and Snail1 complexes to 
these promoters. Expression of miR-200c-resistant Smad5 modestly, but 
significantly, reduced epithelial gene induction by miR-200c.  
miR-200 expression or Zeb2 knockdown are known to inhibit cell invasion 
in in vitro assays. Knockdown of each of 3 novel miR-200 target genes 
identified here, Smad5, Ywhag and Crtap, also profoundly suppressed cell 
invasion. Thus miR-200 suppresses TGF-β/BMP signaling, promotes 
epithelial gene expression and suppresses cell invasion by regulating a 
network of genes. 
In Chapter 3, main conclusions and inherent limitations are discussed and 
future work is outlined. 
xi 
In summary, this thesis provides a framework that can be used to identify 
novel genome-wide targets and miRNA-regulated pathways of other 
miRNAs to better understand their biological role. Importantly, this thesis 
substantially contributes to both the miR-200 and EMT fields by providing a 
global list of novel miR-200c-regulated targets and cellular pathways and 
revealing how miR-200 orchestrates EMT. 
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Resumo da Dissertação 
Durante a última década os microRNAs (miRNAs) têm recebido muita 
atenção devido ao seu relevante papel em vários processos biológicos e 
em várias doenças humanas. Contudo, o progresso nesta área do 
conhecimento tem sido limitado pela grande dificuldade em descobrir os 
genes que são regulados por cada miRNA, já que cada miRNA pode 
potencialmente ligar-se a centenas de mRNAs diferentes. Por isso, o 
principal objectivo desta tese consistiu em desenvolver um framework 
integrado que pudesse ser usado para descobrir os genes e vias de 
sinalização que são regulados por um dado miRNA. Este framework foi 
aplicado ao estudo da família miR-200, a qual já se sabia que participava 
no desenvolvimento embrionário e na formação de metástases, mas para a 
qual apenas alguns mRNAs alvo eram conhecidos. 
No Capítulo 1, a biogénese dos miRNAs e o seu mecanismo de acção são 
abordados. As ferramentas computacionais e experimentais que existem 
para descobrir que genes são regulados pelos miRNAs são também 
descritas. Além disso, a transição epitelial-mesenquimal (EMT) e a via de 
sinalização TGF-β são também revistos pois ambos estes processos são 
regulados pela família miR-200. Também é feita uma revisão da família 
miR-200, incluindo uma lista detalhada dos genes que foram publicados 
como sendo regulados por esta família. 
No Capítulo 2, o framework que desenvolvemos para descobrir novos 
genes e vias de sinalização celular regulados pelo miR-200c é descrito. 
Descobrímos que este miRNA potencialmente regula 520 mRNAs em 
ratinho. Para a maioria destes mRNAs não se sabia que eram regulados 
pelo miR-200c, já que no início deste projecto somente uma dezena de 
genes eram conhecidos como sendo regulados por este miRNA. Como 
esperado, estes mRNAs possuem um grande número de sequências 
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complementares à sequência do miR-200c e para a grande maioria deles a 
sua expressão é negativamente regulada pelo miR-200c. Além disso, 
mostrámos que este framework permite descobrir novos mRNAs regulados 
pelo miR-200c com um reduzido número de falsos positivos. Os nossos 
resultados mostram que o miR-200c principalmente regula 13 vias de 
sinalização celular. As duas vias de sinalização mais significativamente 
reguladas pelo miR-200c são a do receptor do factor de crescimento 
epidérmico (EGFR) e a da MAP cinase (MAPK). Adicionalmente, os 
resultados mostram que o miR-200c também regula a via de sinalização do 
factor beta de transformação do crescimento (TGF-β), entre outras vias. De 
acordo com estes resultados, mostrámos experimentalmente que o miR-
200c contraria o efeito suppressor que o TGF-β e a 
proteína morfogenética do osso tipo 2 (BMP-2) têm na expressão de genes 
epiteliais. Adicionalmente, mostrámos que o miR-200c regula a região não 
traduzida da extremidade 3’ (3’UTR) de 12 (Crtap, Fhod1, Smad2, Map3k1, 
Tob1, Ywhag/14-3-3γ, Ywhab/14-3-3β, Smad5, Zfp36, Xbp1, Mapk12, 
Snail1) de 14 mRNAs que foram escolhidos para serem validados como 
sendo regulados pelo miR-200c. Esta validação foi feita através da 
identificação precisa dos elementos que são reconhecidos pelo miR-200c 
no 3’UTR de cada um destes 12 mRNAs. Também mostrámos 
experimentalmente que o grau de interacção entre cada um destes 12 
mRNAs e o miR-200c está fortemente correlacionado com o grau que cada 
um dos mRNAs é reprimido.  
As proteínas Smad2 e Smad5 formam um complexo com a proteína Zeb2, 
e por sua vez as proteínas Ywhab/14-3-3β e Ywhag/14-3-3γ formam um 
complexo com a proteína Snail1. Estes dois complexos ligam-se aos 
promotores de genes epiteliais e reprimem a sua transcrição. Nós 
mostrámos que a sobre-expressão de miR-200c induz a ligação da RNA 
polimerase II aos promotores de genes epiteliais enquanto que reduz a 
ligação dos complexos Zeb2 e Snail1 a estes mesmos promotores. 
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Mostrámos também que a expressão de uma versão sintética do mRNA 
Smad5 que é resistente ao miR-200c reduziu significativamente, ainda que 
modestamente, a indução de genes epiteliais que se verifica quando o 
miR-200c é sobre-expressado.  
É sabido que a expressão da família miR-200 ou a supressão de Zeb2 
inibem a invasão celular em ensaios in vitro. Supressão de cada um dos 
três mRNAs que nós indentificámos como sendo regulados pelo miR-200c, 
Smad5, Ywhag and Crtap, também inibiram fortemente a invasão celular. 
Em conclusão, mostrámos experimentalmente que a família miR-200 
suprime a via de sinalização do TGF-β/BMP, promove a expressão de 
genes epiteliais e inibe a invasão celular através da regulação de uma rede 
de genes.  
No Capítulo 3, são discutidas as conclusões principais e as suas 
limitações assim como possíveis futuras linhas de investigação. 
Sumarizando, nesta tese foi desenvolvido um framework que pode ser 
usado para descobrir novos genes e vias de sinalização regulados por 
outros miRNAs para melhor entender o seu papel biológico. É importante 
referir que esta tese também contribui substancialmente para o estudo da 
família miR-200 e da EMT pois descobriu-se novos genes e vias de 
sinalização que são globalmente regulados pelo miR-200c e que são 
usados por este para regular a EMT. 
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microRNAs (miRNAs) are short (~22-nucleotide (nt)-long), noncoding 
single-stranded RNA molecules that regulate gene expression by binding to 
partially complementary sequences in target mRNAs to induce mRNA 
decay, translational repression or both1. Each miRNA can potentially bind 
to hundreds of mRNAs, sometimes having a strong effect but more often 
having a weak fine-tuning effect. miRNAs participate in a variety of 
biological processes such as development, differentiation, proliferation, 
antiviral defense, metabolism and cellular stress signaling1-2. At least 60% 
of human protein-coding genes are regulated by miRNAs (mostly 
downregulated). Dysregulation of miRNA expression levels has been 
associated with several pathologies such as cancer, neurodevelopmental, 
autoimmune, liver, muscle, skin and cardiovascular diseases3-4. Also, 
mutations in miRNA genes have been shown to cause genetic diseases 
such as nonsyndromic autosomal dominant progressive hearing loss which 
is induced by point mutations in the seed sequence of miR-96. Likewise, 
mutations in miR-196a-2 elevate the risk of developing lung, breast, liver 
and gastric cancer. 
1.2. Biogenesis and action mechanism 
miRNAs are first transcribed from the genome by RNA polymerase II into 
capped and polyadenylated primary miRNA (pri-miRNA) transcripts5 
(Figure 1).  
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Figure 1. Mechanisms that regulate miRNA biogenesis and RISC loading. (A) Biogenesis of 
a miRNA is a stepwise process involving (i) transcription of a primary transcript (pri-miRNA), 
(ii) processing (“cropping”) by the Drosha/DGCR8 microprocessor complex to produce a 
pre-miRNA, (iii) export from the nucleus into the cytoplasm, mediated by the exportin XPO5 
and the guanosine 5′-triphosphate (GTP)–binding protein Ran, and (iv) additional processing 
(“dicing”) by a complex containing the RNase Dicer, a catalytic component, Argonaute 
(Ago), and the RNA-binding protein TRBP (transactivation response RNA binding protein) to 
produce the mature miRNA. The resulting complex of Ago and the mature, single-stranded 
miRNA is called the RISC. The miRNA binds complementary sequences in mRNAs; Ago 
either inhibits the translation of the mRNA or cleaves it to cause its degradation. Figure and 
legend reproduced from Hata A, Lieberman J. Sci Signal 20156.  
Intragenic miRNAs (located within introns, exons or untranslated regions 
(UTRs) of protein-coding transcripts) are transcribed with their host genes 
through shared common promoters7. Alternatively, intergenic miRNAs are 
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transcribed from individual, non-protein coding genes which have their own 
promoters8. 
These pri-miRNA transcripts contain one or more stem-loop structures 
(also called hairpin structures) in which miRNAs are embedded2. Still in the 
nucleus, these stem-loop structures are recognized by the double-stranded 
RNA-binding protein DGCR8 (DiGeorge syndrome critical region 8), also 
known as Pasha in invertebrates. DGCR8 associates with Drosha, a 
ribonuclease (RNase) III family enzyme, and together they form the 
microprocessor complex. Drosha then cleaves the pri-miRNA into a 
precursor miRNA (pre-miRNA). The pre-miRNA (~70-nt long), is then 
transported to the cytoplasm by a nuclear complex formed by Exportin-5 
together with the guanosine 5′-triphosphate (GTP)–binding protein Ran. 
Once in the cytoplasm, the pre-miRNA is cleaved by Dicer (another RNase 
III enzyme) together with the RNA-binding protein TRBP (transactivation-
response RNA-binding protein) to generate an RNA duplex. This duplex 
consists of the mature miRNA (depicted in red in Figure 1), and the miRNA 
star (miRNA*, RNA strand partially complementary to the mature miRNA). 
While the mature miRNA is loaded into an Argonaute (Ago) protein, the 
miRNA* is usually released and degraded. Ago proteins also bind to 
members of the GW182 protein family (in humans there are three GW182 
paralogs known as TNRC6A-C) and this complex bound to a miRNA forms 
the miRNA-induced silencing complex (miRISC)6. Ago proteins are the core 
components of the miRISC complex as they bind to the miRNA and 
mediate recognition of its target mRNAs. 
In addition to this canonical miRNA biogenesis pathway some alternative 
pathways have been discovered. Some miRNAs are generated by Drosha- 
or Dicer independent mechanisms, such as mirtrons (through the splicing of 
miRNA-containing introns) and miRNAs originated from small-nucleolar 
RNAs (snoRNAs) and transfer RNAs (tRNAs)9. 
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The mature miRNA then guides the miRISC complex to partially 
complementary sequences in target mRNAs (mostly in 3’UTRs) termed 
miRNA-recognition elements (MREs). Base pairing between miRNAs and 
their target mRNAs is most critical within the miRNA seed region 
(nucleotides 2-8), but additional base pairing beyond this region also 
occurs. If base pairing between a miRNA and its target mRNA is extensive 
(within and outside the seed region) then the target mRNA is cleaved 
through Ago-catalyzed mRNA cleavage10-11. This type of repression is 
dominant in plants12, but in animals the majority of targets lack the 
extensive base pairing required for Ago-mediated cleavage13 (in animals  
this infrequent Ago-mediated mRNA cleavage is catalyzed by AGO2, the 
most abundant of the four Ago family members14). In animals miRISC 
complexes more frequently silence mRNAs through a combination of 
mRNA translational repression and mRNA degradation, with the latter 
contributing to most of the repression (66-90%)15. The precise molecular 
mechanism of miRISC-induced translational repression is still not 
completely understood, but the current model is that miRISC induces 
mRNA translational repression by interfering with the activity and/or 
assembly of the eukaryotic translation initiation factor 4F (eIF4F) complex 
that is required for cap-dependent mRNA translation. The eIF4F complex 
consists of the cap-binding protein eIF4E, the adaptor protein eIF4G and 
the DEAD (Asp-Glu-Ala-Asp) box RNA helicase eIF4A16. Alternatively or in 
combination with this process of mRNA translational repression, miRISC 
can induce mRNA target degradation. Target mRNA degradation is 
achieved through recruitment of GW182 proteins by miRNA-loaded Ago 
proteins. GW182 proteins in turn interact with the cytoplasmic poly(A)-
binding protein (PABPC) and with the cytoplasmic deadenylase complexes 
PAN2-PAN3 and CCR4-NOT, which catalyze the deadenylation of target 
mRNAs. Deadenylated mRNAs are then decapped and rapidly degraded 
by the 5’-to-3’ exoribonuclease 1 (XRN1).   
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1.3. Computational prediction of miRNA targets 
It is now established that miRNAs have a critical role in virtually all 
biological processes and that at least 60% of all genes are regulated by 
miRNAs4. Therefore, it is extremely important to predict the biologically 
relevant miRNA–mRNA interactions in any given biological context. For this 
end, several computational prediction tools have been developed. 
Computational methods exploit miRNA-targeting features to provide a 
genome-wide prediction of miRNA targets. In animals, as opposed to 
plants, miRNAs pair imperfectly to almost all target mRNAs and therefore 
computational prediction of miRNA targets is more complex. Commonly 
used computational methods (Table 1) place variable weight on base 
pairing between the miRNA-seed region and target mRNA17, evolutionary 
conservation of the MRE4,18, thermodynamic stability of the miRNA/mRNA 
heteroduplex19 and mRNA sequence features outside the MRE20. 
Computational miRNA-target prediction methods are valuable for the 
preliminary identification of miRNA targets but there are inherent limitations 
to consider when applying them to discover new miRNA targets. The main 
limitation is their high false-positive rates, as even the best algorithms such 
as TargetScan typically predict thousands of target genes for any given 
miRNA. The false-positive rates of target prediction tools such as 
TargetScan, PicTar and miRanda are between 22 and 31%21. These high 
false-positive rates are mainly due to the fact that computational target-
prediction tools use sequence determinants to predict miRNA targets. 
However, it has been shown that sequence features alone cannot provide 
accurate prediction of miRNA targets as experimental analyses of Ago-
bound miRNA-mRNA heteroduplexes suggest that 25%–45% of MREs lack 
a perfect seed match22-23 and a growing number of experimentally-validated 
MREs lack a canonical seed24-27. Also, most computational tools limit target 
prediction to the mRNA 3′UTR even though there is experimental evidence 
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suggesting that as many as 25% of functional MREs are in mRNA coding 
regions23.  
Table 1. Characteristic features of algorithms providing information beyond classical miRNA 
target gene interaction. Table reproduced from Tarang S, Weston MD RNA Biology 201428. 
Prediction 
method Characteristic features Resource 
Diana Micro-T Target prediction made with miRNA or mRNA sequences as input 
diana.cslab.ece.ntua.gr/ 
microT/ 
FAME Experimentally verified miRNA pathways infer biological process affected by miRNAs 
acgt.cs.tau.ac.il/ 
fame/ 
Hoctar Information on host genes regulating expression of its embedded microRNA hoctar.tigem.it 




miRNA target prediction based on hybridization energies and 
secondary structures for the miRNA-mRNA hybrid where 
parameters can be modified by the user 
mami.med.harvard.edu 
Microinspector 
Identification of potential miRNA binding sites in user-
submitted sequences, searching against databases of known 
miRNA binding sites 
bioinfo.uni-plovdiv.bg/ 
microinspector/ 
miR2disease Information on miRNA association to a disease process www.mir2disease.org 
miRBase Complete repository of miRNA sequences and targets www.mirbase.org 




Two main modules, experimentally validated targets, and 




miRGator Integrates miRNA expression data with mRNA and protein to interpret the biological functions of miRNAs 
genome.ewha.ac.kr/ 
miRGator/miRGator.html 
miRNAmap Information on statistics of miRNA sequences and target genes mirnamap.mbc.nctu.edu.tw 
MirPath Identification of altered molecular pathways by the expression of specific miRNAs 
83.212.96.7/DianaTools 
New/index.php?r=mirpath 




Information on experimentally verified miRNA targets by data 
mining and manually surveying pertinent literature related to 
functional studies on miRNAs 
mirtarbase.mbc.nctu.edu.tw 
miRWalk 
miRNA-target information on the complete sequence 
(promoter, 5′-UTR, CDS, and 3′-UTR) and target interaction 
information across eight other types of prediction software; 




Patrocles Polymorphisms on miRNA sequences and target genes www.patrocles.org 
PITA Secondary structure of the miRNA-mRNA hybrid for target gene prediction 
genie.weizmann.ac.il/ 
pubs/mir07/index.html 
Tarbase Experimentally validated miRNA targets diana.cslab.ece.ntua.gr/ tarbase/ 
Targetscan Classical software for miRNA target gene prediction www.targetscan.org 
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Also, computational analyses need to take into account cell-specific mRNA 
isoforms. In biological processes such as proliferation29, differentiation30 
and cancer31 some mRNAs are alternatively polyadenylated and generate 
transcripts with unique 3′UTRs, which may have different MREs. Therefore, 
high-throughput mRNA sequencing of the biological system of interest 
combined with computational prediction of miRNA targets can more 
accurately identify functional MREs32. 
1.3.2. Experimental identification of miRNA targets 
Experimental identification and validation of miRNA targets is critical to 
identify miRNA biological functions accurately. This is the most challenging 
and important issue in this field as miRNA functions are determined by their 
target genes. During the past decade several strategies were developed to 
improve experimental miRNA target identification but still relatively few 
targets have been thoroughly experimentally validated. One of the reasons 
is that miRNA targeting is often context-, time-, or tissue-dependent and 
therefore some mRNAs might only be targeted in some contexts even 
though they have extensive sequence complementarity with a given 
miRNA. Some experimental approaches used to identify miRNA targets will 
be briefly described below (Figure 2). 
1.3.2.1. Reporter assays 
One common approach to test if a given mRNA can be targeted by a 
specific miRNA is to use a dual-luciferase reporter assay33. In this method, 
a putative mRNA target sequence (e.g. full or partial 3’UTR) is inserted 
downstream of the luciferase coding sequence before the polyadenylation 
signal. In order to normalize the luciferase luminescence level, two 
luciferase genes with different light-emission wavelengths are usually used, 
a constitutively-expressed Firefly luciferase and a Renilla luciferase 
containing the putative target sequence. The ratio of Renilla to firefly-
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luciferase activity level is used to determine the extent of miRNA target 
repression after cells are transfected with both luciferase reporter genes 
together with the miRNA of interest.  
 
 
Figure 2. Methods for identifying miRNA targets. Putative target genes can be identified by 
expression profiling of cells in which the miRNA is overexpressed or antagonized, by 
biochemical isolation of the miRISC or by target prediction algorithms. These methods 
generally identify hundreds of candidate genes or more. Bioinformatic analysis of these 
large candidate gene lists for over-represented Gene Ontology (GO) terms, enriched 
biological pathways or gene interaction networks can then help researchers to select 
candidate genes to evaluate experimentally. Figure and legend reproduced from Thomas M, 
Lieberman J, Lal A. Nat Struct Mol Biol 20101. 
As a negative control, similar constructs in which the putative MRE was 
mutated can be used. Even though a dual-luciferase reporter assay should 
always be used to confirm direct miRNA targeting and identify functional 
MREs it does not definitely show that a given mRNA is targeted by a 
specific miRNA in vivo, as the supraphysiological miRNA concentrations 
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used and the inherent limitations of reporter assays might result in artifacts. 
Also, this method is low-throughput, expensive and labor intensive and 
therefore not appropriate to identify miRNA targets globally.  
1.3.2.2. mRNA and protein expression profiling 
One common approach to identify genome-wide miRNA targets is to 
measure global mRNA/protein levels after overexpressing or inhibiting a 
given miRNA, as its targets’ mRNA/protein often change (Figure 2). 
However, measuring global mRNA/protein levels after manipulating a given 
miRNA doesn’t allow to distinguish between direct and indirect targets as 
changes at the mRNA or protein level may be due to downstream effects 
instead of direct miRNA targeting.  
Global mRNA levels can be measured by microarray or more recent high-
throughput mRNA sequencing. To measure global miRNA effects at the 
protein level, proteins can be labeled using a stable isotope (stable-isotope 
labeling with amino acids in cell culture, SILAC) followed by mass 
spectrometric analysis34. However, this approach is time-consuming, 
expensive and only a fraction of the proteome can be resolved at a time. 
Therefore, microarray analysis is often used instead, as mRNA and protein 
levels are in most cases correlated. 
There are several approaches to manipulate intracellular miRNA 
concentration. miRNAs can be overexpressed by transfecting cells with 
synthetic miRNA duplexes that contain the miRNA of interest. Once the 
synthetic miRNA duplex is assembled into the miRISC it behaves as the 
endogenous miRNA. Alternatively, miRNAs can be antagonized for loss-of-
function studies using several strategies. First, for permanent and complete 
miRNA knockdown, transcription activator-like effector nucleases (TALENs) 
or CRISPR/Cas9 (clustered regularly interspaced short palindromic repeat/ 
CRISPR associated protein 9) technology can be used to specifically edit 
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miRNA genes and totally abrogate miRNA expression35. Second, 
antagomirs, which are chemically modified single-stranded RNA 
oligonucleotides complementary to target miRNAs, are able to bind and 
prevent miRNAs from interacting with their targets, thereby upregulating 
their mRNA levels36-37. In addition to sequester miRNAs, antagomirs can 
instead bind to a specific target mRNA sequence and prevent miRNAs from 
binding to it, which also upregulates target mRNA levels38. Lastly, miRNAs 
can be inhibited by using miRNA sponges. miRNA sponges are transcripts 
that contain multiple, tandem binding sites complementary to a miRNA of 
interest39. When plasmid vectors encoding miRNA sponges are transfected 
into cells, sponges can derepress miRNA target mRNAs, in some cases as 
strongly as antagomirs. It is important to keep in mind that all these miRNA 
manipulations have their caveats. Transfecting excessive amounts of 
synthetic miRNA duplexes can be toxic to cells or may introduce off-target 
effects40-41. Also, miRNA overexpression above physiological levels may 
lead to artifacts, as excess miRNA can saturate all available miRISC in the 
cell and affect the endogenous miRNA pathway40. On the other hand, 
inhibition of a highly expressed miRNA might be difficult to achieve with 
antagomirs and miRNA sponges, and might only be achieved with more 
laborious knockout technology. Also, inhibition of a poorly expressed 
miRNA might not have a detectable effect on its target genes. 
1.3.2.3. Immunoprecipitation of miRISC components 
Because of the direct interaction between Ago proteins, miRNAs and their 
target mRNAs in the miRISC complex, direct targets can be identified by 
immunoprecipitating individual miRISC components42-43, such as Ago or 
Tnrc6 protein-family cofactors44, followed by identification of the pulled-
down mRNAs by microarray or high-throughput RNA sequencing. For these 
studies the miRNA of interest is usually overexpressed to saturate all 
available miRISC and isolate specific miRNA targets. While some studies 
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perform immunoprecipitation (IP) of endogenous miRISC components42 
others overexpress epitope-tagged miRISC components inside cells before 
immunoprecipitating43,45-47. All these studies have high false-positive rates 
(~40-70%23) for several reasons. First, target mRNAs identified by 
immunoprecipitating a specific Ago family member might not be identical to 
those bound by other Ago family members48 (in humans there are four Ago-
family members (Ago1-4)49). Second, endogenous and epitope-tagged Ago 
proteins bind to transfer RNAs50 and overexpression of Ago proteins has 
been shown to increase global miRNA production,51-52 which might result in 
artifacts. Additionally, as Ago proteins can still bind to mRNAs in vitro in cell 
extracts after cell lysis46 some of the mRNAs isolated through an Ago IP 
might not be targets in vivo. Moreover, Ago IPs only allow identification of 
putative target mRNAs without providing any information on the precise 
location of functional MREs in those mRNAs. Also, Ago IPs are usually not 
completely specific for the miRNA of interest, even after overexpression of 
the miRNA, as there are always other endogenous miRNAs still bound to 
miRISC complexes that may skew results. Finally, Ago IPs require miRNAs 
to be strongly bound to their target mRNAs and therefore this assay has 
low sensitivity for weak or transient miRNA/mRNA interactions.  
To overcome these limitations a recently-developed technique called Ago 
HITS-CLIP (high-throughput sequencing by crosslinking and 
immunoprecipitation) can be used instead to identify functional MREs22-23. 
In this technique, short-wavelength (254 nm) UV light is firstly used to 
crosslink miRISC proteins to any bound RNA. RNA is then isolated by 
immunoprecipitating one of the miRISC components. RNA in the 
immunoprecipitate undergoes partial digestion to remove RNA that is not 
miRISC-protected. Then RNA fragments that are crosslinked to the miRISC 
go through high-throughput RNA sequencing to identify both Ago-
associated miRNAs and their target MREs. This method identifies direct 
miRNA targets with low false-positive rates (~13–27%23). However, the use 
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of short-wavelength UV light has low crosslinking efficiency, can produce 
non-specific crosslinks and may photo-damage RNAs.  
A new approach called PAR-CLIP (photoactivatable-ribonucleoside-
enhanced crosslinking and immunoprecipitation) has been developed to 
overcome the limitations of previous CLIP methods53. In this technique 
(Figure 3), a photoreactive ribonucleoside analog (such as 4-thiouridine 
(4SU), which can substitute for uridine during transcription) is supplied to 
cells and incorporated into nascent transcripts. This modified nucleoside 
facilitates crosslinking by UV radiation at 365 nm and increases RNA yields 
compared to the conventional short-wavelength (254 nm) UV light 
crosslinking without 4-thiouridine53. The 4SU nucleoside analog allows 
precise identification of functional MREs as 4SU preferentially binds to 
guanine instead of adenine during the cDNA generation step. This results 
in thymine to cytosine (T-to-C) mutations after the PCR-amplification step 
(Figure 3). These T-to-C mutations will be detected during sequencing by 
comparing the sequencing reads to a reference genome. These T-to-C 
mutations are then used to identify which mRNA sequences (MREs) were 
bound by Ago in vivo. 
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Figure 3. Illustration of PAR-CLIP. 4SU-labeled transcripts were crosslinked to RBPs and 
partially RNase-digested RNA-protein complexes were immunopurified and size-
fractionated. RNA molecules were recovered and converted into a cDNA library and deep 
sequenced. Figure and legend reproduced from Hafner M, Landthaler M, Burger L, Khorshid 
M, Hausser J, Berninger P et al. Cell 201053. 
Recently, a modified CLIP method, iCLIP (individual-nucleotide resolution 
CLIP), was introduced to increase resolution of MRE identification54 (Figure 
4). This method does not use photo-reactive nucleosides and their 
associated T-to-C mutations to determine miRNA binding sites. Instead, it 
takes advantage of the fact that some cDNAs are truncated at the UV 
cross-linking site as Proteinase K digestion leaves a covalently bound 
polypeptide fragment on the RNA that causes premature truncation of the 
reverse transcription reaction at the cross-link site. Therefore, cDNA 
circularization is used to reveal the exact nucleotide at the crosslinking site 
via high-throughput sequencing. 
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Figure 4. Schematic representation of the iCLIP protocol. After UV irradiation, the covalently 
linked RNA is co-immunoprecipitated with the RNA-binding protein (RBP) and ligated to an 
RNA adapter at the 3′ end. Proteinase K digestion leaves a covalently bound polypeptide 
fragment on the RNA that causes premature truncation of reverse transcription (RT) at the 
cross-link site. The red bar indicates the last nucleotide added during reverse transcription. 
Resulting cDNA molecules are circularized, linearized, PCR-amplified and subjected to high-
throughput sequencing. The first nucleotides of each sequence contain the barcode followed 
by the nucleotide where cDNAs truncated during reverse transcription. Figure and legend 
reproduced from Sugimoto Y, Konig J, Hussain S, Zupan B, Curk T, Frye M et al. Genome 
Biol 201254. 
For each of these different CLIP methods laborious bioinformatic analyses 
have to be performed to finally miRNA targets, as these CLIP methods are 
not able to identify which specific miRNA was associated with each Ago-
bound RNA that was immunoprecipitated. Extensive bioinformatic analyses 
are then performed to the sequencing data to assign a miRNA to each 
immunoprecipitated RNA fragment based on the assumption that each of 
these RNA fragments has to have a sequence complementary to the seed 
sequence of the miRNA that was bound to it. Since many MREs do not 
have an exact seed pairing sequence, this bioinformatics method discards 
many bona fide miRNA/mRNA interactions. Therefore, non-specific 
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Ago/RNA interactions can result in false-positives. Also, these CLIP 
methods are technically-challenging multistep protocols. 
1.3.2.4. Pull-down of biotinylated miRNAs 
To address these problems, recent studies55-60 have used a much simpler 
approach that avoids cross-linking that consists on transfecting cells with a 
synthetic, biotinylated version of the miRNA of interest followed by 
streptavidin pull-down (PD) of its target RNAs (Figure 5). The synthetic 
miRNA mimics (RNA duplexes consisting of the mature miRNA of interest 
and its partially complementary passenger strand) have a biotin molecule 
covalently attached to the 3′ end of the mature miRNA strand (also called 
antisense strand). The pulled-down RNA can then be identified by 
microarray or high-throughput RNA sequencing. Putative miRNA targets 
can then be easily identified by comparing the enrichment level of each 
identified RNA in the PD performed with the miRNA of interest versus a 
control PD performed with an unrelated miRNA without any predicted 
targets in the system of interest (for example, the unrelated C. elegans 
miR-67 is usually used as a control miRNA mimic for PDs performed in 
mammalian cells). Even though the transfected synthetic-miRNA mimic will 
be present at much higher intracellular levels than the corresponding 
endogenous miRNA, recent evidence suggests that this still allows 
identification of physiologically-relevant miRNA/mRNA interactions. In fact a 
10-fold increase in miRNA concentration produces only a 10% increase in 
target repression61. This simple and fast method has been used to identify 
miRNA targets with high specificity55-60. 




Figure 5. Overview of the pulldown method. 3′-Biotinylated miRNA mimics are transfected 
into cells and cytoplasmic extracts are prepared after 24h. The Biotin–miRNA–mRNA 
complexes are isolated from cytoplasmic extracts using streptavidin beads. RNA isolated 
from the pulldown material is used to determine the enrichment of known targets of the 
miRNA. Microarray analysis from the pulldown RNA can be used to identify the genome-
wide mRNAs bound by the transfected Biotin-miRNA. Figure and legend reproduced from 




2. Epithelial to mesenchymal transition 
Epithelial to mesenchymal transition is a complex process that converts 
polarized epithelial cells into migratory and invasive mesenchymal cells63 
(Figure 6). EMT is a normal process during embryo development and is 
required for the formation of the neural crest64, fusion of the hard palate65, 
and other developmental processes. However, in tumorigenesis EMT is a 
pathological event that allows carcinomas to metastasize66-68.  
EMT is a complex process at the molecular level, with multiple biological 
pathways involved from its initiation until its completion. These pathways 
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comprise activation of several transcription factors, expression of specific 
cell surface proteins, expression and reorganization of cytoskeletal 
proteins, production of metalloproteinases that degrade extracellular matrix 
(ECM) components, as well as changes in miRNA expression profiles63.  
 
 
Figure 6. Epithelial to mesenchymal transition (EMT). An EMT involves a functional 
transition of polarized epithelial cells into mobile and ECM component-secreting 
mesenchymal cells. The epithelial and mesenchymal cell markers commonly used by EMT 
researchers are listed. ZO-1, zona occludens 1; MUC1, mucin 1, cell surface associated; 
miR200, microRNA 200; SIP1, survival of motor neuron protein interacting protein 1; 
FOXC2, forkhead box C2. Figure and legend reproduced from Kalluri R, Weinberg RA. J 
Clin Invest 200963. 
 
EMT is activated under normal or pathological biological contexts and 
therefore some authors63,69 classify it into three different subsets. Type 1 
EMT occurs during the formation and implantation of the embryo and organ 
development. Type 2 EMT is associated with wound healing, tissue 
regeneration and fibrosis. This type of EMT is a repair mechanism that 
normally generates fibroblasts to replace and restore tissue integrity after 
inflammation or injury. In this case EMT ceases when the inflammation is 
mitigated in the case of wound healing and tissue regeneration. Type 3 
EMT is a pathological event that contributes to the ability of carcinomas to 
metastasize (Figure 7). About 90% of cancer-related deaths are caused by 
metastasis. For example, breast cancer begins as a local disease and later 
metastasizes to lymph nodes and vital organs such as lung, liver, bone and 
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brain70. Metastasis is a complex, multistep process that starts when 
epithelial cells in the primary tumor undergo EMT and acquire a 
mesenchymal phenotype. These cells are then able to detach from their 
neighboring cells, such as nearby stromal cells, and invade through the 
basement membrane (Figure 7). Subsequently, metastasizing cells enter 
the bloodstream or the lymphatic system (intravasate) and then exit 
(extravasate) at distant organs forming micrometastases. The reversal of 
the EMT process, mesenchymal to epithelial transition (MET), is also an 
important event in cancer progression, as it has been hypothesized that 
MET is required for the final step of metastasis formation, the colonization 
of the metastatic site by proliferation of the established micrometastases71-
72. Although great advances have been made in cancer treatment, 
particularly in its early stages, metastasis remains a challenging and 
frequently fatal process73. Therefore, blocking the metastatic process holds 
great therapeutic promise. 
Many cytokines induce EMT, including hepatocyte growth factor (HGF), 
epidermal growth factor (EGF), platelet-derived growth factor (PDGF), 
transforming growth factor-beta (TGF-β) and bone morphogenetic proteins 
(BMPs). These cytokines activate transcription factors such as Zeb1 (zinc 
finger E-box binding homeobox 1), Zeb2 (zinc finger E-box binding 
homeobox 2, also known as SIP1), Twist (Twist1), Snail (Snail1), Slug 
(Snail2), Hmga2 (high mobility group A2) and Sp1 (specificity protein 1)68,74-
75. These transcription factors activate downstream signaling molecules and 
pathways including mitogen activated protein kinases (MAPKs), 
phosphoinositide 3-kinase (PI3K), Akt (also known as protein kinase B), 
small mothers against decapentaplegic (Smad) protein family, RhoB (Ras 
homolog gene family, member B), β-catenin, Ras, c-Fos and integrin 
signaling63. Several of these factors transcriptionally repress E-cadherin, an 
important cell adhesion molecule. Loss of E-cadherin is an hallmark of 
oncogenic EMT and knockdown of E-cadherin alone is sufficient to induce 
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EMT and metastasis76, highlighting the importance of E-cadherin regulation 
during EMT. 
 
Figure 7. EMT contribution to cancer progression. Progression from normal epithelium to 
invasive carcinoma goes through several stages. The invasive carcinoma stage involves 
epithelial cells losing their polarity and detaching from the basement membrane. The 
composition of the basement membrane also changes, altering cell-ECM interactions and 
signaling networks. The next step involves EMT and an angiogenic switch, facilitating the 
malignant phase of tumor growth. Progression from this stage to metastatic cancer also 
involves EMTs, enabling cancer cells to enter the circulation and exit the blood stream at a 
remote site, where they may form micro- and macro-metastases, which may involve METs 
and thus a reversion to an epithelial phenotype. Figure and legend reproduced from Kalluri 
R, Weinberg RA. J Clin Invest 200963. 
 
2.1. TGF-β superfamily signaling 
The transforming growth factor-β (TGF-β) protein superfamily has an 
important role in development and carcinogenesis. The TGF-β protein 
superfamily consists of four main subgroups of structurally-related protein 
families that share a common signaling pathway. The TGF-β protein 
superfamily includes the TGF-β family, the bone morphogenetic protein 
(BMP) family, the inhibin/activin family and the mullerian inhibitory 
substance (MIS) family77. Mechanistically, this signaling pathway is 
activated when a TGF-β superfamily ligand (TGF-β, BMPs, etc) binds to a 
TGF-β superfamily type II receptor. Ligand-bound type II receptors become 
activated and phosphorylate the cytoplasmic domain of type I receptors, 
consequently activating them (Figure 8). Vertebrates have seven distinct 
type I receptors, each of which can assemble with one of five type II 
receptors to mediate signaling for each specific TGF-β superfamily ligand. 
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Figure 8. General mechanism of TGF-β superfamily signaling and Smad activation. At the 
cell surface, a TGF-β superfamily ligand binds a complex of transmembrane receptor 
serine/threonine kinases (types I and II) and induces transphosphorylation of the type I 
receptor by the type II receptor kinases. The consequently activated type I receptors 
phosphorylate selected Smads (Smad2 or -3 for TGF-β and Smad1, -5 or -8 for BMPs), and 
these receptor-activated Smads (R-Smads) then form a complex with a common Smad4. 
Activated Smad complexes translocate into the nucleus, where they regulate transcription of 
target genes, through physical interaction and functional cooperation with DNA-binding 
transcription factors (X) and CBP or p300 coactivators. Activation of R-Smads by type I 
receptor kinases is inhibited by Smad6 or Smad7. R-Smads and Smad4 shuttle between 
nucleus and cytoplasm. The E3 ubiquitin ligases Smurf1 and Smurf2 mediate ubiquitination 
and consequent degradation of R-Smads. Figure and legend adapted from Derynck R, 
Zhang YE. Nature 200378. 
 
The activation of type I receptors leads to Smad protein phosphorylation 
and activation. These receptor-phosphorylated Smad proteins are also 
called receptor regulated Smads or R-Smads. For example, TGF-β induces 
phosphorylation of Smad2 or -3 while BMPs activate Smad1, -5 or -8. 
These activated Smad proteins then form a complex with Smad4. Together, 
this complex translocates into the nucleus where it transcriptionally 
activates or represses target genes by binding to several co-factors79. Many 
EMT-promoting transcription factors can act as Smad cofactors to repress 
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or activate EMT-related genes (Table 2). Of note, other intracellular 
signaling pathways besides the Smad signaling pathway respond to TGF-β 
superfamily ligands such as the MAPK, Erk and JNK pathways78. 
Table 2. EMT-promoting Smad complexes and their target genes 
Cofactor Smad partner Target genes Transcriptional activity type Ref. 
Snail1 Smad3 or -4 E-cadherin, occludin, claudin-3, claudin-4 Repression 
80 
Zeb1 Smad2, -3 or -4 E-cadherin, claudin-3, claudin-4 Repression 
81 
Zeb2 Smad1, -2, -3 or -5 E-cadherin, claudin-3, claudin-4 Repression 
82 
Sp1 Smad3 Endoglin, collagen, vimentin Activation 
74 
Hmga2 Smad2 or -4 Snail1 Activation 75 
 
The TGF-β superfamily signaling is inhibited by molecules such as the 
Sloan-Kettering Institute proto-oncogene (Ski), the Ski-related novel gene, 
non-Alu-containing (SnoN) and the transforming growth interacting factor 
(TGIF) which have been shown to prevent gene transcription through 
inhibition of R-Smads83-84. Also, two other Smad protein family members, 
Smad6 and Smad7, are called inhibitory Smads as they antagonize R-
Smad phosphorylation by blocking their access to type I receptors and/or 
promote the degradation of the receptor complex85-86. Additionally, TGF-β 
superfamily signaling is inhibited by Smurf1 (Smad-ubiquitination-regulatory 
factor 1) and Smurf2 which interact with R-Smads and target them for 
degradation87.  
3. miR-200 family  
The miR-200 family is composed by five homologous miRNAs (miR-141, 
miR-429, miR-200a, miR-200b and miR-200c), whose sequences are 
completely conserved between humans and mice. These miRNAs belong 
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to two subfamilies, whose seed regions (nucleotides 2 to 7 of the mature 
active strand, which is the most important region for miRNA target 
recognition), differ by a single nucleotide (Figure 9).  
 
 
Figure 9. miR-200 family. A. Stem-loop structure of hsa-mir-200c (precursor miRNA). B. 
The miR-200 family members. The human miR-200 family is located in two fragile 
chromosomal regions on 1p36.33 (200b, 200a and 429) and 12p13.31 (200c and 141), 
respectively. It consists of two clusters based on seed sequence similarity: miR-200bc/429 
(red) and 200a/141 (blue), distinguished by a single nucleotide change (U to C). Figure and 
legend reproduced from Mutlu M SÖ, Raza U, Eyüpoglu E, Yurdusev E, Sahin Ö. Atlas 
Genet Cytogenet Oncol Haematol 201588. 
 
The seed for miR-200b/c/429 sequence is 5’-AAUACU-3’, while for miR-
200a/141 is 5’-AACACU-3’. Additionally, they are encoded in two different 
gene clusters in humans and mice (in humans miR-200c and miR-141 are 
located on chromosome 12, while miR-200b, miR-200a and miR-429 are 
on chromosome 1; in mice, miR-200c and miR-141 are located on 





3.1. Published miR-200 family target genes 
During the progression of this project various miR-200 family target genes 
have been described in humans and mice (Table 3) in addition to those 
identified in this project89 (see Chapter 2). 
Table 3. Published miR-200 target genes. Only genes experimentally validated to be directly 
targeted by miR-200 were considered. Species (Human (H), Mouse (M) or Rat (R)) in which 
gene was experimentally validated and miR-200 family members used for validation are 
shown. 
 
 Gene Species miR-200 family member Ref. 
1 ACVR2B H 200c, 141 90 
2 AP-2Α (TCFAP2A) H 200c, 200b, 429 
91 
3 ARHGAP19 H 200c 92 
4 BCL-2 H H 

















6 BRD3 H 141 102 
7 BRD7 H 200c 103 
8 CAGE H 200b 104 
9 CD47 H 141 105 
10 CDC25B H 141 106 





12 CDK2 H 200b 109 
13 CDK6 H 200a 110 
14 CDKN1B (p27/kip1) H 200b 
111 





16 c-Maf M 200c 113 
17 c-MYB H 200b, 200c, 429 114 
18 C-MYC H 429 115 
19 CREB1 H 200b 116 
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Table 3 (cont.). Published miR-200 target genes. Only genes experimentally validated to be 
directly targeted by miR-200 were considered. Species (Human (H), Mouse (M) or Rat (R)) 
in which gene was experimentally validated and miR-200 family members used for validation 
are shown. 
 
21 CUL3 H 141 105 
22 CXCL1 H 200a, 200b 122 
23 CXCL12β H, M 141 123 
24 CYCLIN E2 H 200a, 200b, 200c 124 
25 DLC-1 H 141 125 
26 Dlx5 M 141, 200a 126 
27 DNMT3A H 200b, 200c 127 
28 DNMT3B H 200b, 200c 127 
29 E2f3 M 200c 128 
30 eIF4E H 141 129 
31 EPHA2 H 200a 130 




33 ERRFI-1 H 200c 132 
34 ETAR (EDNRA) H 200c 
133 





36 FAP-1  (PTPN13) H 200c 
136 
37 FBLN5 H 200c 137 





































42 FOG2 (ZFPM2) H 
200a, 200b, 200c 
141, 429 
145 
43 FTH1 (Ferritin) H 200b 
146 
44 GATA2 H 200b 138 





46 GNA13 H 200a 141 
149 
47 Grb2 M 200a 111,150 
48 HDAC4 H 200a 151 
49 HDGF H 141 152 




Table 3 (cont.). Published miR-200 target genes. Only genes experimentally validated to be 
directly targeted by miR-200 were considered. Species (Human (H), Mouse (M) or Rat (R)) 
in which gene was experimentally validated and miR-200 family members used for validation 
are shown. 
 
51 IL-8 (Cxcl15) H 200a, 200b 
122 












54 KINDLIN-2 (FERMT2) H 200b 
109 
55 KLF4 H 200b 96 
56 KLF9 H 200c 141 
57 KRAS H 200c 158 
58 LEPR H 200c 92 
59 LPAR1 H 200c 133 
60 Lrp1 M 200c 112 
61 MAML2 H 200c 154 
62 MAML3 H 200c 154 
63 MAP4K4 H 141 159 
64 MAPK14 (P38Α) H 200a, 141 
160 
65 MARCKS H 200c 161 
66 MKK4 H 141 162 





68 MUC16 H 200c 164 
69 MUC4 H 200c 164 
70 NCAM1 H 200c 165 
71 Noggin (Nog) M 200c 
166 





73 NOXA H 200c 169 
74 Nrp1 M 200a 108 
75 NTF3 H 200c 170 
76 NTRK2 (TRKB) H 200c 
92 
77 ONECUT2 H 429 171 
78 OREBP H 200b 172 
79 OXR1 H 200b 173 
80 P53 H 200a 174 
81 PAF H 200b 109 






M 200a, 200b 176 
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Table 3 (cont.). Published miR-200 target genes. Only genes experimentally validated to be 
directly targeted by miR-200 were considered. Species (Human (H), Mouse (M) or Rat (R)) 
in which gene was experimentally validated and miR-200 family members used for validation 
are shown. 
 
84 PLCG1 H 200b,200c,429 177 
85 PPARA H 141 178 
86 PPM1F H 200c 179 
87 PRKAR2B H 200b 180 
88 PSMD1 H 200b 181 
89 PSMD1 H 200b 181 


















92 RAB21 H 200b 186-187 
93 RAB23 H 200b 186-187 
94 RAB3B H 200b 186-187 
95 RBBP4 H 429 188 
96 RHOA H 200c 133 










98 ROCK2 H 200b, 200c 191 





100 Serca2b (Atp2a2) M 200b 
193 
101 SHP (NR0B2) H 141 
194 
102 SIRT1 H 200a 195 
103 Slc25a3 M 141 196 












106 Snail (Snai1) M 200b 
199 















110 Srf R 200b 203 
111 STAT5B H 200a 204 





113 TBK1 H 200c 206 
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Table 3 (cont.). Published miR-200 target genes. Only genes experimentally validated to be 
directly targeted by miR-200 were considered. Species (Human (H), Mouse (M) or Rat (R)) 
















115 TGFΒR1 H 141, 200a 198 
116 THBS1 H 200a 209 
117 TIAM1 H 141 210 
118 TIMP2 H 200b 211 
119 TIMP2 H 200c 137 
120 TM4SF1 H 141 212 





122 UBAP1 H 141 102 
123 UBASH3B H 200a 215 
124 UBQLN1 H 200b 181 

















127 WAVE3 (WASF3) H 200b 
218 
128 Wnt1 M 200b 219 
129 XIAP H 200b, 200c, 429 93 





131 YWHAG (14-3-3γ) H 141 
223 












134 ZMPSTE24 H 141 226 
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3.2. miR-200 family role in EMT and metastasis 
Because of its role as a master EMT regulator, miR-200 has been 
extensively studied. Besides targeting EMT-inducers Zeb1 and Zeb2, miR-
200 also targets other important EMT activators such as Ets1, Snail1 
(Snail) and Snail2 (Slug) (Table 3). miR-200 has also been shown to 
regulate cell-cell adhesion207,224,228, cancer stem cell self-renewal and 
differentiation96,229-230, cell division and apoptosis136,147,177,189 and 
chemoresistance93,231 (Figure 10). 
 
Figure 10. miR-200c targets several genes regulating numerous processes involved in 
cancer development and progression. Figure and legend reproduced from Mutlu M SÖ, 
Raza U, Eyüpoglu E, Yurdusev E, Sahin Ö. Atlas Genet Cytogenet Oncol Haematol 201588. 
 
miR-200c accounts for 93% of the mature miR-200b/c/429 subfamily 
expression in human breast tumors232. Due to the dominant presence of 
miR-200c over its other subfamily members and given the expected overlap 
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between miR-200b/c/429 and miR-200a/141 subfamily target genes, we 
chose for this project to focus on miR-200c as a representative member of 
the miR-200 family. 
Even though miR-200 was shown to regulate metastasis formation, its 
effect is controversial as miR-200 expression enhances metastasis in some 
cancer models,112,202,225,233-234 but reduces it in others95,186,235. Different 
cancer cell models may have different factors that alter miR-200’s role in 
metastasis. Additionally, the microenvironment surrounding the primary 
tumor may also contribute to these differences. Extracellular cytokines at 
the invasive front, such as TGF-β, may activate miR-200 repressors such 
as Zeb1/2 that repress miR-200 expression at the transcriptional level. 
Finally, the microenvironment at secondary metastatic sites may also 
cooperate or counteract miR-200’s colonization-promoting effect.  
Circulating miR-200 levels can also be used as a prognostic tool in 
oncology, as high levels of miR-200 in the bloodstream of cancer patients 
are associated with poor prognosis in several cancers, including ovarian, 
prostate, pancreatic and metastatic colorectal cancers236-239. 
 
4. Thesis Scope 
The main goals of the work within this thesis were to provide the first 
genome-wide map of miR-200c target genes and investigate their biological 
role. Although miR-200 family was already known to regulate EMT, a 
genome-wide list of its targets and a comprehensive map of miR-200-
regulated pathways was yet to be obtained.  
To achieve these main goals an integrated framework was developed that 
consisted on coupling a high-throughput method for miRNA target 
discovery with bioinformatic analyses. This method identified hundreds of 
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miR-200c putative targets. This genome-wide list of miR-200c target genes 
was then bioinformatically analyzed to provide a global list of miR-200-
regulated pathways. Some of these putative target genes were selected for 
experimental validation. Results show that this high-throughput method for 
miRNA target discovery has a low false-positive rate. Additionally, 
biochemical assays were performed to study the role of some novel target 
genes in miR-200-dependent processes. Some of these target genes had 
novel and unexpected biological functions.  
Overall, the framework developed in this thesis allowed us to generate the 
most complete genome-wide map of miR-200-regulated pathways to date 
and discover new genes involved in EMT. Moreover, this framework can be 
used to identify the genome-wide targets of other miRNAs. 
Importantly, this thesis makes a significant contribution to the study of both 
miR-200 and EMT and will be the springboard for future mechanistic and 
biological investigations of the molecular basis for their actions. 
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Summary 
The miR-200 family promotes the epithelial state by suppressing the 
Zeb1/Zeb2 epithelial gene transcriptional repressors. To identify other miR-
200-regulated genes, we isolated mRNAs bound to transfected biotinylated 
miR-200c in mouse breast cancer cells. 520 mRNAs were significantly 
enriched in miR-200c binding at least 2-fold. Putative miR-200-regulated 
genes included Zeb2, enriched 3.5-fold in the pull-down. However, Zeb2 
knockdown does not fully recapitulate miR-200c over-expression, 
suggesting that regulating other miR-200 targets contributes to miR-200’s 
enhancement of epithelial gene expression. Candidate genes were highly 
enriched for miR-200c seed pairing in their 3’UTR and CDS and for genes 
that were down-regulated by miR-200c over-expression. EGFR and 
downstream MAPK signaling pathways were the most enriched pathways. 
Genes whose products mediate TGF-β signaling were also significantly 
over-represented, and miR-200 counteracted the suppressive effects of 
TGF-β and BMP-2 on epithelial gene expression. miR-200c regulated the 
3’UTRs of 12 of 14 putative miR-200c-binding mRNAs tested. The extent of 
mRNA binding to miR-200c strongly correlated with gene suppression. 
Twelve targets of miR-200c (Crtap, Fhod1, Smad2, Map3k1, Tob1, 
Ywhag/14-3-3γ, Ywhab/14-3-3β, Smad5, Zfp36, Xbp1, Mapk12, Snail1) 
were experimentally validated by identifying their 3’UTR miR-200 
recognition elements. Smad2 and Smad5 form a complex with Zeb2 and 
Ywhab/14-3-3β and Ywhag/14-3-3γ form a complex with Snail1. These 
complexes that repress transcription assemble on epithelial gene 
promoters. miR-200 over-expression induced RNA polymerase II 
localization and reduced Zeb2 and Snail1 binding to epithelial gene 
promoters. Expression of miR-200-resistant Smad5 modestly, but 
significantly, reduced epithelial gene induction by miR-200. miR-200 
expression and Zeb2 knockdown are known to inhibit cell invasion in in 
vitro assays. Knockdown of each of 3 novel miR-200 target genes identified 
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here, Smad5, Ywhag and Crtap, also profoundly suppressed cell invasion. 
Thus miR-200 suppresses TGF-β/BMP signaling, promotes epithelial gene 
expression and suppresses cell invasion by regulating a network of genes. 
 
Chapter 2. The role of the miR-200 family in EMT 
50 
CONTENTS 
1. Introduction....................................................................................................... 51 
2. Materials and methods..................................................................................... 54 
3. Results............................................................................................................... 66 
3.1. miR-200c pull-down .................................................................................................. 66 
3.2. miR-200 bound genes are enriched for genes involved in EGFR, MAPK and TGF-β 
signaling and metabolic pathways implicated in metastasis and oncogenic transformation
......................................................................................................................................... 69 
3.3. miR-200-bound genes form a dense interaction network.......................................... 70 
3.4. Experimental validation of the predictions of the Bi-miR-200c pull-down.................. 72 
3.5. miR-200 targets Snail1 and Zeb2 transcription complexes....................................... 77 
3.6. miR-200 inhibits the EMT-promoting effects of TGF-β and BMP-2........................... 82 
3.7. Smad5 gene regulation contributes to miR-200 enhancement of epithelial gene 
expression ....................................................................................................................... 84 
3.8. The miR-200c target Crtap promotes cell invasion ................................................... 86 
3.9. CRTAP and miR-200 expression are inversely correlated in NCI-60 tumors and 
primary human breast cancers ........................................................................................ 87 
4. Discussion......................................................................................................... 89 
5. Note added in proof.......................................................................................... 95 
6. Conflict of Interest ............................................................................................ 97 
7. Acknowledgements.......................................................................................... 97 
8. Supplemental figures ....................................................................................... 98 
10. Supplemental tables..................................................................................... 102 
9. References ...................................................................................................... 135 
 
 
The role of the miR-200 family in the epithelial-to-mesenchymal transition (EMT) 
51 
1. Introduction 
The miR-200 family promotes the epithelial state of cells and suppresses 
mesenchymal properties during development and cellular differentiation. 
Transitions between epithelial and mesenchymal states (epithelial to 
mesenchymal (EMT) and mesenchymal to epithelial (MET)), which alter the 
motility of cells during development1, play an important role in tumor 
metastasis2. Epithelial cells express high levels of E-cadherin, occludin and 
claudins, while mesenchymal cells express high levels of N-cadherin, 
vimentin and fibronectin3. Some tumor cell lines, especially less 
differentiated cells, show plasticity in their display of epithelial and 
mesenchymal traits. Although the early steps of metastases - penetration 
through the basement membrane, invasion of the vasculature and 
extravasation - are facilitated by cells acquiring mesenchymal traits, the 
ability to colonize distant tissues and form macroscopic metastases may be 
facilitated by epithelial properties.1,4-6 Accordingly, miR-200 expression has 
been associated with both increased4,7-10 and decreased11-13 malignancy 
and metastases, depending on the cancer model. High levels of circulating 
miR-200 are associated with poor prognosis in several human cancers, 
including ovarian, prostate, pancreatic and metastatic colorectal cancers14-
17.  
The miR-200 miRNAs are five homologous miRNAs (miR-141, miR-429, 
miR-200a, miR-200b and miR-200c), whose sequences are conserved 
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between human and mouse. These miRNAs belong to two families whose 
seed regions (nucleotides 2 to 7 of the mature active strand, which form the 
most important region for target recognition) differ by a single nucleotide. 
The seed for miR-200b/c/429 sequence is 5’-AAUACU-3’, while for miR-
200a/141 it is 5’-AACACU-3’. Because of its role as a master regulator of 
MET, miR-200 has been extensively studied. The Zeb epithelial gene 
transcriptional repressors contain multiple miR-200 binding sites in their 
3’UTR (Zeb1 has 5 and Zeb2 has 6 conserved predicted binding sites) and 
their expression is profoundly downregulated by miR-200. Much of miR-
200’s effect on increasing epithelial gene expression and inhibiting cell 
motility and invasivity can be reproduced by knocking down Zeb1 and/or 
Zeb2.4,18-21  Many other gene targets have been described in mouse or man 
(Table S1), including the transcription factors Ets122, Snail1 (Snail)23 and 
Snail2 (Slug)24. miR-200 has also been shown to regulate cell-cell 
adhesion18-19,21, cancer stem cell self-renewal and differentiation25-27, cell 
division and apoptosis28-31 and chemoresistance.32-33  
miRNAs accomplish their biological functions by regulating networks of 
genes34. Transfection of a biotinylated (Bi-)miRNA mimic and streptavidin 
pull-down (PD) of associated mRNAs provides an unbiased method to 
identify the genes regulated by a particular miRNA with high specificity34-39. 
To better understand how miR-200 functions, we carried out a Bi-miR-200c 
PD in the mouse breast cancer cell line 4TO7. 4TO7 is a mouse triple 
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negative breast cancer (TNBC) cell line that is able to perform all the steps 
of metastasis when implanted in the mammary fat pad, except colonization 
of metastatic sites. 4TO7 does not express the miR-200 family, but ectopic 
expression of miR-200c, which accounts for 93% of mature miR-200b/c/429 
family expression in human breast tumors40, leads to efficient colonization 
of lung and liver, macroscopic metastases and reduced survival.4,8 
Moreover, 4T1E, an isogenic clone derived from the same primary, 
spontaneously arising tumor that metastasizes, differs from 4TO7 by high 
expression of the miR-200 family. mRNAs for 520 genes, including Zeb2 
and other known miR-200 target genes, were significantly enriched at least 
2-fold in the PD with miR-200c relative to a C. elegans control miRNA. The 
pulled down genes were highly enriched for miR-200c seed-binding 
sequences and for genes knocked down by miR-200 over-expression. Of 
18 genes chosen for experimental validation, 14 (78%) were confirmed as 
significantly enriched by PD and qRT-PCR. Of those, 12 (86%) had 
functional miR-200 recognition elements in their 3’UTR. Genes that 
participate in EGFR and TGF-β/BMP signaling were highly over-
represented in the miR-200 target gene set. In addition to Zeb2 and Snail1, 
we found that miR-200 also suppressed expression of their cofactors, 
Smad2/Smad5 and Ywhab/Ywhag, respectively.41-42 Suppression of these 
multiple epithelial gene regulators enhanced the ability of miR-200 to 
promote MET. Crtap, which is required for type I collagen prolyl-
hydroxylation, was a novel strong target of miR-200, whose knockdown 
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strongly inhibited invasivity through Matrigel. Crtap is postulated to facilitate 
TGF-β binding to extracellular matrix. 
 
2. Materials and methods 
2.1. Cell culture 
4TO7 and 4T1 cells were kindly provided by Fred Miller (Wayne State 
University).43 4T1E cells were previously generated in our laboratory44. 
4TO7, 4T1, 4T1E and NIH/3T3 cell lines were grown in DMEM (Gibco) 
supplemented with 10% fetal bovine serum (FBS), 1 mM L-glutamine and 
penicillin/streptomycin (Gibco). 
2.2. siRNA and miRNA mimics transfection 
4TO7, 4T1 or NIH/3T3 cells were transfected with 50 nM negative control 
miRNA mimic (Dharmacon, CN-001000-01-10), miR-200c miRNA mimic 
(Dharmacon, C-310569-07-0010), control siRNA (Dharmacon, D-001210-
04-05) or siRNAs against Zeb2 (Dharmacon, M-059671-01-0005), Snail1 
(Dharmacon, M-062765-00-0005), Ywhag (Dharmacon, M-059307-00-
0005), Smad5 (Dharmacon, M-057015-00-0005), Crtap (Dharmacon, M-
049986-00-0005) or Firefly luciferase (sequence listed in Table S6) using 
Lipofectamine 2000 (Invitrogen). Cells were incubated with miRNA or 
siRNA-containing lipid complexes, according to the manufacturer’s 
protocol, for 4 h before culture supernatants were removed and replaced 
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with complete growth medium. Cells were harvested 48 or 72 h post 
transfection for mRNA and protein analyses. 
2.3. RNA isolation and quantitative RT–PCR 
Total RNA was isolated using Trizol reagent (Ambion), treated with DNase I 
(Promega) and reverse transcribed using random hexamers and 
Thermoscript RT kit (Invitrogen) as per the manufacturer’s protocols. 
Quantitative real time PCR (qRT-PCR) was performed in triplicate samples 
using SsofastTM Evagreen qPCR assay (BioRad) on a BioRad CFX96 
C1000 Thermal Cycler. mRNA levels were normalized to the housekeeping 
gene Gapdh. miRNA was quantified in triplicate using the TaqMan 
MicroRNA Assay (Applied Biosystems) as per the manufacturer’s 
instructions and normalized to snoRNA234. Primer sequences are listed in 
Table S6. 
2.4. Immunoblot 
Whole cell lysates were prepared using RIPA buffer (150 nM NaCl, 1% NP-
40, 0.5% sodium deoxycholate, 0.1% SDS, 50 mM Tris pH 8.0) 
supplemented with Complete Mini-protease Inhibitor Cocktail (Roche). For 
phosphoprotein analysis, lysis buffer was further supplemented with 10 mM 
NaF, 2 mM Na3VO4 and 2.5 mM sodium pyrophosphate. Protein 
concentration was determined using the BCA Protein Assay (Pierce). 
Samples were resolved on SDS-Page gels and transferred using a 
Transblot semi-dry transfer apparatus (BioRad). Blots were probed with 
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antibodies to Smad5 (sc-7443) and Ywhab (sc-59419) from Santa Cruz 
Biotechnology; Ywhag (EMD Millipore, 05-639); Claudin-3 (Life 
Technologies, 341700); Crtap (kind gift of Prof. Brendan Lee, Baylor 
College of Medicine); Snail1 (3895), phospho-Smad1/5/8 (9511), Smad2 
(5339) and phospho-Smad2 (3101) from Cell Signaling; E-cadherin (BD 
Biosciences, 61081); and α-Tubulin (Sigma, T5168). Blots were quantified 
by densitometry. 
2.5. Bi-miR-200c pull-down 
4TO7 cells (2.4×106) were transfected as described above with 50 nM Bi-
miR-200c or Bi-cel-miR-67 miRNA mimics biotinylated at the 3’-end of the 
active strand (Dharmacon). Biotin PDs were performed 24 h after 
transfection as previously described34. The level of mRNA in the Bi-miR-
200c or Bi-cel-miR-67 control PD was then quantified by mRNA microarray 
(Illumina) and analyzed as described below. For technical validation of the 
PD using qRT-PCR, cells were transfected as described above and an 
optimized version of the PD protocol was used39. In this case, mRNA levels 
in the PD and input samples were first normalized to Gapdh and then the 
enrichment ratio of the control-normalized PD mRNA to the control-
normalized input levels was calculated.  
2.6. Microarray analysis 
Total RNA (from two independent experiments) was amplified, labeled and 
hybridized to Illumina MouseRef-8 v2.0 expression beadchip (Illumina) 
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mouse whole-genome expression arrays. The quality of the RNA was 
assessed before performing the microarray and the quality of the 
microarray data was assessed using affyPLM and Affy software. The 
microarray data were normalized using RMA45 to reduce interarray 
variation. Probes were mapped to Entrez Gene identifications (IDs) using 
systematically updated annotations from AILUN (Array Information Library 
Universal Navigator)46. The PD enrichment ratio was defined as (Bi-miR-
200c PD/Bi-cel-miR-67 PD)/(Bi-miR-200c input/Bi-cel-miR-67 input) and 
calculated for each probe. A detection P cutoff of 0.05 was used to exclude 
probes in any of the control arrays. For each probe, a significance value 
associated with the enrichment ratio was obtained using a t-test that 
compared the PD to input ratio for the Bi-miR-200c experiments to the 
control Bi-cel-miR-67 experiments. Probes with a P of less than 0.01, and 
an enrichment ratio of greater than 2 were considered ‘hits’ for the 
informatic analysis of the PD data. 
2.5. Bi-miR-200c pull-down 
The fold change in probe expression caused by Bi-miR-200c over-
expression was calculated by the ratio of input RNA from Bi-miR-200c-
transfected 4TO7 cells to the ratio of input RNA from Bi-cel-miR-67-
transfected cells. A cumulative distribution function plot was used to 
compare the distribution of Bi-miR-200c over-expression fold changes for 
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PD gene lists defined by different cutoffs. The Kolmogorov-Smirnov [KS] 
test was used for statistical comparisons between gene sets. 
2.8. Analysis of miR-200c target genes by target prediction 
algorithms 
To determine whether a gene was also a predicted target of miR-200c, the 
presence of miR-200c binding sites was analyzed using TargetScan 6.2 
(www.targetscan.org/)47-49, PITA 
(genie.weizmann.ac.il/pubs/mir07/mir07_prediction.html)50 or RNAhybrid 
(bibiserv.techfak.uni-bielefeld.de/rnahybrid)51. 
2.9. Hexamer analysis 
The mature mmu-miR-200c sequence was downloaded from miRBase; all 
RefSeq mouse mRNAs were obtained from NCBI. Hexamers 
complementary to each position of the miR-200c sequence were found in 
the complete gene set and their frequency was length normalized 
(matches/kb). Significance of enrichment was calculated by Monte Carlo 
sampling without replacement from the complete expressed gene set as 
described.34 
2.10. Pathway enrichment analysis and network visualization 
Canonical pathway gene sets were compiled from Wikipathways52 and 
genes not expressed in 4TO7 cells (as determined by using Bi-cel-miR-67-
transfected 4TO7 microarray data using a detection P cutoff of 0.05) were 
The role of the miR-200 family in the epithelial-to-mesenchymal transition (EMT) 
59 
removed. The hypergeometric test was used to assess the enrichment of 
these biological gene sets in the list of Bi-miR-200c PD genes. The 
interactome of directly-interacting pulled-down genes was generated using 
the Ingenuity Pathway Analysis software (Ingenuity Systems, 
www.ingenuity.com). Edges represent direct functional interactions 
(protein-protein or protein-DNA/RNA interactions) between gene products. 
2.11. miRNA and mRNA correlation in NCI-60 cell lines and primary 
human breast cancers 
The relationship between CRTAP, SDHA, ZEB2 and miR-200c expression 
levels in the NCI-60 panel of cancer cell lines was analyzed from genome-
wide mRNA and miRNA profiling data using Cellminer 
(http://discover.nci.nih.gov/cellminer)53. Matched miRNA and mRNA 
profiling in human primary breast tumor samples was reported in 
GSE19783 deposited in GEO (www.ncbi.nlm.nih.gov/geo/). Multiple probes 
mapping to the same gene were aggregated using the median expression. 
Pearson correlation with a one-sided test for negative correlation was used 
to investigate the correlation between miR-200c and CRTAP, ZEB2 and 
SDHA expression levels. 
2.12. Dual-luciferase reporter assay 
The full 3’UTR of each gene was amplified by PCR from genomic DNA 
isolated from 4TO7 cells and cloned into the psiCHECK-2 vector (Promega) 
immediately upstream of the Renilla luciferase gene. These constructs 
Chapter 2. The role of the miR-200 family in EMT 
60 
were used to generate constructs containing mutations in putative miR-
200c MREs within the full 3’UTR of indicated genes. The sequences of all 
constructs were verified by sequencing. 4T1E cells were cotransfected with 
50 nM miRNA mimics together with psiCHECK-2 vector containing the 
3’UTR of indicated genes. Cells were lysed 24 h after transfection in 
Passive Lysis Buffer (Promega) and Firefly and Renilla luciferase activities 
were measured using the Dual Luciferase Assay System (Promega) on a 
Synergy2 plate reader (Biotek). Renilla luciferase activity levels were 
normalized to Firefly luciferase and results from three independent 
experiments were compared to activity in cells expressing empty 
psiCHECK-2 vector. Sequence of primers used for cloning 3’UTRs and to 
generate mutated 3’UTRs are listed in Table S6. 
2.13. E-cadherin promoter reporter assay 
The -178/+92 fragment of the mouse E-cadherin promoter was amplified by 
PCR from genomic DNA isolated from 4TO7 cells using oligonucleotides 
linked to KpnI and XhoI restriction sites and cloned into the same restriction 
sites in the pGL3 vector (Invitrogen) fused to the Firefly luciferase reporter 
gene. To determine the activity of the E-cadherin promoter, 4TO7 cells 
(2×104 cells) were co-transfected in 24-well plates with 50 ng of the reporter 
and 50 ng of TK-Renilla plasmid (Promega). Cells were transfected with 50 
nM siRNA or miRNA 24 h later and 48 h after that cells were then lysed in 
Passive Lysis Buffer (Promega) and Firefly and Renilla luciferase activities 
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were measured consecutively using the Dual Luciferase Assay System 
(Promega) on a Synergy2 plate reader (Biotek). Firefly luciferase activity 
was normalized to Renilla luciferase activity and relative to activity 
measured for control siRNA or miRNA transfection. 
2.14. Chromatin immunoprecipitation assay (ChIP) 
4TO7 cells (12.5×106) were transfected with 50 nM miRNA as above and 
24 h later cross-linked with 1% formaldehyde for 10 min at room 
temperature. Crosslinking was stopped by adding glycine to a final 
concentration of 0.125 M. Cells were washed with cold PBS and kept on ice 
for 10 min in 25 mM HEPES (pH 7.8), 1.5 mM MgCl2, 10 mM KCl, 0.1% 
NP-40, 1 mM DTT and Complete Mini-protease Inhibitor Cocktail (Roche). 
Following homogenization, nuclei were pelleted and resuspended in 
sonication buffer (50 mM HEPES (pH 7.9), 140 mM NaCl, 1 mM EDTA, 1% 
Triton X-100, 0.1% Na deoxycholate, 0.1% SDS, and Complete Mini-
protease Inhibitor Cocktail (Roche)) and sonicated on ice to an average 
length of 200–1500 bp. Chromatin from ~5×106 cells was used for each 
immunoprecipitation, which was carried out overnight in the presence of 25 
μL Protein G Dynabeads (Life Technologies, 10004D) using 2 μg of mouse 
monoclonal antibody against RNA Polymerase II (Santa Cruz 
Biotechnology, sc-56767), 5 μg of rabbit antiserum against Zeb2 (kind gift 
of Prof. Danny Huylebroeck, University of Leuven), 1 μg of rabbit antiserum 
against Snail1+Snail2 (Abcam, ab85931; we confirmed by qRT-PCR (data 
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not shown) that Snail2 is not expressed in 4TO7 cells) or equal amounts of 
rabbit IgG (Cell Signaling, 2729S) or mouse IgG (Santa Cruz, sc-2025). 
Samples were then extensively washed with sonication buffer, wash buffer 
A (50 mM Hepes pH 7.9, 500 mM NaCl, 1 mM EDTA, 1% Triton X-100, 
0.1% Na deoxycholate, 0.1% SDS and Complete Mini-protease Inhibitor 
Cocktail (Roche)), wash buffer B (20 mM Tris, pH 8.0, 1 mM EDTA, 250 
mM LiCl, 0.5% NP-40, 0.5% Na deoxycholate and Complete Mini-protease 
Inhibitor Cocktail (Roche)) and Tris-EDTA buffer to remove unbound DNA. 
Immunoprecipitated DNA was then eluted using elution buffer (50 mM Tris, 
pH 8.0, 1 mM EDTA, 1% SDS, 50 mM NaHCO3) and treated with 
proteinase K (Ambion, AM2546) and RNAse (Sigma, R4642) overnight at 
65ºC. DNA was then purified using a PCR purification kit (Qiagen) and 
analyzed by qRT-PCR using the primers listed in Table S6. 
2.15. Transwell invasion assays 
4TO7 cells (4×105) were transfected in 6-well plates with 50 nM siRNA or 
miRNA mimics as described above and 48 h later were incubated in serum-
free medium for 2 h. Cells were then harvested with TrypLE™ Express 
(Invitrogen) and counted using a hemocytometer. A BD BioCoat Tumor 
Invasion System (BD Biosciences, 354165) containing BD Falcon 
Fluoroblock 24-Multiwell inserts (8-μm pore size; PET membrane) was 
used to measure invasion following the manufacturer’s instructions. Briefly, 
1.5 x 105 cells were added in serum-free medium to each insert and 
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complete medium containing 10% FBS was added into each basal 
chamber. After 20 h, invaded cells were quantified by labeling with calcein 
AM (BD Biosciences), and measuring the fluorescence underneath the 
membrane using a Synergy2 plate reader (Biotek). 
2.16. Smad5 and Ywhag expression plasmids 
Smad5 and Ywhag CDS were cloned into the multiple cloning site of 
pcDNA3.1(+) (Invitrogen) by RT-PCR using mRNA from 4TO7 cells. 
Primers used for PCR amplification are listed in Table S6. 
2.17. TGF-β treatment 
4TO7 cells (4×105) were transfected in 6-well plates with 50 nM miRNA 
mimics as described above. Culture supernatants were removed after 4 h 
and replaced with complete medium containing 5 ng/mL TGF-β (Cell 
Signaling, 5231) or the same volume of vehicle (20 mM sodium citrate, pH 
3.0). After 24 h, medium was replaced with fresh medium containing TGF-β 
or vehicle. Cells were harvested 24 h after that for mRNA analysis. 
2.18. Plasmid DNA transfection and BMP-2 treatment 
4TO7 cells (4×105) were co-transfected in 6-well plates as described above 
with 6 μg empty vector, Ywhag or Smad5 expression vectors together with 
50 nM miRNA mimics. Culture supernatants were removed after 4 h and 
replaced with complete medium containing 25 ng/mL BMP-2 (Cell 
Signaling, 4697) or the same volume of vehicle (10 mM HCl, 0.1% BSA). 
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After 24 h, medium was replaced with fresh medium containing BMP-2 or 
vehicle. Immunoblot was performed on cell lysates harvested 24 h after 
that. 
2.19. Cell viability assay 
4TO7 cells (2×104), transfected in 24-well plates with 50 nM siRNA or 
miRNA mimics, were analyzed 48 h later for cell viability by CellTiter-Glo 
assay (Promega) following the manufacturer’s protocol.  An siRNA 
targeting Plk1 (Dharmacon, M-040566-01-0005) was used as a control. 
Signals were normalized to control siRNA or miRNA treatment. 
2.20. E-cadherin immunostaining 
4TO7 cells, transfected with siRNA or miRNA mimics as described above, 
were plated 24 h later (104 cells/well) on a Lab-Tek chamber slide (Thermo 
Fisher, 177445) in 0.2 mL and fixed 48 h later in 4% formaldehyde in PBS. 
The slides were washed twice with PBS, then incubated in blocking buffer 
(PBS with 0.5% BSA and 0.05% Triton-X) for 30 min, then for 1 h in 
blocking buffer plus E-cadherin antibody (BD Biosciences, 61081) at a final 
dilution of 1:100. After washing, slides were placed in blocking buffer with 
Alexa-Fluor-488-conjugated donkey anti-mouse secondary antibody (Life 
Technologies, A-21202) for 1 h and then washed and stained with 4 µg/mL 
DAPI in PBS and mounted using polyvinyl alcohol (Sigma, P-8136) 
aqueous mounting medium. Cells were imaged using an Axiovert 200M 
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microscope (Pan Apochromat, 1.4 NA; Carl Zeiss) and analyzed with 
SlideBook 4.2 (Intelligent Imaging Innovations Inc.). 
2.21. Statistical analysis 
In all experiments, except where indicated, paired Student’s t-tests (two-
tailed) were used to analyze the difference between two groups of data. 
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3. Results 
3.1. miR-200c pull-down 
A previously published protocol34, which showed 90% specificity for 
identifying miR-34a-regulated genes, was used to capture miR-200-bound 
mRNAs. 4TO7 cells were transfected with control C. elegans miRNA mimic 
(Bi-cel-miR-67) or miR-200c mimic (Bi-miR-200c), both biotinylated at the 
3’-end of the mature active strand. The next day cells were lysed and 
streptavidin-coated beads were used to isolate mRNAs bound to the 
biotinylated miRNAs. mRNA abundance in Bi-cel-miR-67 or Bi-miR-200c 
PD and input samples from 2 independent experiments were assessed on 
mRNA microarrays. An enrichment ratio R ((Bi-miR-200c PD/Bi-cel-miR-67 
PD)/(Bi-miR-200c input/Bi-cel-miR-67 input)) was calculated as a measure 
of how much each transcript was enriched in the PD relative to its 
expression in the miRNA-transfected cells. We then calculated the average 
enrichment ratio and associated P-value for each microarray probe. 520 
transcripts had an enrichment ratio >2 and P<0.01 (Figure 11a, Table S2). 
To determine the sensitivity of the Bi-miR-200c PD, we first determined 
how many of the known mouse miR-200 family published targets were 
enriched (Table S1). 13 experimentally validated mouse targets of any miR-
200 family member are expressed in 4TO7 cells (Zeb1 and Snail2 are not 
expressed in these cells) and 9 of these are known to be regulated by miR-
200c. 7 of the 13 (54%) and 5 of the 9 (56%) were identified in the PD.  
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Figure 11. Bi-miR-200c PD identifies 520 putative miR-200c target genes (a) Volcano plot 
for Bi-miR-200c PD showing the log2-transformed enrichment ratio for each probe detected 
above background in the microarray versus its corresponding log10-transformed P. Probes 
with a PD-enrichment ratio R>2 are shown in dark gray and the horizontal dashed line 
corresponds to  P=0.01. 520 genes fit the criteria R>2 and P<0.01. Probes detecting Zeb2 (a 
known miR-200 target) and each of the 18 putative miR-200c targets chosen for validation 
are labeled (if there were multiple probes for the same gene, the one with the highest R was 
labeled). (b) Fold enrichment of hexamer sequences complementary to each 6-nucleotide 
segment of mature miR-200c in the CDS or 3’UTR of the 520 PD genes. Grey shading 
indicates hexamer enrichment ratios that did not differ by P<0.01 from that in equal-sized 
gene sets drawn randomly from all expressed genes. *, P=0.002; **, P<0.0001. (c) 
Cumulative distribution plots of mRNA reduction in 4TO7 cells after transfection with miR-
200c vs cel-miR-67 comparing the set of genes enriched in the Bi-miR-200c PD (R>2 and 
P<0.01 (red) or P<0.001 (blue)) with all expressed genes detected above background in the 
microarray (black), and TargetScan predictions of evolutionarily conserved (dark green) or 
all (light green) miR-200c target genes. Numbers in parentheses indicate the number of 
genes in each set. (*, Kolmogorov–Smirnov test P=0.02; **, P=1.1E-6). (d) Canonical 
pathways (Wikipathways) most enriched (adjusted P (AdjP)<0.01) in the Bi-miR-200c PD 
(R>2,  P<0.01). The PD genes in each enriched canonical pathway are listed in Table S3. 
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To estimate the false-positive rate of the Bi-miR-200c PD, we counted the 
number of transcripts that specifically bound to the control worm Bi-cel-
miR-67, which has no mammalian orthologue, using the same criteria 
(enrichment ratio (Bi-cel-miR-67 PD/Bi-miR-200c PD)/(Bi-cel-miR-67 
input/Bi-miR-200c input) >2 and P<0.01). Comparing 81 mRNAs enriched 
for binding to Bi-cel-miR-67 as background with 520 transcripts enriched for 
binding to Bi-miR-200c, the estimated false-positive rate is 15.6%. 
The putative miRNA target genes had properties expected of canonical 
miR-200c-regulated genes. 43% of the 520 enriched mRNAs were 
predicted miR-200c targets by TargetScan. These therefore contain a 
perfect match to the miR-200c seed in their 3’UTR. The CDS and 3’UTRs 
(Figure 11b), but not the 5’UTRs (data not shown), of the 520 genes were 
also significantly enriched for hexamer seed matches (P<0.0001). 
Transcripts of the 520 pulled-down genes compared to all genes expressed 
in 4TO7 were significantly downregulated after Bi-miR-200c transfection 
(P<2.2E-16, Figure 11c). The extent of their downregulation was 
significantly greater than that of the 384 evolutionarily conserved, 
TargetScan predicted target genes (P=0.023) or the 1175 TargetScan 
predicted genes that included nonconserved binding sequences (P=2.1E-
15). 196 genes were enriched in the PD using a more stringent P cut-off of 
<0.001. This gene set was even more strongly down-regulated than the 
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larger set of 520 genes enriched by P<0.01 (P=1.8E-3) or the conserved 
TargetScan target gene set (P=1.1E-6). 
3.2. miR-200 bound genes are enriched for genes involved in EGFR, 
MAPK and TGF-β signaling and metabolic pathways implicated in 
metastasis and oncogenic transformation 
To understand better the biological processes regulated by miR-200, we 
first performed pathway enrichment analysis of the 520 enriched PD genes 
(Figure 11d, Table S3). The most enriched pathways were MAPK and 
EGFR signaling, both with P-values of 8E-07, each containing 17 putative 
miR-200c targets, of which 6 overlapped. The MAPK and EGFR signaling 
were also significantly enriched pathways in the more stringently chosen 
gene list of 196 putative targets (R>2, P<0.001) (Figure S1a, Table S4). 
Other cell surface receptor signaling pathways were also enriched, such as 
the T and B cell receptor and Kit signaling pathways, which overlap with the 
EGFR pathway and use MAPK signaling. However, these other receptors 
are not expressed in breast tumor cells. TGF-β signaling genes were also 
significantly overrepresented (P<0.005) with 11 annotated genes. These 
included the Zeb2, Smad2, Smad5, and Tgif transcription factors that help 
control epithelial gene expression (see below) and other oncogenic 
transcription factors, including Fosb and Skil. The sphingosine-1-phosphate 
receptor signaling pathway, implicated in tumor metastasis, as well as 
enzymes in sphingolipid and cholesterol biosynthesis pathways, were also 
overrepresented. The mRNAs for 3 enzymes involved in amino acid 
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metabolism, which is altered in cancer cells, were also significantly 
enriched. 
3.3. miR-200-bound genes form a dense interaction network  
The 520 putative miR-200c target genes were analyzed by Ingenuity 
Pathway Analysis software (Ingenuity Systems, www.ingenuity.com) to 
identify directly-interacting target gene products. 222 gene products 
enriched in the PD were annotated to interact directly by protein-protein or 
protein-DNA/RNA interactions (Figure 12). Of note, the interactome 
contained a small module composed of genes that regulate transcriptional 
changes during EMT. These included the master epithelial gene 
suppressors Snail1 and Zeb2, the Snail1 co-repressors Ywhag (14-3-3γ) 
and Ywhab (14-3-3β)42, the Zeb2 co-repressors Smad2 and Smad541 and 
Smad corepressor, Tgif1. Relieving suppression of epithelial gene 
expression may also be enhanced by inhibition of Anp32e, which removes 
histone H2A.Z from promoters and enhancers to initiate transcription from 
paused RNA pol II54. Snail1, Zeb2, Smad2 and Smad5 are activated by the 
canonical TGF-β and BMP signaling pathways, suggesting that miR-200’s 
induction of MET is accomplished in part by suppressing TGF-β and BMP 
signaling. Map2k6 and Mapk12 in the direct-interaction network also 
mediate Smad-independent TGF-β responses. 
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Figure 12. Interactome of directly-interacting pulled-down genes. 222 gene products 
enriched in the PD were annotated to interact directly. 45% of them (red border) are 
predicted by TargetScan (TScan) to be miR-200c targets in mice. 18 genes (green) were 
selected for experimental validation. Edges represent direct protein-protein or protein-
DNA/RNA interactions. A module of genes involved in regulating transcription of epithelial 
genes is highlighted in pink.  
 
These results suggest that miR-200 inhibits both Smad-dependent and -
independent TGF-β and BMP signaling pathways. Another EMT-promoting 
transcription factor is Xbp1, which activates EMT in response to 
endoplasmic reticulum stress55 and has a major role in the tumorigenicity, 
progression and recurrence of TNBC.56 Genes known to regulate cell 
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adhesion such as Fhod157, Wave1/Wasf158 and Map3k159 were also in the 
miR-200 target gene interactome. 
3.4. Experimental validation of the predictions of the Bi-miR-200c 
pull-down 
To determine how reliable the predictions of miR-200-regulated genes 
were, we selected 18 putative target genes to test individually. These 
genes, which covered the full range of enrichment in the PD (2.3-33.7 fold, 
Figure 11a), were chosen because they were located at hubs in the 
interactome, were exceptionally enriched in the PD or might be related to 
miR-200’s known functions. In particular, we were particularly interested in 
the five genes (Ywhag, Ywhab, Snail1, Smad2 and Smad5) implicated with 
the known target Zeb2 in suppression of epithelial gene expression. To 
validate these genes as miR-200c targets, we used an optimized version of 
the PD protocol39 coupled with qRT-PCR to measure their enrichment for 
binding to Bi-miR-200c vs Bi-cel-miR-67 as a control. Bi-miR-200c PD in 
4TO7 cells significantly enriched 14 of the 18 genes (Figure 13a). The 4 
genes that did not confirm (Skil, Bim/Bcl2l11, Mapk1 and Bax) had lower 
enrichment ratios (2.3-3.0). As a control, the housekeeping mRNAs Sdha 
and Tuba1a were not enriched in the Bi-miR-200c PD.  
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Figure 13. Experimental validation of miR-200c target genes identified by the PD (a) Bi-miR-
200c enrichment ratio R in 4TO7 cells 24 h after transfection with Bi-miR-200c or Bi-cel-miR-
67 mimics by qRT-PCR normalized to Gapdh for 18 genes chosen for validation. R = {miR-
200c PD (gene mRNA/Gapdh mRNA)}/{Cel-miR-67 PD (gene mRNA/Gapdh mRNA)}. 
Tuba1a and Sdha are negative controls and Zeb2 is a positive control. (b) miR-200c 
regulation of the 3’UTR of the 14 putative target genes confirmed to be pulled down by Bi-
miR-200c. 4T1E cells, co-transfected with the dual luciferase reporter psiCHECK-2 bearing 
the full 3’UTR of each gene in the 3’ UTR of the Firefly reporter and with control or miR-200c 
mimics, were analyzed by luciferase assay 24 h later. Firefly luciferase activity was 
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normalized to Renilla activity. Results obtained for miR-200c transfection were normalized to 
control miRNA transfection. (c) qRT-PCR PD enrichment ratio (a) correlates inversely with 
3'UTR luciferase assay (b). (d) Effect of miR-200c over-expression on mRNA levels of the 
14 confirmed pulled down genes, assessed by qRT-PCR normalized to Gapdh 48 h after 
transfection of 4TO7 cells with miR-200c vs control miRNA mimics. (e) qRT-PCR 
comparison of miR-200 target gene mRNA expression, relative to Gapdh, in 4TO7 and 4T1 
cells. (f) Immunoblot of total cell lysates extracted 48 h after transfecting 4TO7 cells with 
control (Ctrl) or miR-200c (m200c) mimics. α-Tubulin is a loading control. The bar graph 
shows the relative ratio of the signal (normalized to α-Tubulin) in replicate experiments by 
densitometry, relative to cells transfected with control mimic. Bar graphs represent mean ± 
SD of three independent experiments. *, P<0.05. 
 
To determine whether the confirmed pulled-down genes are direct miR-200 
targets, we cloned their full 3’UTRs into a dual-luciferase reporter vector 
and measured changes in luciferase activity in 4T1E cells after co-
transfection with control or miR-200c mimic. miR-200c significantly 
repressed the 3’UTRs of 12 of the 14 genes by ~15-85% (Figure 13b), 
confirming that their 3’UTRs are directly regulated by miR-200c. The 
degree of repression of luciferase activity by miR-200c acting on the 
3'UTRs strongly correlated with their enrichment ratio in the PD, suggesting 
that those mRNAs that bound most strongly were the most highly regulated 
(Figure 13c). We next looked at whether miR-200c over-expression 
significantly reduced mRNA levels of the 14 genes in 4TO7 cells, which do 
not express endogenous miR-200, 48 h later. mRNAs for 13 of the 14 
genes were significantly reduced by 25-85% (Figure 13d). To confirm this 
result in another cell line, we looked at whether miR-200c over-expression 
significantly reduced mRNA levels of the 12 of these genes expressed in 
NIH/3T3 cells 48 h later. mRNAs for all 11 target genes that confirmed in 
4TO7 were significantly reduced by 15-80% (Figure S1b). (The Zfp36 gene 
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that didn’t confirm in 4TO7 also wasn’t suppressed in 3T3 cells.) The 
confirmed genes included the two genes (Scmh1 and Skp2) whose 3’UTRs 
were not regulated by miR-200 over-expression. These might contain miR-
200c miRNA recognition elements (MREs) in the CDS. However, this 
possibility was not examined experimentally. We also compared expression 
of the 14 target genes in 4TO7 and 4T1 cells. 4T1 cells are fully metastatic, 
express high levels of miR-200b/c/429 and have an epithelial-like 
morphology. In contrast, 4TO7 cells are poorly metastatic, don’t express 
the miR-200 family and have a mesenchymal-like morphology4. Expression 
of the 13 of the 14 genes that were validated as targets was significantly 
downregulated in 4T1 cells compared to 4TO7 cells (Figure 13e). For 4 
genes (Crtap, Smad5, Ywhag and Ywhab), we also examined the effect of 
miR-200c over-expression on protein levels 48 h later (Figure 13f). All 4 
proteins were significantly reduced after miR-200c over-expression.  
To confirm that the 12 genes whose 3’UTRs were regulated by miR-200c 
were bona fide targets, we next wanted to determine whether their 3’UTRs 
contain miR-200c MREs. We used TargetScan47, PITA50 and RNAhybrid51 
algorithms to identify potential MREs in their 3’UTRs (Table S5). For all 12 
genes, except Smad2, we identified one MRE, all but one of which had 
exact seed pairing and verified that it was functional by showing that 
mutation of its seed sequence within the full 3’UTR restored luciferase 
reporter activity (Figure 14). 
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Figure 14. Identification of miR-200c microRNA recognition elements (MREs) in the 3’UTRs 
of 12 new target genes (a) 4T1E cells, co-transfected with control or miR-200c mimics and 
with a psiCHECK-2 luciferase reporter plasmid bearing the wild-type full 3’UTR of each gene 
or a mutated 3’UTR (mut) in which the miR-200c seed region of one or two MREs was 
mutated were analyzed for luciferase activity 24 h later. Firefly luciferase activity was 
normalized to Renilla activity and results obtained for miR-200c mimic transfection were 
normalized to control mimic. Data represent mean ± SD of three independent experiments. 
*, P<0.05. (b) Functional miR-200c MREs in each 3’UTR are shown (numbers in 
parentheses indicate the position of the MRE in each 3’UTR). Point mutations in residues in 
red were introduced in each full 3’UTR in the mutant plasmid. Perfect matches are indicated 
by a line; G:U pairs, by a colon. Table S5 shows all the predicted MREs that were tested. 
 
For Smad2 we identified 2 MREs, neither of which had canonical seed 
pairing, but both had at least 7 continuous exact matches to miR-200c 
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overlapping with the seed; mutation of these pairing sequences in both 
MREs restored luciferase activity, but each individually only partially 
restored activity (data not shown). The results in Figures 13 and 14 taken 
together demonstrate that the miR-200c PD is highly specific for identifying 
miR-200c regulated genes. The low false positive rate in our data set 
suggests that miR-200c can potentially regulate hundreds of genes. 
3.5. miR-200 targets Snail1 and Zeb2 transcription complexes 
To confirm that miR-200 enhances epithelial gene expression in 4TO7 
cells, we measured the effect of miR-200c over-expression on Zeb2 and 
epithelial gene (Cdh1, the gene encoding E-cadherin; Cldn3 and Cldn7, 
claudin genes) mRNAs by qRT-PCR (Figure 15a). As expected, Zeb2 
mRNA significantly declined, while the epithelial gene mRNAs increased 3-
10-fold. To determine how much of the effect of miR-200 could be 
attributed to Zeb2 knockdown (KD), we compared the effect of miR-200 
over-expression and Zeb2 KD, both of which caused a comparable 
reduction in Zeb2 mRNA. Zeb2 KD only induced the epithelial genes by ~2-
fold. Thus miR-200 regulation of other genes likely contributes substantially 
to promoting epithelial transition.  
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Figure 15. miR-200 induces epithelial gene expression by repressing Zeb2 and Snail1 
complexes (a) miR-200c over-expression enhances epithelial gene expression more than 
Zeb2 KD. Gene expression in 4TO7 cells was analyzed by qRT-PCR, relative to Gapdh, 48 
h after transfection with the indicated siRNA or miRNA mimics, relative to control siRNA or 
miRNA transfection. (b) Effect of miR-200c over-expression and Zeb2, Smad5, Ywhag and 
Snail1 KD on the transcriptional activity of a luciferase reporter plasmid bearing the -178 to 
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+92 fragment of the Cdh1 promoter. 4TO7 cells were co-transfected with the Firefly 
luciferase promoter construct and a control Renilla reporter vector and 24 h later with the 
indicated siRNA or miRNA mimics. Relative luciferase activity measured 48 h after the last 
transfection were normalized to that in cells transfected with the respective control siRNA or 
miRNA. (c) Schematic of putative Zeb2 and Snail1 binding sites (E-boxes) in the 1000 bp 
genomic sequence upstream of the transcription start sites (nucleotide +1) of the mouse 
Cdh1 (E-cadherin) and Cldn3 (claudin-3) genes. Sequences amplified by qPCR are 
indicated in red. (d-f)  Binding of RNA polymerase II, Zeb2 or Snail1 to sequences in the 
Cdh1 or Cldn3 promoter (Pr) or exon 24 h after transfecting 4TO7 cells with control (Ctrl) or 
miR-200c (m200c) mimics was analyzed by ChIP. Graphs show the binding to the specific 
antibody compared to binding to the same amount of IgG as measured by qPCR. The Hbb1 
(β-globin) promoter region was used as a control. (g) Immunoblot analysis of total protein 
extracted 48 h after 4TO7 cells were transfected with control (Ctrl) or miR-200c (m200c) 
mimics. α-Tubulin is a loading control. The bar graph shows the relative ratio of the signal 
(normalized to α-Tubulin) in replicate experiments by densitometry, relative to cells 
transfected with control mimic. Bar graphs show mean ± SD of three independent 
experiments. *, P<0.05. 
 
In addition to Zeb2, miR-200c pulled down the E-cadherin transcription 
repressor Snail1 and the corepressors Smad2/Smad5 and Ywhag/Ywhab 
(Figure 12 and Figure 13). Moreover the mRNAs of all of these genes were 
significantly down-regulated by miR-200 over-expression in 4TO7 cells. 
The other Smad and 14-3-3 genes were not pulled down with miR-200c 
and their mRNA levels were not reduced by miR-200c over-expression 
(Table S2, Figure S2a). To examine whether suppression of these other 
miR-200c target genes contributes to epithelial gene expression, we co-
transfected 4TO7 cells with miR-200c or control miRNA mimics or siRNAs 
against Zeb2, Snail1¸ Ywhag or Smad5 and a pGL3 reporter vector 
containing the Firefly luciferase gene under the control of the –178 to +92 
fragment of the mouse E-cadherin promoter (Figure 15b). Depletion of 
endogenous Snail1, Smad5 and Ywhag individually (verified by qRT-PCR, 
data not shown) enhanced transcription from the E-cadherin promoter 
about ~2.5-fold (almost as much as KD of Zeb2, which increased promoter 
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activity ~3-fold) and more than the 2-fold increase in promoter activity 
caused by miR-200 over-expression.  
Zeb260 and Snail161 are zinc finger transcription factors that bind to a 
consensus E-box hexanucleotide sequence (CACCTG) in the promoters of 
epithelial genes to repress their expression. Cdh1 and Cldn3 promoters 
have several E-box sequences (Figure 15c) that render them transcriptional 
targets of Zeb2 and Snail1. To determine whether miR-200 regulates the 
binding of endogenous Zeb2 and Snail1 to these promoters and 
transcription of epithelial genes, we performed Zeb2, Snail1 and RNA pol II 
chromatin-immunoprecipitation (ChIP) assays one day after 4TO7 cells 
were transfected with control or miR-200c mimics. miR-200 over-
expression significantly enhanced RNA pol II  occupancy of the Cdh1 and 
Cldn3 promoter and exonic regions, but not of the Hbb1 (β-globin) promoter 
used as a control (Figure 15d), as expected, consistent with enhanced 
transcription of epithelial genes. In control cells, Zeb2 bound to the Cdh1 
promoter and Snail1 bound to both the Cdh1 and Cldn3 promoters, but 
neither bound above background to exonic regions of these genes (Figures 
15e and 15f). miR-200 over-expression completely suppressed Zeb2 and 
Snail1 binding to these promoters. Thus miR-200c over-expression 
enhances transcription of epithelial genes, likely by reducing binding of both 
the Snail1 and Zeb2 transcriptional suppressor complexes.  
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Zeb2 is a well validated strong target of miR-200c, which we confirmed in 
this mouse system by showing 80-90% reduction in luciferase reporter 
activity of the 3’UTR (Figure 13b) and mRNA level (Figure 13d) after miR-
200 over-expression. We previously showed that Zeb2 protein becomes 
undetectable in 4TO7 cells upon miR-200c-over-expression4, so it is not 
surprising that Zeb2 binding to epithelial gene promoters became 
undetectable. Changes in Snail1 mRNA level and luciferase activity after 
miR-200c over-expression and Snail1 miR-200c binding were much less 
than for Zeb2 (Figure 13a-d), suggesting that it is a weaker target. In fact, 
miR-200c over-expression had no significant effect on Snail1 protein level 
(Figure 15g), presumably because other mechanisms compensated. Thus 
reduced binding of Snail1 to the epithelial gene promoters (Figure 15f) was 
not due to a reduction in Snail1 protein. However, Snail1 binding to E-
boxes and its repressor activity requires it to bind to Ywhag or Ywhab, 
since removing the Snail1 14-3-3 binding domain completely blocks its 
binding and repressor activity.42 Ywhag and Ywhab protein levels declined 
with miR-200c-over-expression (Figure 13f). Reduced 14-3-3 protein levels 
by miR-200c targeting likely contributed to the absence of detectable Snail1 
binding to epithelial gene promoters, although other unknown mechanisms 
may have contributed. 
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3.6. miR-200 inhibits the EMT-promoting effects of TGF-β and BMP-2 
Genes that mediate TGF-β signaling, which promotes mesenchymal 
properties, were significantly enriched in the miR-200 target network (Fig. 
1d). Both Smad2 and Smad5, the receptor-Smads (R-Smad), which we 
validated as miR-200 targets (Figures 13 and 14 and S2a), were 
phosphorylated in response to TGF-β treatment of 4TO7 and 4T1 cells, as 
has been previously reported62 (Figure S2b). To investigate the effect of 
miR-200 on TGF-β signaling, we treated 4TO7 and 4T1 cells transfected 
with miR-200c or control miRNA with TGF-β or control vehicle. In both cell 
lines, TGF-β significantly reduced Cdh1 expression as expected and also 
up-regulated Zeb2. Cells over-expressing miR-200 significantly inhibited 
these TGF-β-mediated  effects in both cell lines (Figure 16a). Bone 
morphogenic proteins (BMPs) belong to the TGF-β superfamily, but 
mediate their signaling via R-Smads 1, 5 and 8. To study the effect of miR-
200 on BMP signaling further, we treated 4TO7 cells transfected with miR-
200c or control miRNA with BMP-2. BMP-2 treatment, as expected, 
significantly decreased the expression of 2 epithelial genes (Cdh1 and 
Cldn3) and increased phosphorylation of the BMP-activated R-Smads 
(Figure 16b and c). miR-200 over-expression also significantly inhibited 
both these effects and also decreased Smad5 protein (Figure 16b and c). 
miR-200 didn’t affect Smad1 and Smad8 levels (Figure S2a). Reduced 
Smad1/5/8 phosphorylation was recapitulated by knocking down Smad5  
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Figure 16. Snail1, Smad5, Ywhag and Crtap are physiologically important miR-200c targets  
(a) Effect of miR-200c over-expression on TGF-β signaling. qRT-PCR data were normalized 
to Gapdh. 4TO7 and 4T1 cells were transfected with control (Ctrl) or miR-200c (m200c) 
mimics in the presence of TGF-β or vehicle. RNA was harvested 48 h after transfection. For 
each cell line, results were normalized to transfection with control miRNA and treatment with 
vehicle. Asterisks above bars indicate significant differences in relative mRNA expression 
compared to control miRNA-transfected, untreated samples, while asterisks above brackets 
indicate significant differences between paired control miRNA and miR-200-transfected 
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samples. (b) Effect of over-expression of miR-200-resistant Smad5 and Ywhag or empty 
vector control (EV) on miR-200c-mediated epithelial gene mRNA upregulation in cells 
treated with vehicle or BMP-2. qRT-PCR data were normalized to Gapdh. 4TO7 cells were 
co-transfected with the indicated pcDNA3.1 expression vectors and control (C) or miR-200c 
(M) mimics in the presence of BMP-2 or vehicle. RNA was harvested 48 h after transfection. 
All results were normalized to control conditions in which cells were co-transfected with 
pcDNA3.1 EV and control miRNA and treated with vehicle. Asterisks above bars indicate 
significant differences in relative mRNA expression compared to the vehicle-treated sample 
co-transfected with EV and control mimic, while an asterisk above a bracket indicates 
significant differences between paired EV and expression plasmid-transfected samples. (c) 
Effect of miR-200c over-expression (top) or Smad5 KD (bottom) on BMP signaling. 
Immunoblot of total protein extracted at indicated times after BMP-2 stimulation of serum-
starved 4TO7 cells that were transfected with the indicated miRNA or siRNA 48 h earlier. α-
Tubulin is a loading control. (d) Effect of Zeb2, Snail1, Smad5, Ywhag and Crtap KD on 
epithelial gene expression. mRNA was analyzed by qRT-PCR relative to Gapdh 72 h after 
transfection of 4TO7 cells with indicated target gene siRNAs. Asterisks above bars indicate 
significant differences in relative mRNA expression compared to control siRNA-transfected 
samples, while asterisk above brackets indicates significant difference when Snail1 KD is 
combined with Zeb2 KD. (e) Immunoblot of total protein extracted 72 h after 4TO7 cells were 
co-transfected with control (Ctrl) or miR-200c (200c) mimics and indicated target gene 
siRNAs or control (Ctrl) siRNAs. α-Tubulin is a loading control. (f) Invasion through Matrigel 
of 4TO7 cells co-transfected with miRNA mimics or 50 nM target gene siRNAs and an 
siRNA against Crtap or control (Ctrl) siRNA. In (d-f) 50 nM of each siRNA was used. Ctrl 
siRNA was added if needed to achieve a final total siRNA concentration of 100 nM. Results 
were normalized to control siRNA or miRNA transfection. An siRNA targeting Firefly 
luciferase (Lucif.) was used as a control. Bar graphs show mean ± SEM of three 
independent experiments. Bar graphs show mean ± SD of three independent experiments, 
unless otherwise specified. *, P<0.05. 
 
(Figure 16c), suggesting that miR-200 represses BMP signaling by 
suppressing its signaling mediator, Smad5. Thus miR-200 inhibits both 
TGF-β and BMP signaling. 
3.7. Smad5 gene regulation contributes to miR-200 enhancement of 
epithelial gene expression 
The experiments performed so far have involved miR-200c over-
expression, which can sometimes exaggerate the role or mechanism of 
endogenous miRNAs. To investigate the contribution of targeting individual 
gene targets to miR-200-mediated MET, we first assessed the effect on 
epithelial gene expression of knocking down some of the epithelial gene 
transcriptional repressor and corepressor genes in 4TO7 cells. KD of Zeb2 
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or Snail1 increased E-cadherin and claudin-3 mRNA and protein 
expression as expected (Figures 16d and 16e), and knocking down both 
was additive. Smad5 or Ywhag KD did not affect epithelial gene 
expression, probably because other family members, known to have 
overlapping functions, may have substituted. The effect of miR-200c over-
expression and Zeb2, Snail1, Smad5, Ywhag and Crtap KD on E-cadherin 
expression and cell morphology of 4TO7 cells was also analyzed by 
fluorescence microscopy (Figure S3). Over-expression of miR-200c in 
4TO7 cells increased E-cadherin protein and changed 4TO7 morphology 
from spindle-shaped to cobblestone-forming epithelial-like cells. Although 
there was no clear microscopic effect of Snail1 KD, KD of Zeb2 increased 
E-cadherin protein expression and epithelial morphology, and knocking 
down Zeb2 together with Snail1 was additive. KD of Smad5, Ywhag or 
Crtap individually did not affect E-cadherin protein expression, consistent 
with qRT-PCR and immunoblotting analyses.  
To probe the contribution of Ywhag and Smad5 suppression in miR-200c-
mediated epithelial gene activation, we cotransfected 4TO7 cells with miR-
200c or control miRNA and miR-200c-resistant expression plasmids for 
these genes. Ywhag and Smad5 protein increased in these cells even in 
the presence of exogenous miR-200c (Figure S2c). BMP-2, which 
increased phosphorylation of Smad1/5/8 (Figure 16c), reduced epithelial 
gene expression and the induction of epithelial genes by miR-200 (Figure 
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16b). Expression of miR-200-resistant Smad5 slightly, but significantly, 
reduced miR-200c-mediated E-cadherin and claudin-3 upregulation in cells 
treated with the Smad5 activator (BMP-2), but not in cells not treated with 
BMP-2. Thus, miR-200 suppression of endogenous Smad5 contributes 
modestly to promoting the MET. However, over-expression of miR-200-
resistant Ywhag had no significant effect in this assay. 
3.8. The miR-200c target Crtap promotes cell invasion 
Crtap was one of the strongest miR-200c targets, based on its enrichment 
in the PD (~34-fold) and reduction in luciferase activity and mRNA 
expression (Figure 13). Not much is known about Crtap. Crtap is an 
enzyme cofactor that facilitates prolyl-hydroxylation of type I collagen, and 
its homozygous mutation leads to osteogenesis imperfecta, a severe defect 
in bone mineralization. Of note, a recent study suggests that prolyl-
hydroxylation of type I collagen is required for collagen binding to decorin, a 
proteoglycan that captures TGF-β in the extracellular matrix. KD of Crtap 
had no effect on epithelial gene expression (Figures 16d and 16e). One of 
the hallmarks of mesenchymal cells and TGF-β stimulated cells is their 
motility and ability to invade basement membranes. However, Crtap has no 
known role in cell motility. To determine whether suppression of Crtap or 
the epithelial gene suppressor targets of miR-200c promote invasion, we 
knocked them down in 4TO7 cells and measured the effect on cell invasion 
across a collagen-containing Matrigel-coated membrane (Figure 16f) (KD of 
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these genes had no effect on cell viability (Figure S2d). KD of Zeb2 
reduced invasivity comparably to transfection of miR-200c. KD of Smad5, 
Ywhag or Snail1 inhibited invasivity even more strongly than either miR-200 
over-expression or Zeb2 KD. However, KD of Crtap had the most potent 
inhibitory effect on invasion. These results suggest that Crtap and other 
miR-200-regulated gene products have unexpected roles in cell 
motility/invasion. 
3.9. CRTAP and miR-200 expression are inversely correlated in NCI-
60 tumors and primary human breast cancers 
To further study the potential relationship between Crtap and miR-200c in 
cancer, we analyzed the correlation between CRTAP and miR-200c 
expression in the NCI-60 panel of human cancer cell lines. The miR-200 
MRE we identified in the mouse gene is evolutionarily conserved in 
mammals, and human CRTAP is a high confidence TargetScan-predicted 
miR-200c target, which contains a perfect 8-mer seed binding site (Figure 
S4a). CRTAP expression was almost as strongly inversely correlated with 
miR-200c expression in the NCI-60 panel of human cancer cell lines 
(Pearson r = -0.44, P<0.05) as ZEB2 expression (r =-0.50, P<0.05). The 
housekeeping gene SDHA used as a control was not significantly 
correlated. We also analyzed data from a study that performed genome-
wide mRNA and miRNA profiling in 101 human primary breast cancer 
samples63. CRTAP and ZEB2 expression were also significantly inversely 
correlated with miR-200c expression in that cohort (Figure S4b). These 
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Figure 17. Schematic model of how miR-200c induces epithelial gene expression. miR-200c 
inhibits the expression of multiple members of the Zeb2 and Snail1 epithelial gene 
suppressor complexes that are activated by BMP or TGF-β signaling. Both of these 
complexes also suppress miR-200 transcription in a negative feedback loop64-65. 
Additionally, miR-200 knocks down Crtap, which is required for type I collagen prolyl-
hydroxylation by prolyl 3-hydroxylase (P3H1) in complex with cyclophilin B (CyPB) in the 
endoplasmic reticulum. This post-translational modification is required for collagen to bind to 
decorin, which sequesters TGF-β in the extracellular matrix. Thus, miR-200 KD of Crtap may 
change TGF-β capture by the extracellular matrix and alter TGF-β-stimulated EMT and 





The role of the miR-200 family in the epithelial-to-mesenchymal transition (EMT) 
89 
4. Discussion 
In this study, we used a biochemical method with high specificity to identify 
without bias candidate genes that bind to Bi-miR-200c as putative miR-
200c target genes. 520 gene mRNAs were enriched at least 2-fold in 
binding to miR-200c with a P<0.01 and 196 were similarly enriched with 
greater confidence (P<0.001). Gene expression of these biochemically 
identified miR-200 putative target genes was much more significantly 
downregulated (P=E-6) after miR-200c over-expression than genes 
predicted to be miR-200c-regulated genes by the best available prediction 
algorithm (evolutionarily conserved TargetScan targets). The most 
significantly enriched pathways were EGFR and other cell surface receptor 
signaling pathways and the MAPK pathways activated secondarily. 
Importantly, genes involved in TGF-β receptor signaling, which promotes 
mesenchymal transition and mesenchymal properties, were significantly 
enriched, and BMP and TGF signaling effects were inhibited by miR-200 
over-expression. These target genes, included genes encoding the R-
Smad transcription factors, Smad2 (activated by TGF-β signaling) and 
Smad5 (activated by BMP signaling), which we confirmed were miR-200c 
targets, and Tgif, a corepressor of Smad transcription, which we did not 
experimentally validate. Ectopic expression of miR-200c-resistant Smad5 
slightly but significantly reduced epithelial gene suppression by BMP-2 
when miR-200 was ectopically expressed. These results suggest that 
inhibition of TGFβ/BMP signaling genes by miR-200 contributes to 
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maintaining epithelial gene expression. miR-200 expression is known to be 
repressed by BMP-266 and TGF-β67. Thus our data suggest that miR-200c 
reinforces the epithelial state not only by inhibiting epithelial gene 
suppressors, but also by inhibiting TGFβ/BMP signaling.  
The miR-200 family is well known to promote epithelial transition through 
suppression of the epithelial gene transcriptional repressors, Zeb1/2 and 
Snail1/2 (Snail and Slug).4,18-21,23-24 Here we confirmed that Zeb2 and Snail1 
were miR-200c target genes (Zeb1 and Snail2 were not expressed in these 
cells). However, although we previously showed that exogenous miR-200c 
expression strongly suppressed Zeb protein levels in these cells4, Snail1 
protein levels did not change. Snail1 protein was also not downregulated in 
4TO7 cells by miR-200c over-expression in a previous study8. Although 
Snail1 mRNA was consistently down-regulated by miR-200 and an MRE 
was identified, verifying that it is a bona fide target of miR-200, it was a 
weak target. Snail1 is a very labile protein with a short half-life (~25 min) 
regulated by phosphorylation and ubiquitylation68. Post-translational 
modifications of Snail1 protein likely counteracted the weak effect of miR-
200 on Snail1 mRNA. miR-200c orchestrates the expression of epithelial 
genes not only by suppressing key transcriptional repressors, but also by 
targeting multiple gene products that act as cofactors in the Zeb and Snail1 
repressor complexes, namely Smad2 and Smad5 (with Zeb) and 14-3-3β 
and 14-3-3γ (with Snail1) (Figure 17).42 In fact miR-200c-over-expression 
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had a much stronger effect on epithelial gene expression than Zeb2 KD, 
and KD of any of these genes strongly induced the E-cadherin promoter. 
As a consequence, miR-200 over-expression greatly reduced Zeb2 and 
Snail1 binding specifically to epithelial gene promoters and enhanced RNA 
pol II binding to these promoters and transcription of epithelial genes. 
Snail1 binding to promoters likely depends on the availability of its co-
repressors. A previous study showed that KD of the Snail1 co-repressor 
Ajuba69 also impairs Snail1 binding without changing Snail1 protein level. 
KD of other genes in the miR-200c PD, especially Cbf-A (Nfyb)70, whose 
product is a component of the CBF-A/KAP-1/FTS-1 complex that is a 
master transcriptional regulator of mesenchymal genes, and the NURD 
complex component Mta171, which enhances transcription of Snail1/2 and 
their recruitment to epithelial gene promoters, may also contribute to 
promoting the epithelial transition. Thus the ability of miR-200c to foster 
MET is reinforced by its suppression of multiple components of epithelial 
gene repressor complexes, its suppression of TGF-β/BMP signaling and 
likely direct suppression of mesenchymal gene transcriptional activators as 
well. 
We experimentally examined the accuracy of the PD predictions for 18 
genes that were not known miR-200c targets when we began this study. 14 
of 18 (78%) identified as enriched by the PD and microarray analysis, were 
found to be enriched by at least 2-fold by more accurate qRT-PCR 
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analysis. The 4 genes that were not confirmed had a fold-enrichment that 
was close to our arbitrary cut-off of 2-fold enrichment. We estimated the 
false positive rate of the PD method used here as 16%, which compares 
favorably with estimated false positive rates of the best bioinformatics 
prediction algorithms (which vary between 22 and 31%72) or Ago-
immunoprecipitation (~40-70%73). It is similar to the estimated false positive 
rate of Ago HITS-CLIP (~13-27%73). Our method, which does not use 
cross-linking, has the advantages that it is simpler and easier to do and 
requires much fewer cells. The current estimate is similar to an estimate we 
made for the specificity of a miR-34a PD, where only 1 of 11 (9%) of a 
random list of putative miR-34a-regulated targets was not verified34. That 
paper required a higher enrichment in the PD (>2.5 fold) than we used 
here, which could explain the higher specificity. Increasing the cut-off for 
the microarray data would undoubtedly improve the specificity of the PD 
method for identifying bona fide target genes, but at the cost of reduced 
sensitivity. Performing more replicates, and/or changing from microarray 
analysis of bound mRNAs to RNA sequencing (as we recently described39) 
would likely increase the specificity of the PD. The 3’UTRs of 12 of the 14 
confirmed enriched genes (86%) had miR-200-regulated 3’UTRs and we 
were able to identify 3’-UTR MREs for all of them. Four of these hits were 
meanwhile independently identified as miR-200-regulated genes by other 
groups, further supporting our results (Snail123, Smad223, Fhod174 and 
Ywhag75). Most of these new 3’UTR MREs (11/13) had exact seed 
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matches, suggesting that recognition of target genes by miR-200c closely 
follows canonical seed pairing. The remaining 2 confirmed gene targets 
may either be false positives or have MREs in the CDS, since recent 
studies suggest that a large fraction of MREs are in coding regions73,76-77 
and the target gene list was significantly enriched for mRNAs that contain 
seed pairing sequences in the CDS. The extent of enrichment in the PD 
correlated well with the extent of miR-200 suppression by luciferase activity 
(Figure 13c) or mRNA down-regulation after miR-200c over-expression 
(data not shown). These results suggest that strong enrichment in the PD 
can be used to identify the set of genes most highly regulated by a miRNA, 
which may be the more important targets.  
The high level of specificity of the PD, coupled with the large number of 
enriched genes in one cell line that we examined, suggest that miR-200c is 
capable of regulating hundreds of genes. How many genes are suppressed 
under physiological conditions is uncertain, since our study relied on miR-
200c over-expression where miR-200c levels are not rate-limiting. 
Moreover, how much the set of regulated genes varies amongst cell types 
is also unclear for miR-200c or, for that matter, for any individual miRNA. 
Another open question is how much the target genes for miR-200c are 
shared with miR-200b and miR-429, which have identical seed sequences 
or with miR-200a and miR-141, which, although they are considered family 
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members, actually have seed sequences that differ by one nucleotide. The 
Bi-miRNA PD method could be used to address these questions. 
Crtap, which was enriched in the Bi-miR- 200c PD by ~30-fold by 
microarray binding to each of 2 probes (Table S2) and by qRT-PCR (Figure 
13a) and whose mRNA and protein both were substantially reduced by 
miR-200c over-expression (by ~6-fold and ~2-fold, respectively; Figure 
13d,f), was found to play an unanticipated role in cell invasivity through 
Matrigel. CRTAP expression in human tumor cell lines and a human breast 
cancer cohort was inversely correlated with miR-200c expression, 
suggesting that CRTAP is also an important miR-200 target in humans. 
Crtap, which is hypomorphic in some patients with osteogenesis imperfecta 
(OI), is an endoplasmic reticulum cofactor for prolyl 3-hydroxylation of 
collagen. Tumor cell secretion of collagen with reduced prolyl 3-
hydroxylation may promote tumor invasion. Loss of Crtap may reduce 
collagen binding of small leucine-rich proteoglycans, such as decorin78, that 
sequester mature TGF-β within the extracellular matrix. In fact, many of the 
symptoms of OI in Crtap-/- mice can be ameliorated by injection of anti-TGF-
β. Changes in TGF-β capture by the extracellular matrix could alter TGF-β-
stimulated EMT and invasivity. Another possibility is that modifications of 
prolines on other unknown secreted substrate(s) are responsible for 
enhanced invasivity/metastasis of miR-200 over-expressing cells. Further 
study of the role of Crtap in cancer and metastasis is warranted. Another 
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highly enriched gene in the PD, which was previously identified as a miR-
200c target gene74, which we showed is a strongly regulated miR-200c 
target gene, was Fhod1. Fhod1 is a formin that bundles and stabilizes actin 
filaments in lamellipodia and filopodia at the leading edge of moving cells 
and has been implicated in regulating cytokinesis during mitosis in an E-
cadherin dependent pathway. Fhod1 is upregulated in cancer cells and 
during EMT and has been linked to enhanced invasion and metastasis in 
some models. In this study we did not look at the functional consequences 
of Fhod1 suppression on cancer properties. Because miR-200 expression 
enhances metastasis in some cancer models4,7-10 and reduces it in others11-
13, it will be worthwhile to study more the effect of miR-200 on Crtap and 
Fhod1 in cancer cell migration and metastasis. 
5. Note added in proof 
After the submission of this manuscript, a report79 was published, which 
used Ago-HITS-CLIP to identify candidate miR-200a/b targets in MDA-MB-
231 human breast cancer cells. They found that miR-200a/b controls actin 
cytoskeleton dynamics by regulating gene products involved in Rho-ROCK 
signaling, invadopodia formation, matrix metalloproteinase activity and focal 
adhesions. They also identified cell adhesion and TGF-β signaling as 
among the most enriched pathways for miR-200a/b targets in human cells 
in agreement with our findings for miR-200c targets in mouse. Integrin-
mediated cell adhesion (Figure 1d) and focal adhesion (adjusted P=2.1E-
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02, data not shown) networks, which share 29 and 48 genes, respectively, 
with the actin cytoskeleton regulation network were amongst the most-
enriched pathways we identify here for miR-200c targets in mouse. About 
25% of the target genes we identified for miR-200c in mice were also found 
by Bracken et al. for miR-200a/b in humans. Of note, 50% of the 12 genes 
we validated as direct miR-200c targets in mouse by luciferase assay were 
also identified by Bracken et al. to be miR-200a/b targets (Crtap, Map3k1, 
Smad5, Ywhag, Zfp36 and Ywhab), further supporting our findings. 
However, we did not identify control of actin cytoskeleton dynamics on its 
own as a significantly enriched process in miR-200c-regulated mouse cells. 
This difference in conclusions between our study, which studied a mouse 
TNBC that has both mesenchymal and epithelial properties, and theirs, 
which examined a mesenchymal human TNBC cell line, could reflect 
differences in technique, differences between the relevant miR-200 family 
members (miR-200c vs miR-200a/b), differences in mouse and human 
targets, or differences in gene expression between these cell lines. In fact, 
about half of the mouse miR-200c target genes we found that were not 
identified as targets of miR-200a/b in human cells do not have TargetScan-
predicted miR-200 binding sites that are conserved between mice and 
humans. Additionally, the Bracken et al. study showed that epithelial human 
TNBC cell lines, which are not motile, do not express many of the actin 
motility-related targets identified in the mesenchymal cell line they studied. 
These differences suggest that some of the target genes and functions of a 
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miRNA may be shared in different cellular contexts, while others may be 
context-specific. 
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8. Supplemental figures 
 
Figure S1. (a) Canonical pathways (Wikipathways) most enriched (adjusted P (AdjP)<0.05) 
in the Bi-miR-200c PD (R>2,  P<0.001). The PD genes in each enriched canonical pathway 
are listed in Table S4. (b) Effect of miR-200c over-expression on target gene mRNA levels in 
NIH/3T3 cells. Relative mRNA level, normalized to Gapdh, was assessed 48 h after 
transfection of miR-200c vs control miRNA mimics. N.D., not detected (transcript not 
expressed). Shown are mean ± SD of three independent experiments. *, P<0.05. 
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Figure S2. (a) Effect of miR-200c on mRNA expression of 14-3-3 and Smad family genes, 
Ajuba and Prmt5. qRT-PCR, performed 48 h after 4TO7 cells were transfected with control 
(Ctrl) or miR-200c (m200c), was normalized to Gapdh. (b) Immunoblot of total protein 
extracted at indicated times after adding TGF-β to serum-starved 4TO7 or 4T1 cells. α-
Tubulin is a loading control. (c) Immunoblot of total cell lysates extracted 48 h after co-
transfecting 4TO7 cells with the indicated over-expression vector or empty vector (EV) and 
control (Ctrl) or miR-200c (m200c) mimics. α-Tubulin is a loading control. (d) 4TO7 cell 
viability, assessed by CellTiter-Glo 72 h after co-transfection of miRNA mimics or indicated 
target gene siRNAs and an siRNA against Crtap or control (Ctrl) siRNA. Bar graphs 
represent mean ± SD of three independent experiments. *, P<0.05. 
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Figure S3. Effect of miR-200c over-expression and Zeb2, Snail1, Smad5, Ywhag or Crtap 
KD on 4TO7 cell morphology and E-cadherin staining (green). DAPI (blue) was used to stain 
nuclei. Scale bar,10 μm. 




Figure S4. (a) TargetScan-predicted miR-200c MRE in human CRTAP 3’UTR (numbers in 
parentheses indicate the position of the MRE in the 3’UTR). Perfect matches are indicated 
by a line; G:U pairs, by a colon. (b) Correlation of miR-200c and CRTAP, ZEB2 and SDHA 
expression in a cohort of human primary breast tumors. 
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10. Supplemental tables 
 
Table S1. Published miR-200 target genes and their overlap with the PD gene list. Only 
genes experimentally validated to be directly targeted by miR-200 were considered. Species 
(Human (H), Mouse (M) or Rat (R)) in which gene was experimentally validated and miR-
200 family members used for validation are shown. N.D., not detected (transcript not 
expressed by Bi-cel-miR-67-transfected 4TO7 cells). N.P., no probe (microarray had no 
probe for transcript). 
 
 





1 ACVR2B H 200c, 141 1.5 80 
2 AP-2Α (TCFAP2A) H 200c, 200b, 429 2.3 
81 
3 ARHGAP19 H 200c N.D. 82 
4 BCL-2 H H 


















6 BRD3 H 141 N.P. 89 
7 BRD7 H 200c N.P. 90 
8 CAGE H 200b N.D. 91 
9 CD47 H 141 1.9 92 
10 CDC25B H 141 1.1 93 





12 CDK2 H 200b 1.7 96 
13 CDK6 H 200a N.D. 97 
14 CDKN1B (p27/kip1) H 200b N.D. 
98 





16 c-Maf M 200c N.D. 99 
17 c-MYB H 200b, 200c, 429 N.D. 100 
18 C-MYC H 429 1.5 101 
19 CREB1 H 200b N.D. 102 











21 CUL3 H 141 0.95 92 
22 CXCL1 H 200a, 200b 2.1 108 
23 CXCL12β H, M 141 N.D. 109 
24 CYCLIN E2 H 200a, 200b, 200c N.D. 110 
25 DLC-1 H 141 N.D. 111 
26 Dlx5 M 141, 200a N.D. 66 
27 DNMT3A H 200b, 200c N.D. 112 
28 DNMT3B H 200b, 200c 1.0 112 
29 E2f3 M 200c 1.1 113 
30 eIF4E H 141 N.D. 114 
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Table S1 (cont.). Published miR-200 target genes and their overlap with the PD gene list. 
Only genes experimentally validated to be directly targeted by miR-200 were considered. 
Species (Human (H), Mouse (M) or Rat (R)) in which gene was experimentally validated and 
miR-200 family members used for validation are shown. N.D., not detected (transcript not 
expressed by Bi-cel-miR-67-transfected 4TO7 cells). N.P., no probe (microarray had no 
probe for transcript). 
 





31 EPHA2 H 200a 0.53 115 




33 ERRFI-1 H 200c 4.0 117 
34 ETAR (EDNRA) H 200c 0.93 
118 





36 FAP-1  (PTPN13) H 200c N.D. 
31 
37 FBLN5 H 200c N.D. 120 
38 FHOD1 H 200c 6.9 117 




































42 FOG2 (ZFPM2) H 
200a, 200b, 200c 
141, 429 N.D. 
128 
43 FTH1 (Ferritin) H 200b 1.2 
129 
44 GATA2 H 200b 2.6 121 





46 GNA13 H 200a 141 2.2 
131 
47 Grb2 M 200a N.D. 98,132 
48 HDAC4 H 200a 0.65 133 
49 HDGF H 141 1.7 134 
50 IKKΒ (Ikbkb) H 200c 0.93 
124 
51 IL-8 (Cxcl15) H 200a, 200b N.D. 
108 
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Table S1 (cont.). Published miR-200 target genes and their overlap with the PD gene list. 
Only genes experimentally validated to be directly targeted by miR-200 were considered. 
Species (Human (H), Mouse (M) or Rat (R)) in which gene was experimentally validated and 
miR-200 family members used for validation are shown. N.D., not detected (transcript not 
expressed by Bi-cel-miR-67-transfected 4TO7 cells). N.P., no probe (microarray had no 
probe for transcript). 
 
 Gene Species miR-200 family member 
PD enrichment-
ratio Ref. 
54 KINDLIN-2 (FERMT2) H 200b 1.9 
96 
55 KLF4 H 200b 1.2 26 
56 KLF9 H 200c 1.0 124 
57 KRAS H 200c 0.76 140 
58 LEPR H 200c N.D. 82 
59 LPAR1 H 200c N.P. 118 
60 Lrp1 M 200c 1.4 8 
61 MAML2 H 200c N.D. 136 
62 MAML3 H 200c N.D. 136 
63 MAP4K4 H 141 0.71 141 
64 MAPK14 (P38Α) H 200a, 141 0.80 
142 
65 MARCKS H 200c 2.2 143 
66 MKK4 H 141 0.79 144 





68 MUC16 H 200c N.P. 146 
69 MUC4 H 200c N.D. 146 
70 NCAM1 H 200c N.D. 147 
71 Noggin (Nog) M 200c N.D. 
148 





73 NOXA H 200c N.D. 151 
74 Nrp1 M 200a N.D. 95 
75 NTF3 H 200c N.D. 152 
76 NTRK2 (TRKB) H 200c N.D. 
82 
77 ONECUT2 H 429 N.D. 153 
78 OREBP H 200b 1.09 154 
79 OXR1 H 200b 1.6 155 
80 P53 H 200a 0.86 156 
81 PAF H 200b 0.94 96 





M 200a, 200b 7.1 158 
84 PLCG1 H 200b,200c,429 N.D. 28 
85 PPARA H 141 N.D. 159 
86 PPM1F H 200c 5.2 74 
87 PRKAR2B H 200b N.D. 160 
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Table S1 (cont.). Published miR-200 target genes and their overlap with the PD gene list. 
Only genes experimentally validated to be directly targeted by miR-200 were considered. 
Species (Human (H), Mouse (M) or Rat (R)) in which gene was experimentally validated and 
miR-200 family members used for validation are shown. N.D., not detected (transcript not 
expressed by Bi-cel-miR-67-transfected 4TO7 cells). N.P., no probe (microarray had no 
probe for transcript). 
 





88 PSMD1 H 200b 0.96 161 
89 PSMD1 H 200b 0.96 161 



















92 RAB21 H 200b 3.1 13,166 
93 RAB23 H 200b N.D. 13,166 
94 RAB3B H 200b N.D. 13,166 
95 RBBP4 H 429 N.P. 167 
96 RHOA H 200c N.D. 118 











98 ROCK2 H 200b, 200c N.D. 169 





100 Serca2b (Atp2a2) M 200b 1.3 
171 
101 SHP (NR0B2) H 141 N.D. 
172 
102 SIRT1 H 200a 1.0 173 
103 Slc25a3 M 141 1.1 174 













106 Snail (Snai1) M 200b 2.3 
23 















110 Srf R 200b 0.98 178 
111 STAT5B H 200a N.D. 179 
112 SUZ12 H H 
200b 
200b, 200c 0.86 
26,180 
169 
113 TBK1 H 200c 1.1 181 
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Table S1 (cont.). Published miR-200 target genes and their overlap with the PD gene list. 
Only genes experimentally validated to be directly targeted by miR-200 were considered. 
Species (Human (H), Mouse (M) or Rat (R)) in which gene was experimentally validated and 
miR-200 family members used for validation are shown. N.D., not detected (transcript not 
expressed by Bi-cel-miR-67-transfected 4TO7 cells). N.P., no probe (microarray had no 
probe for transcript). 
 



















115 TGFΒR1 H 141, 200a 0.99 175 
116 THBS1 H 200a N.D. 183 
117 TIAM1 H 141 0.75 184 
118 TIMP2 H 200b 0.86 185 
119 TIMP2 H 200c 0.86 120 
120 TM4SF1 H 141 N.D. 186 





122 UBAP1 H 141 1.1 89 
123 UBASH3B H 200a N.D. 189 
124 UBQLN1 H 200b 1.3 161 


















127 WAVE3 (WASF3) H 200b N.D. 
192 
128 Wnt1 M 200b N.D. 193 
129 XIAP H 200b, 200c, 429 N.D. 33 





131 YWHAG (14-3-3γ) H 141 2.4 
197 
132 ZEB1 H M 
200a, 200b 
200b, 200c N.D. 
21 
4 




200b, 200c 3.5 
21 
4 
134 ZMPSTE24 H 141 1.1 198 
135 ZNF217 H 200c N.D. 199 
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Table S2. Set of genes enriched in the Bi-miR-200c PD with an enrichment ratio R>2 and 
P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
620593 56693 Crtap 33.22289891 1.02E-05 
7050056 56693 Crtap 33.68810046 1.02E-05 
4200731 57437 Golga7 48.02714017 1.02E-05 
6110646 102920 Cenpi 18.25184738 2.31E-05 
780242 26987 Eif4e2 19.94589604 2.31E-05 
20136 12632 Cfl2 24.51199083 3.77E-05 
1090398 15463 Agfg1 14.11147309 3.77E-05 
2850014 50996 Pdcd7 12.87986176 3.77E-05 
4150747 235293 Sc5d 14.95113518 3.77E-05 
6350687 30953 Schip1 13.02135145 3.77E-05 
4280053 57743 Sec61a2 12.68069478 3.77E-05 
2000041 104725 1110002B05Rik 14.35794069 3.79E-05 
7570577 234407 Glt25d1 11.58566241 3.92E-05 
5870435 244373 Erlin2 9.520712401 5.75E-05 
5360577 98404 AI597479 9.783340291 6.69E-05 
430332 56431 Dstn 8.876270519 6.74E-05 
6520403 74325 Cltb 11.84292104 6.79E-05 
2100537 217615 Ctage5 9.362829844 6.79E-05 
3800600 74325 Cltb 12.81466702 6.79E-05 
6110438 69786 Tprkb 9.186277535 6.79E-05 
130768 116972 2310047D13Rik 7.679200315 7.24E-05 
7320162 116972 Fam57a 7.602296549 7.24E-05 
3180114 19347 Dennd5a 7.595606923 7.24E-05 
5690181 58233 Dnaja4 7.843275237 7.24E-05 
5670082 67468 Mmd 9.672890863 7.24E-05 
2970554 18201 Nsmaf 8.062782705 7.24E-05 
4880035 78600 Pde6h 8.753688404 7.24E-05 
3840561 18701 Pigf 8.263484844 7.24E-05 
520121 19347 Dennd5a 8.093986252 7.24E-05 
6520424 19349 Rab7 7.674612253 7.24E-05 
5290121 18983 Cnot7 9.523114355 7.54E-05 
3780463 15463 Agfg1 10.34231315 7.54E-05 
1010528 13196 Asap1 7.450264451 7.54E-05 
1400386 17122 Mxd4 8.15693624 7.54E-05 
3190735 59021 Rab2a 7.246960893 7.54E-05 
870167 19349 Rab7 10.68476717 7.54E-05 
1580653 22232 Slc35a2 9.739732145 7.54E-05 
6110132 27058 Srp9 9.044670818 7.54E-05 
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Table S2 (cont.). Set of genes enriched in the Bi-miR-200c PD with an enrichment ratio R>2 
and P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
4260544 108927 Lhfp 21.28056787 7.55E-05 
1430176 78653 Bola3 9.360663488 8.16E-05 
7200168 56428 Mtch2 7.220782687 8.41E-05 
20139 192292 Nrbp1 7.044515953 8.45E-05 
1110520 74450 Pank2 7.132803968 8.52E-05 
150709 11637 Ak2 7.906066037 8.88E-05 
1710242 13601 Ecm1 8.002126269 8.88E-05 
2490369 18201 Nsmaf 6.921245127 8.88E-05 
2970035 67105 1700034H14Rik 6.542570796 8.89E-05 
4890327 107566 Arl2bp 13.10371209 8.89E-05 
2260471 68337 Crip2 8.419543226 8.89E-05 
580682 15980 Ifngr2 7.012866948 8.89E-05 
2060162 217615 Ctage5 8.795716759 8.89E-05 
1450369 72085 Osgepl1 6.775492411 8.89E-05 
520176 18763 Pkd1 7.12348883 8.89E-05 
5050192 26936 Mprip 6.809780009 9.01E-05 
6280056 56428 Mtch2 6.781643143 9.01E-05 
540603 56878 Rbms1 6.08129812 9.01E-05 
7550463 67554 Slc25a30 8.584525383 9.22E-05 
3360431 108927 Lhfp 6.475258638 9.32E-05 
110181 104771 Jkamp 8.107069662 9.35E-05 
2450504 27058 Srp9 6.796239793 0.000104009 
7570324 223473 Nipal2 6.796311217 0.00010631 
3310270 116914 Slc19a2 5.951480509 0.000106694 
5420538 108927 Lhfp 6.833107635 0.000114594 
2850133 17698 Msn 9.300612375 0.000114594 
360725 66917 Chordc1 5.496606703 0.000134838 
4050274 17126 Smad2 5.484380137 0.000137289 
4010021 106064 AW549877 6.035423702 0.000151789 
4830433 70369 Bag5 5.734568778 0.000151789 
1990333 76987 Hdhd2 7.283177642 0.000154043 
5720241 18645 Pfn2 5.874332926 0.000154043 
3890538 107566 Arl2bp 11.06715274 0.0001545 
3310037 20403 Itsn2 5.153094516 0.0001545 
730327 118451 Mrps2 5.618507159 0.0001545 
4050039 68192 Leprotl1 5.290632358 0.000157021 
870519 68606 Ppm1f 5.245202624 0.000157021 
3400474 26399 Map2k6 5.030075183 0.000162865 
5310427 116870 Mta1 6.065842398 0.000162865 
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Table S2 (cont.). Set of genes enriched in the Bi-miR-200c PD with an enrichment ratio R>2 
and P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
3870070 57743 Sec61a2 5.217878032 0.000165304 
4830288 74763 Nat15 5.933865377 0.000192329 
6270603 67105 1700034H14Rik 5.90274568 0.000192329 
6840440 12238 Commd3 6.588954516 0.000213656 
670113 76987 Hdhd2 4.945811358 0.000213656 
3890300 19349 Rab7 4.724972037 0.000213656 
5560615 74205 Acsl3 4.922986204 0.000218511 
3390687 227154 Stradb 5.933634328 0.000218511 
5080348 80517 Herpud2 6.785977698 0.000218511 
290672 18645 Pfn2 5.093305958 0.000218511 
3930154 232086 Tmem150a 7.367786459 0.000218511 
2680372 234686 Fhod1 6.864070779 0.000222253 
1300674 26936 Mprip 5.646587014 0.000224573 
6250273 227154 Stradb 6.155144831 0.000224573 
1710133 11974 Atp6v0e 5.188267071 0.000224573 
1450608 16525 Kcnk1 4.656544525 0.000224573 
770288 21366 Slc6a6 4.926992876 0.000224573 
2900010 101476 Plekha1 4.635681438 0.000225939 
580463 226151 Fam178a 4.887157937 0.000226324 
4670598 67105 1700034H14Rik 6.056782057 0.000226761 
1090400 76987 Hdhd2 5.449436639 0.000226761 
6620132 80517 Herpud2 4.710270859 0.000226761 
7160328 53885 Nphp1 4.835917925 0.000228311 
4280020 56494 Gosr2 14.50022666 0.000239523 
2710343 232679 Zc3hc1 5.695254256 0.000239523 
4670156 56494 Gosr2 6.158971069 0.000241355 
7210440 56772 Mllt11 5.69237131 0.000241355 
3610470 19330 Rab18 4.414877695 0.000241355 
4040471 27401 Skp2 7.733005571 0.000241355 
1230564 22234 Ugcg 4.605526772 0.000241355 
1440424 332397 Nanos1 5.588278162 0.000246145 
5900445 20437 Siah1a 4.312101706 0.000246631 
2710754 232679 Zc3hc1 4.453973799 0.000246631 
770746 71910 Ppapdc1b 5.597658416 0.000249739 
2480544 22210 Ube2b 6.25388249 0.000249739 
4860181 28084 Vps25 4.806940194 0.000249739 
5090377 17169 Mark3 4.314137338 0.000256298 
6840682 12929 Crkl 4.36328845 0.000261021 
5700168 22319 Vamp3 4.99059457 0.000261021 
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Table S2 (cont.). Set of genes enriched in the Bi-miR-200c PD with an enrichment ratio R>2 
and P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
4180168 67978 Tctn2 4.82628489 0.000262906 
4670653 66279 Tmem218 4.531162273 0.000264145 
3520093 69534 Avpi1 5.368952827 0.000264145 
1980072 20334 Sec23a 5.69614504 0.000264145 
2970685 67657 Rabl3 4.448564314 0.000265025 
610762 108679 Cops8 4.374788558 0.000268846 
1430068 104771 Jkamp 5.039415539 0.000270935 
4040520 211556 Ap1ar 4.613524792 0.000270935 
2030593 15481 Hspa8 12.96477817 0.000270935 
4150669 57874 Ptplad1 4.265236964 0.000270935 
3850131 56516 Rbms2 5.559895369 0.000270935 
1110564 69587 Pcgf3 4.102938612 0.000279127 
2650494 56737 Alg2 5.545068857 0.000282327 
1660037 28084 Vps25 4.393822659 0.000282327 
4850020 27401 Skp2 5.545992937 0.000285351 
3870474 56210 Rev1 4.690744437 0.000291163 
6290332 231999 Plekha8 4.222556034 0.000294994 
3450100 22433 Xbp1 4.386164703 0.000294994 
620541 271457 Rab5a 4.319166391 0.000295933 
3310170 80517 Herpud2 3.997075649 0.000298019 
1570328 68465 Adipor2 4.24179422 0.000305846 
4880554 98417 Cnih4 5.590864091 0.000305846 
4570368 74155 Errfi1 4.025833967 0.000305846 
2140059 225020 Fez2 4.246037152 0.000305846 
10500 56878 Rbms1 5.522035397 0.000305846 
3290142 59040 Rhot1 3.988721556 0.000305846 
1400332 77733 Rnf170 4.081627001 0.000305846 
3450243 27401 Skp2 5.355364473 0.000305846 
1470324 381356 5930434B04Rik 4.819962775 0.000311648 
2970609 194126 Mtmr11 3.882154204 0.000317435 
3180195 330189 Tmem120b 4.53091871 0.000317435 
6220026 22695 Zfp36 4.387324932 0.000319104 
2850482 109006 Ciapin1 3.912738153 0.000326635 
4610193 226849 Ppp2r5a 3.939804418 0.000326851 
7000307 83435 Plekha3 5.63509596 0.000332467 
10543 215210 Tmem120a 5.551418127 0.000332467 
5690327 75909 Tmem49 5.183617485 0.000332467 
130437 17121 Mxd3 4.083921185 0.000333729 
2100129 56494 Gosr2 8.914243931 0.000334633 
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Table S2 (cont.). Set of genes enriched in the Bi-miR-200c PD with an enrichment ratio R>2 
and P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
1660154 66229 Rpl7l1 3.87939545 0.000342354 
620291 13601 Ecm1 4.935333751 0.000351471 
4810162 328977 Zfp532 3.86717906 0.000351471 
6760088 15980 Ifngr2 5.250525175 0.000392715 
4810347 56205 Ensa 4.862774516 0.000404049 
4150682 76073 Pcgf5 4.049897787 0.000408337 
7000563 12042 Bcl10 3.709597638 0.000410951 
4180577 14057 Sfxn1 4.32842507 0.000418186 
4210274 54401 Ywhab 3.743605538 0.000423615 
1690753 21672 Prdx2 3.686266125 0.000424186 
6840075 108159 Ubxn8 3.679538965 0.00043243 
6770553 233280 Nipa1 3.936264925 0.000442292 
1260093 13559 E2f5 3.851160608 0.000446941 
2070682 104771 Jkamp 7.285768481 0.000449528 
5860148 66701 Spryd4 3.609761997 0.000458427 
290168 20775 Sqle 11.4182398 0.000458427 
2320452 225215 Rsl24d1 3.787064491 0.000464861 
1660170 171095 Il17rc 3.56869606 0.000464861 
3450470 56442 Serinc1 5.276576081 0.000467597 
4250131 22057 Tob1 4.790663807 0.000467597 
2140687 54401 Ywhab 4.742037304 0.000467597 
1440142 233103 4931406P16Rik 3.728686199 0.00047434 
4610468 266690 Cyb5r4 3.61526519 0.00047434 
130138 72536 Tagap 4.471504094 0.00047434 
990537 67878 Tmem33 3.558054623 0.00047434 
2680014 54473 Tollip 5.988522405 0.00047434 
4050370 26936 Mprip 4.924997258 0.000486011 
430717 219144 Arl11 4.861572116 0.000486011 
5890504 26431 Git2 3.654498245 0.000488232 
5860358 22339 Vegfa 3.909604634 0.000491337 
110747 22319 Vamp3 4.62948142 0.000510418 
2850440 80517 Herpud2 4.317272039 0.000523844 
5860064 232679 Zc3hc1 8.255181587 0.000523844 
4760075 67978 Tctn2 3.649521358 0.000529011 
780187 11637 Ak2 3.510294828 0.00053505 
6130390 76890 Memo1 3.569274376 0.000540019 
2760750 381269 Mreg 3.411259612 0.000540019 
5910594 66701 Spryd4 4.276082204 0.000540019 
2510259 232679 Zc3hc1 3.781014022 0.000540019 
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Table S2 (cont.). Set of genes enriched in the Bi-miR-200c PD with an enrichment ratio R>2 
and P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
2120243 67861 Akr1b10 3.689629085 0.000544578 
1090577 56428 Mtch2 4.923094227 0.000544578 
4070400 74194 Rnd3 4.104603098 0.000544578 
3180152 217430 Pqlc3 3.685083005 0.00055343 
7210082 228859 Fitm2 4.353843282 0.000555726 
2600201 57895 Ccdc126 3.500110608 0.000557855 
3180703 106840 Unc119b 5.226992742 0.000557855 
1470470 378702 Serf2 3.908527756 0.000558551 
360091 69674 Mif4gd 3.91869104 0.000579511 
6650215 140546 Eri3 3.455278935 0.000589655 
4670370 194126 Mtmr11 6.511425766 0.000611935 
3870039 171095 Il17rc 3.417615968 0.000629896 
5960594 231506 Lin54 3.481921163 0.000629896 
940164 208638 Slc25a38 3.419878238 0.000629896 
2370414 104416 Bap1 3.309695075 0.000634044 
6660725 18457 Pldn 3.348305564 0.000649679 
7610731 69786 Tprkb 3.838240894 0.00065732 
5340246 22121 Rpl13a 3.451909692 0.000657678 
6330309 108705 Pttg1ip 3.654712814 0.000664888 
2370754 217430 Pqlc3 3.241300633 0.000671263 
7040133 69534 Avpi1 3.679632122 0.000672833 
2140743 545085 Wdr70 3.926387921 0.000682082 
160672 328977 Zfp532 3.65878069 0.000682082 
4730066 30953 Schip1 7.376623524 0.000737209 
4200100 19252 Dusp1 3.491153759 0.000743182 
2940209 22193 Ube2e3 3.59990988 0.000743182 
7200463 71448 Tmem80 3.371656009 0.000745628 
1660075 225215 Rsl24d1 5.835571293 0.000751007 
3460026 100047167 LOC100047167 3.659034738 0.000752904 
4780671 21665 Tdg 4.065891604 0.000752904 
1450364 20471 Six1 4.253343773 0.000753716 
1780132 16210 Impact 3.166821688 0.000761857 
7570008 27965 Spg21 3.157345704 0.000761857 
3170292 215449 Rap1b 3.199829759 0.000791057 
2570008 117198 Ivns1abp 3.177879523 0.000792761 
2340039 218630 Ccno 3.360540084 0.000793088 
7400725 17313 Mgp 4.246552872 0.000796369 
2140678 232086 Tmem150a 6.247263126 0.000797362 
6400403 192656 Ripk2 4.250945336 0.000811618 
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Table S2 (cont.). Set of genes enriched in the Bi-miR-200c PD with an enrichment ratio R>2 
and P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
5960332 71983 Tmco6 4.097802402 0.000814813 
7330241 17346 Mknk1 4.67039567 0.000836066 
3360520 75909 Tmem49 3.309832056 0.000840952 
5270603 106840 Unc119b 5.242387941 0.000840952 
5260369 140546 Eri3 3.128622989 0.000844475 
6580626 66588 Cmpk1 7.63058055 0.000848359 
940435 11632 Aip 3.104322562 0.000860903 
2490053 13636 Efna1 3.338370091 0.000860903 
7560035 56449 Csda 3.167585408 0.000872308 
3940494 214469 Fam168b 3.194386444 0.000890137 
6100056 26399 Map2k6 3.060927923 0.000890137 
6860390 140546 Eri3 5.863772404 0.000890137 
1570100 21933 Tnfrsf10b 3.274334242 0.000890137 
1030315 235527 Plscr4 3.308738087 0.000894844 
2810040 219132 D14Ertd668e 3.122455292 0.000902937 
6130551 26384 Gnpda1 4.370210232 0.000905553 
4880356 20917 Suclg2 3.037327033 0.000915248 
5890523 217430 Pqlc3 3.170311197 0.000916795 
6110367 236848 BC023829 3.466228466 0.000950072 
6420088 66540 Fam107b 3.394661898 0.000955661 
5890544 28075 Pppde2 3.928512532 0.000955661 
5670475 13002 Dnajc5 4.388238974 0.00098308 
4880392 29871 Scmh1 3.490479913 0.000992355 
3370487 14042 Ext1 3.517738499 0.001021786 
2970091 66279 Tmem218 3.226807551 0.001034388 
4610669 73910 Arhgap18 3.048529259 0.001038072 
6580427 22193 Ube2e3 3.308501333 0.001038072 
6330204 69860 Eif1ad 3.132198086 0.001054343 
2230681 56443 Arpc1a 4.966834031 0.00106122 
5570341 21374 Tbp 3.185560083 0.001066248 
5690239 216344 Rab21 3.115978918 0.001075968 
5490521 217718 Nek9 3.060732847 0.001089272 
2900224 13207 Ddx5 3.176097598 0.001094388 
60609 26413 Mapk1 2.994040365 0.00110034 
3400270 69071 Tmem97 3.165461792 0.001114079 
2850487 13664 Eif1a 2.997863212 0.001154185 
2810025 54473 Tollip 2.912496159 0.001157499 
5550647 72611 Zfp655 3.318549695 0.001157499 
4540095 75616 2810008M24Rik 3.038663218 0.001172543 
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Table S2 (cont.). Set of genes enriched in the Bi-miR-200c PD with an enrichment ratio R>2 
and P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
2070279 11637 Ak2 3.807129984 0.001232427 
4220468 53379 Hnrnpa2b1 3.067213408 0.001242089 
4610328 212427 A730008H23Rik 2.86226892 0.001252008 
4010091 20615 Snapin 3.283153085 0.001252008 
6020477 23938 Map2k5 2.860611062 0.001255124 
2000291 225995 D030056L22Rik 3.154484197 0.001277347 
4040341 56449 Csda 2.854800756 0.001278225 
430215 11886 Asah1 2.912635217 0.001280125 
4850373 231871 Daglb 4.068864638 0.001280125 
6900408 70294 Rnf126 3.007430943 0.001288509 
3420128 98710 Rabif 3.316361842 0.001332527 
4070598 14391 Gabpb1 2.947564098 0.001336578 
7200520 14628 Ostm1 2.913939624 0.001336578 
50279 56422 Hbs1l 2.804373938 0.001377349 
5700541 225027 Sfrs7 3.204509628 0.0013843 
2690392 29857 Mapk12 5.681991239 0.001389186 
6450546 51812 Mcrs1 2.81944432 0.001400104 
4570414 29857 Mapk12 5.566793049 0.001403798 
3780382 17129 Smad5 2.990533784 0.001403798 
2490370 65257 Asb3 3.079647806 0.001417475 
6580563 19298 Pex19 2.987425367 0.001417475 
620010 75717 Cul5 2.993138356 0.001422705 
3400349 56310 Gps2 2.992663812 0.001422705 
4480068 217718 Nek9 2.913314197 0.001422705 
6620209 19365 Rad52 2.826001734 0.001422705 
3440725 20135 Rrm2 5.092085006 0.001422705 
4850487 66827 Ttc1 3.115348295 0.001422705 
5720202 12192 Zfp36l1 2.776681817 0.001422705 
4250255 544752 Tug1 2.884755516 0.00142423 
4560678 103534 Mgat4b 4.851961558 0.001434508 
1660722 67840 Mrp63 2.797111576 0.001434508 
5560646 20135 Rrm2 3.411038666 0.001434508 
7560097 93697 Narg2 2.971128058 0.001445487 
2120053 56443 Arpc1a 4.359366324 0.001489053 
940180 216505 Pik3ip1 3.144004768 0.001523909 
870121 70572 Ipo5 2.893791168 0.001526335 
2750240 59008 Anapc5 5.790992204 0.001536318 
2350706 66257 Nicn1 2.872761446 0.001536318 
3780022 59054 Mrps30 2.731668099 0.001555323 
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Table S2 (cont.). Set of genes enriched in the Bi-miR-200c PD with an enrichment ratio R>2 
and P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
4280445 66510 Rnf181 3.46551706 0.001596815 
4900632 53902 Rcan3 2.743850071 0.001597954 
1030296 56422 Hbs1l 2.719870609 0.001639753 
5870561 107375 Slc25a45 2.851034031 0.001674594 
870324 56233 Hdac7 2.81495238 0.001677626 
2900402 26949 Vat1 3.266844299 0.001706578 
3930202 76789 2410129H14Rik 3.673346577 0.001709364 
1240300 26399 Map2k6 2.939274536 0.001711621 
2850441 52830 Pnrc2 3.509745248 0.001725076 
6660079 208638 Slc25a38 2.852390377 0.001725076 
6520600 56708 Clcf1 3.736072531 0.001725961 
3440242 72482 Acbd6 2.668385737 0.001734771 
4280112 13360 Dhcr7 5.359144086 0.0017632 
780711 171095 Il17rc 3.062793833 0.001766597 
2120707 71801 Plekhf2 2.684074327 0.001766597 
1110095 17828 Muted 2.68414376 0.001781832 
1400685 230789 Fam76a 2.984138288 0.001800603 
4860692 12400 Cbfb 2.896971917 0.001802404 
6370270 105501 Abhd4 2.707617897 0.001803028 
6110474 67921 Ube2f 3.041157263 0.001810136 
5910601 70231 Gorasp2 3.021719691 0.001816934 
650458 52118 Pvr 3.401778779 0.001834095 
4060576 66674 6330409N04Rik 3.037793045 0.001848259 
4570376 227358 Fam132b 2.648025461 0.001848259 
6620609 66815 Ccdc109b 2.81811398 0.001851059 
360626 14391 Gabpb1 2.626885029 0.001851059 
1510270 83922 Tsga14 2.874164584 0.001858701 
4390564 66612 Ormdl3 2.643469337 0.001898468 
5490343 66257 Nicn1 2.781018886 0.001915885 
4670047 68755 Cgrrf1 2.937314817 0.001958861 
3830408 622320 Kctd21 2.738639601 0.001961803 
3890609 14245 Lpin1 2.80805934 0.001961803 
2350730 394430 Ugt1a10 2.634676609 0.001961803 
6250681 217201 Rundc1 2.588197748 0.002035549 
460474 66357 Ostc 2.952960866 0.00206069 
3800537 234875 Ttc13 2.883500378 0.00206634 
2070736 212127 2810046L04Rik 2.781780623 0.002075872 
2900333 72599 Pdia5 2.576285393 0.002190327 
6220202 56443 Arpc1a 3.378823328 0.002201438 
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Table S2 (cont.). Set of genes enriched in the Bi-miR-200c PD with an enrichment ratio R>2 
and P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
2060435 20384 Sfrs5 2.733474489 0.002201438 
2710019 214944 Mobkl2b 5.264709079 0.002221717 
3420736 75734 Mff 2.560516634 0.002224002 
6020605 19205 Ptbp1 2.560779526 0.002224002 
1030170 26401 Map3k1 3.035959709 0.002237914 
3840356 114714 Rad51c 2.550350894 0.002237914 
2030739 22339 Vegfa 2.798588385 0.002243761 
4050112 93692 Glrx 2.839484702 0.002264915 
5960672 12400 Cbfb 3.144354071 0.002272516 
580465 16599 Klf3 2.834909799 0.002278311 
2230528 101739 Psip1 2.549775973 0.002278311 
5820521 20250 Scd2 3.127191099 0.002284083 
2000551 67916 Ppap2b 3.936700949 0.00232022 
5960414 114863 Prosc 3.1524123 0.002323075 
1170202 52477 Angel2 2.657698472 0.002336802 
1570725 53902 Rcan3 2.59006666 0.002336802 
3290541 239555 Smcr7l 3.146917042 0.002336802 
1240678 19300 Abcd4 2.538920764 0.0023394 
6400377 67861 Akr1b10 3.205969697 0.002356317 
4060056 67695 2310016E02Rik 3.334901195 0.002356317 
110594 99650 4933434E20Rik 2.644869602 0.002356317 
4200347 56494 Gosr2 2.81924582 0.002356317 
1660039 108052 Slc14a1 2.689189748 0.002356317 
6760754 384864 Gm1943 3.205971474 0.002370471 
430204 101739 Psip1 2.522140644 0.002370471 
5560598 80294 Pofut2 3.490767025 0.002383646 
270678 56468 Socs5 2.817298631 0.002383646 
1980379 67846 Tmem39a 2.650441362 0.002383646 
6860291 69674 Mif4gd 3.264578622 0.002404949 
1010050 16911 Lmo4 2.667735406 0.00241607 
1570014 76626 Msi2 2.754469461 0.00241607 
6840121 18263 Odc1 2.620661283 0.00241607 
2850703 24136 Zeb2 3.484990711 0.002437985 
2760093 14950 H13 2.97397067 0.00248874 
4540070 67878 Tmem33 2.568746721 0.002492997 
2940681 14461 Gata2 2.604101551 0.002508895 
6590445 245688 Rbbp7 3.060192597 0.002508895 
670463 79560 Ublcp1 2.642653804 0.002508895 
1990491 114713 Rasa2 3.06227144 0.002557144 
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Table S2 (cont.). Set of genes enriched in the Bi-miR-200c PD with an enrichment ratio R>2 
and P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
6940255 67603 Dusp6 2.636407654 0.002579289 
2450224 54197 Rnf5 2.624629565 0.002612116 
1090100 21815 Tgif1 3.967751091 0.002617465 
380240 72465 Zfp131 2.663606586 0.002661034 
5890113 68606 Ppm1f 3.140175633 0.002722895 
2320292 12499 Entpd5 2.446272301 0.002732139 
3870768 232430 Crebl2 2.74529177 0.002746326 
2370017 21933 Tnfrsf10b 2.515797972 0.002746326 
1980168 228769 Psmf1 2.630323755 0.002771879 
6960612 22196 Ube2i 3.267437765 0.002771879 
1230722 78889 Wsb1 3.204942593 0.002798791 
6760367 22628 Ywhag 2.436111281 0.002798791 
4780373 19822 Rnf4 3.158762961 0.002826819 
1510605 170750 Xpnpep1 3.111115444 0.002828319 
270593 11804 Aplp2 3.809412925 0.002844239 
3310181 54130 Actr1a 2.874943739 0.002874141 
3130215 72050 Kdelc1 2.480087956 0.00298188 
4920273 109129 Mmadhc 3.391673981 0.002986079 
2760202 382406 Wdr51b 2.856111378 0.002986079 
6060521 228876 Zfp334 2.453405605 0.003078834 
160121 12908 Crat 2.447383142 0.003089508 
4810577 78287 Zfyve20 2.398820842 0.003089508 
1500373 72065 Rap2c 2.732261354 0.003194861 
4570670 29819 Stau2 2.621190662 0.003194861 
4280072 54208 Arl6ip1 2.528097362 0.003248626 
6550343 12928 Crk 2.806916828 0.003248626 
10176 319520 Dusp4 2.519163443 0.003248626 
6520484 13690 Eif4g2 2.539150438 0.003248626 
2070747 75612 Gns 2.659930371 0.003248626 
7000465 68151 Gpr177 2.387588855 0.003248626 
6060646 18515 Pbx2 2.808514975 0.003248626 
670711 245688 Rbbp7 3.380775497 0.003261885 
2680754 237082 Nxt2 2.517367714 0.003282901 
3460670 67041 Oxct1 2.859343007 0.003282901 
3800446 94284 Ugt1a6a 2.463475308 0.003331404 
3800601 17828 Muted 2.441044873 0.003339412 
3800274 20482 Skil 2.735743193 0.003403003 
1230017 83396 Glis2 3.050940111 0.003406474 
2340239 94065 Mrpl34 2.888086072 0.003406474 
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Table S2 (cont.). Set of genes enriched in the Bi-miR-200c PD with an enrichment ratio R>2 
and P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
6020440 98910 Usp6nl 2.408818598 0.003406474 
2650193 65098 Zfand6 3.453685796 0.003444891 
5220187 74246 Gale 3.385753958 0.003446095 
510341 50849 Rnf10 2.543418838 0.003451801 
5960333 67921 Ube2f 3.000335872 0.003475472 
2900592 14057 Sfxn1 2.796605221 0.00348087 
1050379 140499 Ube2j2 2.483759851 0.00348087 
3840762 74044 Ttf2 2.746884318 0.003544395 
1440685 72881 Zdhhc4 3.67421067 0.003575505 
7610161 71774 Shroom1 2.588556517 0.003677863 
160064 76688 Arfrp1 2.433960379 0.003677863 
2570132 17187 Max 2.600089815 0.003677863 
2570754 81535 Sgpp1 2.466457336 0.003681613 
1300372 13445 Cdk2ap1 2.585479344 0.003698024 
1450164 67009 Ttc23 2.450389346 0.003699229 
6330561 16784 Lamp2 2.353934299 0.003708007 
780427 112405 Egln1 2.583428492 0.003715995 
6040204 229658 Vangl1 2.509496837 0.003746657 
650064 19345 Rab5c 2.374443182 0.003746657 
3130048 19367 Rad9 2.514280747 0.003747938 
1510020 19731 Rgl1 2.343069438 0.003747938 
2750286 26384 Gnpda1 3.767653114 0.003755401 
50136 320204 4833442J19Rik 2.365197547 0.003805555 
2190743 71720 Osbpl3 2.322689101 0.003805555 
5050634 80795 Selk 2.824102666 0.0038192 
2100717 59038 Pxmp4 3.358680978 0.003845463 
7560538 108052 Slc14a1 2.350074524 0.00386937 
650411 17252 Rdh11 2.361946306 0.00389354 
7560114 71720 Osbpl3 2.395967854 0.003899828 
7650338 15980 Ifngr2 2.57735241 0.003949992 
7330435 72465 Zfp131 2.423208093 0.003989067 
6450056 20775 Sqle 2.323727466 0.004054224 
7160343 14683 Gnas 2.732947875 0.004069549 
1770435 70351 Ppp4r1 2.795718343 0.004069549 
3830707 67958 2610101N10Rik 2.61911897 0.004077445 
1780735 12125 Bcl2l11 2.642170297 0.004077445 
670431 259300 Ehd2 2.650703735 0.004077445 
2810280 71994 Cnn3 2.49294667 0.004077445 
3170477 76281 Tax1bp3 2.365220468 0.004077445 
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Table S2 (cont.). Set of genes enriched in the Bi-miR-200c PD with an enrichment ratio R>2 
and P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
1710746 13043 Cttn 2.428306759 0.004091038 
520053 219132 D14Ertd668e 2.521366592 0.004091038 
4290088 17169 Mark3 2.531407968 0.004098436 
1410279 83767 Wasf1 2.496008587 0.004098436 
6450291 330171 Kctd10 2.278746701 0.00416243 
5080093 66471 Anp32e 2.390553314 0.004238939 
5820672 21454 Tcp1 2.532959629 0.004253787 
7380246 12972 Cryz 2.954481782 0.004258154 
4890400 233724 Tmem41b 2.446966451 0.004258154 
1580678 106957 Slc39a6 2.342199119 0.004270563 
3870079 29857 Mapk12 2.478777194 0.00429975 
2570747 53323 Ube2k 2.565943658 0.00429975 
1710500 67771 Arpc5 2.4014256 0.004309855 
6420520 14282 Fosb 2.618354216 0.004309855 
4900747 21418 Tcfap2a 2.299255934 0.004323251 
4570184 319765 Igf2bp2 2.683486492 0.004386669 
5420458 67921 Ube2f 2.338664465 0.004410033 
2070088 67149 Nkain1 2.445895888 0.004416216 
1710193 14609 Gja1 2.303982929 0.004551183 
6370025 108652 Slc35b3 2.320156333 0.004551183 
1990541 21933 Tnfrsf10b 2.786959406 0.004610892 
5960398 75541 1700019G17Rik 2.276997359 0.004614187 
5080136 20405 Sh3gl1 2.386472312 0.004616525 
4050768 56291 Styx 2.901547996 0.004627833 
6840112 107652 Uap1 2.57809224 0.004627833 
450491 18018 Nfatc1 2.327397847 0.004627835 
4200468 107569 Nt5c3 2.56525316 0.004635887 
4180086 214597 Sidt2 3.001068255 0.004635887 
6130131 14950 H13 3.3277986 0.004642304 
6200762 330064 Slc5a6 2.836807608 0.004676532 
3450735 22375 Wars 2.403758578 0.004790759 
130121 11886 Asah1 2.40212753 0.00480309 
5870301 16975 Lrp8 2.231010029 0.00480309 
5390669 14712 Gnpat 2.329061029 0.004816508 
3140209 15945 Cxcl10 2.558193053 0.004834371 
4920301 13852 Stx2 2.662009956 0.005025214 
20400 234076 Tmco3 2.232352604 0.005025214 
2060722 67921 Ube2f 2.369273832 0.005025214 
2030286 244373 Erlin2 3.180796796 0.005031569 
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Table S2 (cont.). Set of genes enriched in the Bi-miR-200c PD with an enrichment ratio R>2 
and P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
4880008 56298 Atl2 2.215224875 0.00512118 
5910347 72033 Tsc22d2 2.283112076 0.005129591 
6550133 75705 Eif4b 2.383052323 0.005130421 
1690397 63873 Trpv4 3.391303892 0.005194622 
4860255 20613 Snai1 2.270830559 0.005204941 
4560114 50780 Rgs3 2.383975693 0.00527219 
6940053 17344 Pias2 2.256379684 0.005281135 
5260682 63873 Trpv4 3.291153257 0.005281135 
160519 74868 Tmem65 2.476829945 0.005285967 
1470554 14661 Glud1 2.64472164 0.005317515 
4050328 66902 Mtap 2.191647298 0.005317515 
2120048 59013 Hnrnph1 2.20601676 0.005331653 
6290452 16526 Kcnk2 2.708539489 0.005350408 
6550446 271457 Rab5a 2.532647169 0.005356835 
2120201 99650 4933434E20Rik 2.530927846 0.005410487 
50224 26394 Lypla2 2.32653999 0.005413026 
1820224 17118 Marcks 2.229204234 0.005413026 
4560309 18242 Oat 2.287496428 0.005413026 
2750091 11566 Adss 2.357989602 0.005423731 
160187 18602 Padi4 3.368660176 0.005442881 
1070592 208638 Slc25a38 2.643390886 0.005471969 
2120296 170750 Xpnpep1 2.56529258 0.005493028 
2360131 72050 Kdelc1 2.255191415 0.005510821 
5670192 15510 Hspd1 2.728588566 0.005515583 
5130630 59003 Maea 3.303042788 0.005515583 
5870537 109113 Uhrf2 2.832943586 0.005515583 
3310402 232164 Paip2b 2.677116696 0.00556161 
3180450 66366 Ergic3 3.828498026 0.005574107 
2650598 245688 Rbbp7 2.897083877 0.005574107 
7100326 17129 Smad5 2.263548372 0.005646738 
110474 54128 Pmm2 2.589881346 0.005672602 
510441 19367 Rad9 2.300258457 0.005687408 
50603 23797 Akt3 2.455802902 0.00574416 
2490209 76899 Golga1 2.529707195 0.00574416 
7040719 68090 Yif1a 2.228253162 0.00574416 
6040292 21807 Tsc22d1 3.752290459 0.005788052 
360528 19707 Reps1 2.717747083 0.005827099 
670164 56422 Hbs1l 2.270406132 0.00587121 
3890687 81018 Rnf114 2.80806567 0.00587121 
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Table S2 (cont.). Set of genes enriched in the Bi-miR-200c PD with an enrichment ratio R>2 
and P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
3780279 12028 Bax 2.294553037 0.005895339 
6840433 18148 Npm1 2.928322271 0.005895339 
3830114 14254 Flt1 2.461110354 0.005919982 
450064 18537 Pcmt1 2.321726361 0.005923004 
5960471 13929 Amz2 2.22861385 0.005992656 
2480475 140742 Sesn1 2.354923583 0.006093557 
4220605 228998 Arfgap1 2.479907855 0.006135465 
2120475 23873 Faim 2.310172704 0.006178186 
5290279 97165 Hmgb2 2.16828169 0.006262413 
2510519 110842 Etfa 2.158692777 0.006262413 
5130497 66286 Sec11c 2.361337405 0.006369503 
1050382 54161 Copg 2.175791456 0.006372113 
650168 117198 Ivns1abp 2.400912397 0.006372113 
780338 223455 March6 2.404425 0.006372113 
5340288 109232 Sccpdh 2.157824011 0.006372113 
580717 109113 Uhrf2 2.277439237 0.006416578 
3120446 27041 G3bp1 3.378433307 0.006446983 
6900646 14009 Etv1 2.148460848 0.006457509 
6220253 66493 Mrpl51 2.273343614 0.006457509 
7000079 70351 Ppp4r1 2.229169914 0.006457509 
5260201 60599 Trp53inp1 2.29460886 0.006459939 
1710747 14536 Nr6a1 2.158212731 0.006487001 
5890202 29864 Rnf11 2.141062452 0.006487001 
2320189 14683 Gnas 3.863093513 0.006525917 
6280484 67296 Socs4 2.146733668 0.006599571 
1940156 22088 Tsg101 2.524334336 0.006613595 
4900577 56708 Clcf1 3.161127733 0.006688864 
4850039 52118 Pvr 2.211037783 0.006709221 
1470598 76375 Det1 2.113047113 0.0067134 
5270102 29864 Rnf11 2.122893397 0.0067134 
5490403 76205 Stard3nl 2.715426492 0.006731797 
1570543 15227 Foxf1a 2.470755975 0.006752698 
3450241 23802 Amfr 2.105158952 0.006791792 
3390735 50927 Nasp 2.178634893 0.006793053 
4070019 214597 Sidt2 2.128107799 0.006807304 
6220168 74197 Gtf2e1 2.177664587 0.007041038 
7150541 11861 Arl4a 2.286731222 0.007042809 
5700468 56205 Ensa 2.100463241 0.007088545 
2630209 52118 Pvr 2.622428837 0.00710238 
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and P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
540288 19248 Ptpn12 3.09621306 0.007117421 
6220750 68276 Toe1 2.159692724 0.007139644 
1190239 66138 Wbscr22 2.691333374 0.007151053 
2340438 208768 BC031781 2.16380928 0.007206172 
10161 218581 Depdc1b 2.122236727 0.007261132 
5890390 105513 Chmp7 2.776337111 0.007266321 
3170414 108052 Slc14a1 2.120342996 0.007266321 
5910554 73724 Mcee 2.681685422 0.007325284 
6130632 15442 Hpse 2.118815151 0.007333941 
1190112 15926 Idh1 2.225418293 0.007333941 
6280376 214987 Chtf8 3.344019461 0.007444836 
6620598 19042 Ppm1a 3.320300764 0.007455647 
4290367 71279 Slc29a3 2.356697654 0.007522657 
610164 75734 Mff 2.087808127 0.007577789 
4540164 218335 Clptm1l 2.119309676 0.007740713 
7510750 17129 Smad5 2.125892892 0.007743079 
6350639 66049 Rogdi 2.145041821 0.007743079 
3940017 94044 Bcl2l13 2.110635538 0.007785541 
5700152 268470 Ube2z 2.409745331 0.007785541 
4810468 14252 Flot2 2.146708961 0.007785541 
5690347 71393 Kctd6 2.161597489 0.007785541 
2470669 18516 Pbx3 2.104096081 0.007785541 
6620717 72599 Pdia5 2.104334605 0.007785541 
5820019 66817 Tmem170 2.184110724 0.007785541 
3120259 81018 Rnf114 3.133699586 0.007785541 
4150670 54613 St3gal6 2.087272002 0.007789235 
6200092 11639 Ak3l1 2.326206907 0.007866019 
3390121 225280 Ino80c 2.760319674 0.007880354 
2320706 67223 Rrp15 2.476269115 0.007924328 
2070615 11744 Anxa11 3.252968532 0.007958692 
2000445 21379 Tbrg4 2.299575614 0.007958692 
7050131 109910 Zfp91 2.161243086 0.007958692 
4780475 232196 C87436 2.104637499 0.008019373 
6520220 104318 Csnk1d 2.280447113 0.008098208 
150128 53323 Ube2k 2.334934961 0.008120461 
4760471 20218 Khdrbs1 2.23897466 0.008183375 
510372 214597 Sidt2 2.053311712 0.008206903 
670161 93684 Sep15 2.083605538 0.008294638 
4570634 19328 Rab12 2.800427919 0.008327901 
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Table S2 (cont.). Set of genes enriched in the Bi-miR-200c PD with an enrichment ratio R>2 
and P<0.01 
 
ProbeID Entrez_Gene_ID Symbol PD_ratio Adj_P_value 
3190048 320685 Dctd 2.056886481 0.008359108 
4850528 72323 Asb6 2.475275999 0.008383468 
540400 26426 Nubp2 2.346173531 0.008436514 
7610059 263876 Spata2 2.386716602 0.008502206 
6250092 53892 Ppm1d 2.049670125 0.00854654 
3140411 234076 Tmco3 2.169403343 0.00860034 
1820674 78308 Gpr108 2.240674979 0.008618662 
6480333 60364 Donson 2.036249089 0.008712249 
7160762 98758 Hnrnpf 2.595744953 0.008712249 
3060162 18515 Pbx2 2.201822324 0.008733401 
5870239 67105 1700034H14Rik 2.14289728 0.008911709 
4010056 54635 Pdgfc 2.155758891 0.008940938 
7510356 72999 Insig2 2.283055095 0.00917537 
3390066 56462 Mtch1 2.836658032 0.009215223 
6650376 21418 Tcfap2a 2.229584592 0.009271185 
3450544 76178 6330578E17Rik 2.314055254 0.00928974 
5720687 59013 Hnrnph1 2.043452856 0.00928974 
1300164 21933 Tnfrsf10b 2.038248397 0.00928974 
2970630 22147 Tuba3b 2.238512144 0.009312858 
5050750 94112 Med15 2.312566286 0.00931926 
3460468 20320 Nptn 2.296603972 0.00931926 
6550392 106840 Unc119b 2.070523923 0.009377213 
3170615 67270 D10Ertd322e 2.53784862 0.009419827 
1440192 235442 Rab8b 2.246139708 0.009419827 
7320239 53614 Reck 2.109142978 0.009429026 
6900088 237339 L3mbtl3 2.209780038 0.00957953 
780634 76281 Tax1bp3 2.10626494 0.009592018 
3440187 68263 Pdhb 2.682085713 0.009641036 
3710719 56190 Rbm38 3.464593959 0.009641036 
2970424 69900 Mfsd11 2.274082374 0.009714707 
4230019 66146 Tmem57 2.151041044 0.009714707 
1110719 319710 Frmd6 2.106528464 0.009719436 
4060180 72065 Rap2c 2.056454175 0.009820154 
540475 52466 Slc46a1 2.020775825 0.009847382 
4560424 13629 Eef2 4.381732169 0.009850651 
1400402 76477 Pcolce2 2.175284807 0.009953539 
7200181 227682 Trub2 2.209155352 0.009962634 
3120491 80743 Vps16 2.991886615 0.009984913 
 
Chapter 2. The role of the miR-200 family in EMT 
124 
Table S3. Bi-miR-200c PD genes (R>2, P<0.01) in each of the most enriched canonical 
pathways (Wikipathways) (AdjP<0.01) 
 
Pathway PD genes 
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Table S3 (cont.). Bi-miR-200c PD genes (R>2, P<0.01) in each of the most enriched 
canonical pathways (Wikipathways) (AdjP<0.01) 
 
Pathway PD genes 
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Table S3 (cont.). Bi-miR-200c PD genes (R>2, P<0.01) in each of the most enriched 
canonical pathways (Wikipathways) (AdjP<0.01) 
 
Pathway PD genes 



















Signaling of Hepatocyte Growth 
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Table S4. Bi-miR-200c PD genes (R>2, P<0.001) in each of the most enriched canonical 
pathways (Wikipathways) (AdjP<0.05) 
  
Pathway PD genes 
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Table S5. Predicted miR-200c MREs in the 3’UTRs of target genes (numbers in 
parentheses indicate the position of the MRE in each 3’UTR). Bottom sequence 
corresponds to miR-200c mature sequence. Experimental validation (Exp. validation) was 
performed by measuring luciferase reporter activity of constructs containing the wild-type or 
mutated seed residues (shown in red) 3’UTR of each gene. MREs that showed a statistically 
significant reduction in luciferase activity are defined as functional (see Figure 4). Perfect 
matches with miR-200c are indicated by a line; G:U pairs, by a colon. 
 
3’UTR Predicted MREs Algorithm Exp. validation 
MRE #1 (319-341) 
 
5’ UCCCUGAAGAAAAAUCAGUAUUA 3’ 
   ||| | |  |     |||||||| 






MRE #2 (135-157) 
 
5’ CCCCUUGUUCACACUCAGUAUUC 3’ 
    || |::||  |   ||||||| 






MRE #1 (86-108) 
 
5’ CUUAUACCCAGAAACCAGUAUUG 3’ 
    ::||    |     |||||||:   







Fhod1 MRE #2 (98-120) 
 
5’ AACCAGUAUUGUGAACAGUAUUA 3’ 
     |     |  :   |||||||| 






MRE #1 (225-247) 
 
5’ AGAUAUGGCCUCUUACAGUAUUU 3’ 
        ::   :|:  ||||||| 





MRE #1 (287-309) 
 
5’ UAAUGUGUCCAGACCCAGUAUUG 3’ 
   |    ::|       |||||||: 







MRE #2 (779-807) 
 
5’ UCCAGGAAAGGUUUGUGUGGGCAGUAAGU 3’ 
   ||||    :||  :   ||||||| 
3’ AGGU----AGUAAUGG--GCCGUCAUAAU 5’ 
RNAhybrid Functional Smad2 
MRE #3 (881-910) 
 
5’ UGUCUCAAACAUGCACAGGUGGCAGUAUAA 3’ 
   | : ||     |:|     :|||||||| | 
3’ AGGUAG---UAAUG----GGCCGUCAUAAU 5’ 
RNAhybrid Functional 
Map3k1 
MRE #1 (1865-1887) 
 
5’ GGGACCUCAGCUAAUCAGUAUUA 3’ 
      | |   :|:   |||||||| 






The role of the miR-200 family in the epithelial-to-mesenchymal transition (EMT) 
129 
Table S5 (cont.). Predicted miR-200c MREs in the 3’UTRs of target genes (numbers in 
parentheses indicate the position of the MRE in each 3’UTR). Bottom sequence 
corresponds to miR-200c mature sequence. Experimental validation (Exp. validation) was 
performed by measuring luciferase reporter activity of constructs containing the wild-type or 
mutated seed residues (shown in red) 3’UTR of each gene. MREs that showed a statistically 
significant reduction in luciferase activity are defined as functional (see Figure 4). Perfect 
matches with miR-200c are indicated by a line; G:U pairs, by a colon. 
 
3’UTR Predicted MREs Algorithm Exp. validation 
Smad5 
MRE #1 (3925-3947) 
 
5’ UGCUAAGAAGGAUAACAGUAUUU 3’ 
   | |   :  :  :  ||||||| 






MRE #1 (601-623) 
 
5’ UCUCUGACGGGUUGACAGUAUUA 3’ 
   ||: | |  : ::| |||||||| 






MRE #2 (627-649) 
 
5’ CUCAAUUGUAGUUUACAGUAUUU 3’ 
    :|| :  || ::  ||||||| 





Not tested Ywhag 
MRE #3 (2005-2027) 
 
5’ UCCAUCCUAUUGAUACAGUAUUG 3’ 
   |||||| |  :    |||||||: 







MRE #1 (444-466) 
 
5’ AGAAGAAUUCCUCUAAAGUAUUU 3’ 
      |  ||| |:|   |||||| 





MRE #1 (581-603) 
 
5’ UGACGACUUUAUUUAUU-GUAUUA 3’ 
   |  |: | |||:::  : |||||| 
3’ AG-GUAGUAAUGGGCCGUCAUAAU 5’ 
RNAhybrid Functional 
Zfp36 MRE #2 (658-680) 
 
5’ AU----GUUAAAACUGAUACUGUAUUA 3’ 
    :    :|||   |:| :|  |||||| 
3’ AGGUAGUAAUG--GGCCGU--CAUAAU 5’ 
RNAhybrid Not functional 
Snail1 
MRE #1 (181-203) 
 
5’ GAGCCUCCUACCCCUCAGUAUUC 3’ 
        :  |||||  ||||||| 
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Table S5 (cont.). Predicted miR-200c MREs in the 3’UTRs of target genes (numbers in 
parentheses indicate the position of the MRE in each 3’UTR). Bottom sequence 
corresponds to miR-200c mature sequence. Experimental validation (Exp. validation) was 
performed by measuring luciferase reporter activity of constructs containing the wild-type or 
mutated seed residues (shown in red) 3’UTR of each gene. MREs that showed a statistically 
significant reduction in luciferase activity are defined as functional (see Figure 4). Perfect 
matches with miR-200c are indicated by a line; G:U pairs, by a colon. 
 
3’UTR Predicted MREs Algorithm Exp. validation 
Ywhab 
MRE #1 (1640-1662) 
 
5’ UGUUUUUUCCCUUACCAGUAUUC 3’ 
   | : |: |  |::  |||||||  






MRE #1 (286-308) 
 
5’ AGUUGUACAUGAAAUCAGUAUUC 3’ 
     :  :|        ||||||| 
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Table S6. List of qPCR and cloning primers. 
 
 Primers used for qRT-PCR 
Gene Sequence of Forward Primer (5' to 3') 
Sequence of Reverse Primer 
(5' to 3') 
Tuba1a CTGGAACCCACGGTCATC GTGGCCACGAGCATAGTTATT 
Gapdh GCACAGTCAAGGCCGAGAAT GCCTTCTCCATGGTGGTGAA 
Sdha TGTTCAGTTCCACCCCACA TCTCCACGACACCCTTCTG 
Crtap GAGCACTTCCAGCCCAGAC TGTTCCTGAGCGAAGTCGTA 
Fhod1 GCTCTGCACCGACTCCTG ATCCGGAGGGAGACACTTG 
Xbp1 TGACGAGGTTCCAGAGGTG TGCAGAGGTGCACATAGTCTG 
Zeb2 CAAGAGGCGCAAACAAGC TGCGTCCACTACGTTGTCAT 
Ywhag CCCCAAACTTGCTTAACTTGTCT GCTCAAGTGGGCGACAAA 
Ywhab GCAGGACATCTGCAACGA CCTGGGTGGCATTGAGAAT 
Ywhae GATCGGGAGGATCTGGTGT TCATTGATTCCACCATTTCG 
Ywhah ATTGGCAGCACAGCTATTCA TGCCCATGAAGGTTTATCTGA 
Ywhaq CCCTCATCATGCAGTTGCT TAGTTTTCGGCCCCCTCT 
Ywhas AAAGGGTGTGGCGAAGACTA AGAAGAGTTGGGCGTGGTC 
Ywhaz CCAGACTGAGGAAGATTAAGCAAT CAGGTTCCAGGTATCATTTGTAATTT 
Zfp36 TCTCTTCACCAAGGCCATTC ATCGACTGGAGGCTCTCG 
Skp2 CGAAGCTTAGTCGGGAGAAC AGGAGCAGCTCATCTGGAAG 
Smad1 AACACCAGGCGACATATTGG CACTGAGGCATTCCGCATA 
Smad2 AGGACGGTTAGATGAGCTTGAG GTCCCCAAATTTCAGAGCAA 
Smad3 TCAAGAAGACGGGGCAGTT CCGACCATCCAGTGACCT 
Smad4 CCGTGGGTGGAATAGCTC GGTCATCCACACCGATGC 
Smad5 GCAGTAACATGATTCCTCAGACC GCGACAGGCTGAACATCTCT 
Smad8 CGGATGAGCTTTGTGAAGG GGGTGCTCGTGACATCCT 
Ajuba AAAATTACGCCCCGAAATG TCACCCTCACAATGTCCTCA 
Prmt5 GCTGTCACCTGAGTGTCTGG ATGCTCACGCCATCATCTTT 
Map3k1 GCACATCCACATCTAGTTCAGAAA CAGCAAGCAGATGGGACAC 
Snai1 CTTGTGTCTGCACGACCTGT AGGAGAATGGCTTCTCACCA 
Scmh1 ACGGCGGTGAAGTCATTT ACGGAGGACATAGGTGATGC 
Mapk12 ACCTGATGAGTCTCTGGACGA CCAGATCAGTGCCCATGAAT 
Tob1 ACTTTTGCTGCCACCAAGTT GAGCTACCTTGCTGCTACGG 
Skil TGCGTCCCAGTCTAAAGAGG GCACACAGCAGACTCAGATTTC 
Bcl2l11 GGAGACGAGTTCAACGAAACTT AACAGTTGTAAGATAACCATTTGAGG 
Mapk1 AAGAACTCATTTTTGAAGAGACTGC CTCTGAGCCCTTGTCCTGA 
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Table S6 (cont.). List of qPCR and cloning primers. 
 Primers used for qRT-PCR 
Gene Sequence of Forward Primer (5' to 3') 
Sequence of Reverse Primer 
(5' to 3') 
Bax GTGAGCGGCTGCTTGTCT GGTCCCGAAGTAGGAGAGGA 
Cdh1 ATCCTCGCCCTGCTGATT ACCACCGTTCTCCTCCGTA 
Cldn3 TGGGAGCTGGGTTGTACG CAGGAGCAACACAGCAAGG 
Cldn7 GACGCCCATGAACGTTAAGTA CCTGGACAGGAGCAAGAGAG 
   
 Primers used for ChIP assay 
 Sequence of Forward Primer (5' to 3') 
Sequence of Reverse Primer 
(5' to 3') 
Cdh1 
promoter CGAACGACCGTGGAATAGGA CCTCCACCCCTGTCTGTAGT 
Cdh1 
exon TTCCCAAGATCTTTCGTGGT CAAGGAATGCCACTGTAAATGA 
Cldn3 
promoter CTCTGCAGGTGGTCGTTGTC AGTCCCTCAGGCTTTGACAC 
Cldn3 
exon GTGGCCACTGCAGCTACTT GTTTCATGGTTTGCCTGTCTC 
Hbb1 
promoter GCCTTGCCTGTTCCTGCTC ATTGAGCCCTTTACTCTCTCTGTTC 
   
 Primers used for cloning 3'UTRs of miR-200c target genes 
3'UTR Sequence of Forward Primer (5' to 3') 
Sequence of Reverse Primer 
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Table S6 (cont.). List of qPCR and cloning primers. 
 Primers used for cloning 3'UTRs of miR-200c target genes 
3'UTR Sequence of Forward Primer (5' to 3') 
Sequence of Reverse Primer 













   
 Primers used to mutate miR-200c MREs in 3'UTRs of target genes 
3'UTR Sequence of Forward Primer (5' to 3') 
Sequence of Reverse Primer 
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Table S6 (cont.). List of qPCR and cloning primers. 
 Primers used to mutate miR-200c MREs in 3'UTRs of target genes 
3'UTR Sequence of Forward Primer (5' to 3') 
Sequence of Reverse Primer 











   
 Primers used to clone Smad5 and Ywhag CDS 
CDS Sequence of Forward Primer  (5' to 3') 
Sequence of Reverse Primer  







   
 siRNA sequences 
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1. Discussion 
Advances in miRNA research have been limited by the ability to predict 
biologically relevant miRNA-mRNA interactions. This is still one of the most 
challenging issues in this field. Overcoming this bottleneck will allow 
comprehensive and accurate identification of miRNA biological functions. 
In this thesis an integrated framework of biochemical experimentation and 
bioinformatic analysis was developed to provide the first high-confidence 
genome-wide map of direct miR-200c target genes. The biological role of 
some of these novel miR-200c target genes was also investigated. 
Together, these results reveal how miR-200 regulates EMT and cell 
adhesion, which are linked to development and tumor metastasis. 
Importantly, this framework can be used to identify the genome-wide 
targets of other miRNAs. In this chapter the main advances achieved in this 
thesis are discussed and their inherent limitations highlighted. 
1.1. Bi-miR-200c pull-down false-positive rate 
The false-positive rate of the Bi-miR-200c PD was estimated to be 15.6%. 
This false-positive rate is similar to an estimate made for the specificity of a 
similarly-performed Bi-miR-34a PD, where only 1 of 11 (9%) of a random 
list of putative miR-34a-regulated targets was not verified1. The false-
positive rates of bioinformatic target prediction tools such as the refined 
versions of TargetScan, PicTar and miRanda are higher (between 22 and 
31%2). Studies in which miRNAs were co-immunoprecipitated with Ago 
proteins have much higher false-positive rates (~40-70%3). More-recent 
Ago HITS-CLIP methods for miRNA target identification have false-positive 
rates comparable to ours (~13–27%3). Given that the PD method is much 
simpler than Ago HITS-CLIP methods (does not require cross-linking, it is 
easier to perform and requires many fewer cells) it has the potential to be 
the method of choice for miRNA target discovery. 
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1.2. miR-200c-regulated pathways 
The framework developed in this thesis was used to generate the first 
genome-wide map of miR-200c-regulated pathways. The most significantly-
enriched pathways (adjusted P<0.01) were EGFR and MAPK signaling 
among thirteen significantly-enriched pathways (Figure 1d). Results show a 
predominance for EMT and cell adhesion-related signaling pathways that 
are targeted by miR-200. Some signaling pathways are involved in both 
EMT and cell adhesion. Specifically, EGF, sphingosine-1-phosphate (S1P), 
TGF-β and HGF ligands are known to induce EMT4-6. Additionally, MAPK 
signaling pathways mediate the EMT-inducing Smad-independent TGF-β 
response, in which TGF-β induces EMT through MAPK signaling instead of 
the canonical Smad signaling pathway for Smad-independent TGF-beta 
responses7. Our results also show that miR-200 regulates cell adhesion by 
targeting the integrin-mediated cell adhesion pathway that mediates cellular 
interactions with the extracellular matrix. miR-200 also regulates cell 
adhesion by silencing the S1P receptor signaling pathway, which regulates 
expression of adhesion molecules8, and it also silences both sphingolipid 
and cholesterol biosynthesis pathways required by the S1P receptor 
signaling pathway. Three enzymes involved in amino acid metabolism, 
frequently altered in cancer cells, were also putative miR-200 targets. 
T/B cell receptor, interleukin-3 (IL-3, mainly active in hematopoietic stem 
cells) and Kit signaling pathways (mainly active in hematopoietic stem cells, 
mast cells, melanocytes and germ cells) are not expressed in these cells, 
but were found to be significantly enriched by the pathway enrichment 
analysis algorithm due to the fact that these signaling pathways share the 
same downstream molecules as the EGFR and MAPK pathways. 
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1.3. miR-200c effect on Snail1 protein 
In this thesis we found that miR-200c had no effect on Snail1 protein 
(Figure 15g) as confirmed by an independent study9, even though miR-
200c down-regulated Snail1 mRNA by ~40% and a functional MRE was 
identified in the Snail1 3’UTR. This raises the question of why some targets 
are more responsive to a given miRNA than others. In the current miRNA 
action-mechanism model, miRISC silences target mRNAs mostly through 
mRNA degradation10. Therefore, genes that are transcribed into mRNAs 
with long half-lives are more sensitive to miRNA silencing than genes that 
are transcribed into mRNAs with short half-lives. Accordingly, Snail1 mRNA 
is a very labile mRNA that is translated into a similarly labile protein, both 
with very short half-lives (Snail1 mRNA half-life is ~15 min11 and Snail1 
protein half-life is ~25 min12). Therefore, the short-lived Snail1 mRNA likely 
makes it less sensitive to miR-200c-mediated regulation. Therefore, no 
miR-200 effect on Snail1 protein was observed. Also, as previously 
mentioned, post-translational modifications that increase Snail1 protein 
half-life might counteract miR-200c-mediated down-regulation of Snail1 
mRNA. Additionally, Snail1 by itself has no transcriptional repressor activity 
and requires other cofactors (14-3-3 proteins, Prmt5, Ajuba, Smad3, 
Smad4, etc) bound together in a protein complex to exert its activity. Some 
of these cofactors (Ywhab/14-3-3β and Ywhag/14-3-3γ) were found in this 
thesis to be silenced by miR-200c. Therefore, miR-200c-mediated silencing 
of these cofactors might counteract Snail1 repressor activity without 
changes in Snail1 protein. This phenomenon of a miRNA targeting several 
components of a protein complex, as found in this thesis for the Zeb2 and 
Snail1 transcriptional repressor complexes, is observed for other miRNAs13. 
It suggests that miRNAs coordinately silence multiple proteins of the same 
complex as a redundant fail-proof system to alter a biological state rapidly 
and unequivocally. 
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1.4. Regulation of E-cadherin expression by Ywhag and Smad5 
E-cadherin expression is a hallmark of MET14 and this thesis shows that 
miR-200c-mediated silencing of Smad5 and Ywhag activates transcription 
from the E-cadherin promoter inserted into a reporter vector (Figure 15b). 
However, when Smad5 and Ywhag (14-3-3γ) mRNAs are silenced by 
siRNA, endogenous E-cadherin expression does not change at the mRNA 
or protein levels (Figures 16d and 16e). These results suggest that the 
overlapping functions between members of the Smad and 14-3-3 protein 
families can compensate for the loss of one of the members to maintain the 
phenotype and homeostasis. Specifically, Zeb2 binds to several Smad 
proteins (Smad1, -2, -3 or -513) and Snail1 binds to five of the seven 14-3-3 
mammalian protein family members (14-3-3γ, ε, τ, η, β15). Therefore, lack of 
one single family member, as exemplified by our results for individual 
Smad5 and Ywhag knock-down, might be readily compensated by another 
family member in order to maintain cell homeostasis. In another set of 
experiments, over-expression of miR-200-resistant Smad5 slightly reduced 
miR-200c-mediated epithelial gene upregulation, and expression of miR-
200-resistant Ywhag had no measurable effect (Figure 16b). This 
apparently minor role for Smad5 and Ywhag in mediating miR-200c-
epithelial gene upregulation could be due to lack of function of the over-
expressed recombinant Smad5 and Ywhag proteins. Even though 
recombinant Smad5 and Ywhag protein over-expression was confirmed by 
immunoblotting analyses (Figure S2c), no functional assays were 
performed to confirm whether these over-expressed proteins are as active 
as the endogenous ones. Both over-expressed recombinant Smad5 and 
Ywhag proteins need to be translocated into the nucleus to regulate 
epithelial gene expression and this was not confirmed. Therefore, it cannot 
be concluded that miR-200-induced epithelial gene upregulation is indeed 
mediated by Ywhag. For Smad5, on the other hand, our results show some 
contribution to mediating miR-200-induced epithelial gene upregulation. 
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Considering the experimental caveats mentioned above, Smad5 might 
even play a stronger role in miR-200-mediated MET than our results 
suggest. 
2. Conclusions 
Based on the work within this thesis, the following conclusions can be 
outlined: 
• The miRNA-target discovery framework developed in this thesis has 
the potential to be the method of choice for miRNA target discovery 
due to its simplicity and low false-positive rate; 
• The framework developed in this thesis identified 520 novel miR-
200 putative target genes and revealed that miR-200 predominantly 
regulates EMT and cell adhesion, processes linked to development 
and tumor metastasis; 
• Twelve genes (Crtap, Fhod1, Smad2, Map3k1, Tob1, Ywhag/14-3-
3γ, Ywhab/14-3-3β, Smad5, Zfp36, Xbp1, Mapk12 and Snail1) were 
experimentally validated as novel miR-200c targets and their miR-
200c recognition elements were precisely identified; 
• We found that miR-200 induces RNA polymerase II localization and 
reduces Zeb2 and Snail1 transcriptional repressor complexes 
binding to epithelial gene promoters by silencing multiple members 
of these complexes; 
• Three novel miR-200 target genes identified in this thesis (Smad5, 
Ywhag and Crtap) were shown for the first time to have an 
important role in regulating cell invasion; 
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Together, the results shown in this thesis make a contribution to the study 
of both miR-200 and EMT and will be the springboard for future 
mechanistic and biological investigations. Importantly, the miRNA-target 
discovery framework developed in this thesis could be used to identify the 
targets of other miRNAs and better understand their biological functions. 
3. Future work 
This thesis provided the first genome-wide map of miR-200c target genes 
and investigated the biological role of some of these novel target genes. As 
only some of the 520 novel miR-200c target genes identified in this thesis 
were experimentally validated, it would be important to experimentally 
validate more of these putative target genes and study their role in miR-
200-mediated biology. This might unravel novel and unexpected biological 
functions for these genes. Also, applying the framework developed in this 
thesis to other members of the miR-200 family would identify the 
overlapping and non-overlapping roles of the several miR-200 family 
members. 
Additional in vitro studies could better clarify the role of Smad5 and Ywhag 
in mediating miR-200-induced epithelial gene upregulation. For example, 
co-immunoprecipitation (co-IP) experiments to identify Zeb2 and Snail1 
associated-proteins could confirm whether in 4TO7 cells Smad5 and 
Ywhag indeed associate with Zeb2 and Snail1 transcriptional repressor 
complexes. Also, repeating the ChIP assays performed in this thesis to test 
whether silencing of Smad5 and Ywhag by siRNA recapitulates miR-200-
mediated reduction of Zeb2 and Snail1 binding to epithelial gene promoters 
would undoubtedly help to clarify the role of Smad5 and Ywhag in miR-200-
mediated biology.  
Additional experiments would help understand the role of Crtap in cell 
invasion. Cotransfection of 4TO7 cells with an expression plasmid encoding 
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miR-200-resistant Crtap together with control miRNA or miR-200c would 
test whether miR-200-resistant Crtap can block miR-200 inhibitory effect on 
cell invasion, which would mean Crtap is required for miR-200-mediated 
effect on cell invasion. Also, as loss of Crtap abolishes prolyl 3-
hydroxylation of type I collagen which mainly affects collagen-protein 
interactions16, it would be important to test if this collagen modification is 
indeed altered in miR-200-transfected cells and in miR-200-expressing 
tumors. Also, it could be tested whether miR-200 over-expression or Crtap 
knockdown decrease the amount of decorin-bound TGF-β in the ECM, as 
release of TGF-β by the ECM could induce EMT in nearby cells. 
Furthermore, performing in vivo metastasis assays using 4TO7 cells in 
which Smad5, Ywhag and Crtap were individually silenced by short-hairpin 
RNAs (shRNAs) would help understand the role of these novel target 
genes in mediating miR-200-induced metastasis formation. 
Together these additional experiments would undoubtedly help clarify the 
fascinating and unexpected roles of the miR-200 family. 
Chapter 1. Introduction 
156 
5. References 
1 Lal A, Thomas MP, Altschuler G, Navarro F, O'Day E, Li XL et al. Capture of microRNA-bound 
mRNAs identifies the tumor suppressor miR-34a as a regulator of growth factor signaling. PLoS 
Genet 2011; 7: e1002363. 
 
2 Ahmadi H, Ahmadi A, Azimzadeh-Jamalkandi S, Shoorehdeli MA, Salehzadeh-Yazdi A, Bidkhori G 
et al. HomoTarget: a new algorithm for prediction of microRNA targets in Homo sapiens. 
Genomics 2013; 101: 94-100. 
 
3 Chi SW, Zang JB, Mele A, Darnell RB. Argonaute HITS-CLIP decodes microRNA-mRNA 
interaction maps. Nature 2009; 460: 479-486. 
 
4 Xue L, Su D, Li D, Gao W, Yuan R, Pang W. miR-200 Regulates Epithelial-Mesenchymal 
Transition in Anaplastic Thyroid Cancer via EGF/EGFR Signaling. Cell Biochem Biophys 2014. 
 
5 Khan KN, Kitajima M, Hiraki K, Fujishita A, Nakashima M, Masuzaki H. Involvement of hepatocyte 
growth factor-induced epithelial-mesenchymal transition in human adenomyosis. Biol Reprod 
2015; 92: 35. 
 
6 Milara J, Navarro R, Juan G, Peiro T, Serrano A, Ramon M et al. Sphingosine-1-phosphate is 
increased in patients with idiopathic pulmonary fibrosis and mediates epithelial to mesenchymal 
transition. Thorax 2012; 67: 147-156. 
 
7 Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family 
signalling. Nature 2003; 425: 577-584. 
 
8 Kimura T, Tomura H, Mogi C, Kuwabara A, Ishiwara M, Shibasawa K et al. Sphingosine 1-
phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion 
molecules in endothelial cells. Cell Signal 2006; 18: 841-850. 
 
9 Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celia-Terrassa T et al. Direct targeting of 
Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat 
Med 2011; 17: 1101-1108. 
 
10 Guo H, Ingolia NT, Weissman JS, Bartel DP. Mammalian microRNAs predominantly act to 
decrease target mRNA levels. Nature 2010; 466: 835-840. 
 
11 Boettiger AN, Levine M. Rapid transcription fosters coordinate snail expression in the Drosophila 
embryo. Cell Rep 2013; 3: 8-15. 
 
12 Zhou BP, Deng J, Xia W, Xu J, Li YM, Gunduz M et al. Dual regulation of Snail by GSK-3beta-
mediated phosphorylation in control of epithelial-mesenchymal transition. Nat Cell Biol 2004; 6: 
931-940. 
 
13 Sass S, Dietmann S, Burk UC, Brabletz S, Lutter D, Kowarsch A et al. MicroRNAs coordinately 
regulate protein complexes. BMC Syst Biol 2011; 5: 136. 
 
14 Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA. Loss of E-cadherin promotes 
metastasis via multiple downstream transcriptional pathways. Cancer Res 2008; 68: 3645-3654. 
 
15 Hou Z, Peng H, White DE, Wang P, Lieberman PM, Halazonetis T et al. 14-3-3 binding sites in the 
snail protein are essential for snail-mediated transcriptional repression and epithelial-mesenchymal 
differentiation. Cancer Res 2010; 70: 4385-4393. 
 
16 Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M et al. CRTAP is required for 
prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell 2006; 127: 
291-304. 
 
 
